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Abstract 
 
 
Towards the Total Synthesis of ()-Gephyrotoxin 287C 
 
By 
 
Maciej E. Domaradzki 
 
 
Advisor: Prof. Stephen Philip Fearnley 
 
Studies directed toward the total synthesis of ()-Gephyrotoxin 287C are described 
herein. Even though the target alkaloid has been synthesized four times to date, it still presents an 
interesting synthetic challenge. Our ultimate goal is to develop an efficient enantioselective 
synthetic route utilizing oxazolone chemistry in order to demonstrate its utility as a dienophilic 
component in intramolecular Diels-Alder reactions. This is part of a greater ongoing study aimed 
at a range of suitable alkaloid targets.  
Chapter 1 provides introduction to frog toxins as secondary metabolites and 
subsequently shifts to the target alkaloid. ()-Gephyrotoxin 287C was originally described by 
Daly and Witkop in 1974 following isolation from the skin of the southwestern Columbian 
poison arrow frog Dendrobates histrionicus.29 Its discovery, isolation structure elucidation and 
biological activity are discussed.  
Chapter 2 delivers detailed accounts of four total and seven formal synthesis of the 
target alkaloid to date. Previous synthetic works were an abundant source of valuable ideas that 
expedited our synthetic efforts.   
 Chapter 3 describes overall retrosynthetic approach to ()-Gephyrotoxin 287C buoyed 
by successful completion of ()-2-epi-Pumiliotoxin C in our lab.164 The initial stage of the 
iv 
 
synthesis (formation of cis-cycloadduct) mimics approach developed by  
Dr. Thongsornkleeb164, a post-doc in our laboratory, but diverges entirely afterwards.  
 Chapter 4 presents the synthetic methods employed to tackle the challenge of  
()-Gephyrotoxin 287C synthesis. It begins with preparation of the key triene followed by 
experimental and theoretical studies of intramolecular [4 + 2] Diels-Alder cycloaddition to 
generate desired cis-decahydroquinoline framework. Afterwards it splits into a model study of 
formation of the pyrrolidine C-ring via tandem elimination/ring closure and cyclopropanation 
studies. The bulk of presented work, however, is dedicated to rather simple, one might say, 
cyclopropane rupture. In spite of numerous attempts and subsequent model studies which proved 
vain reiteratively the last “to be or not to be” struggle provided genuinely desired ring rupture in 
regiospecific manner.   
Chapter 5 concludes completed synthetic efforts and offers a detailed plan for future 
studies, partially completed, that would lead to the total synthesis of ()-Gephyrotoxin 287C. 
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   “In the middle of difficulty lies opportunity” 
 
- Albert Einstein 
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Chapter 1 
1. Introduction 
1.1 Natural Products 
During the course of chemical evolution, nature has developed a rich diversity of 
secondary metabolites commonly referred to as natural products. Distinct from primary 
metabolites, these organic compounds are not directly involved in the regular growth, 
development or reproduction of an organism and their absence does not necessary constitute 
instantaneous death; rather they may or may not lead to chronic impairment of the organism’s 
survivability or fertility.
1,327 
Moreover, secondary metabolites play a vibrant chemo-ecological 
role in day-to-day routines of numerous organisms acting as toxins, anti-feedants, repellents and 
attractants, as means to determine species’ survival or demise.1,327  
A classical instance of a secondary metabolite are the alkaloids; basic nitrogen-containing 
organic compounds ordinarily isolated from plants, and later fungi, bacteria and animals, both 
terrestrial and marine. Numerous alkaloids are characterized by assorted varieties of convoluted 
structural intricacies and architecture which translate to potent yet vastly specific biological and 
pharmacological activities, offering much potential for therapeutic applications. Indeed, 
systematic studies, adaptations and modifications of alkaloids have introduced a plethora of 
medicinal agents with beneficial and thus desired physiological properties and continue to be the 
one of foremost sources of inspiration for drug discovery and design. Nevertheless, quality, in a 
universal sense, is intermittent and nature’s precious offerings do unfortunately come in 
miniscule quantities. Relative scarcity of alkaloids from ecologically sensitive natural sources is 
a major impediment; hence this may be solved in vitro – by methodical development of an 
alternative total synthesis within a laboratory environment. Given the current immense 
knowledge and ceaseless advances in synthetic methods and the superfluity of available chemical 
reagents, do allow for arduous yet rewarding development and improvement in synthetic 
methodologies to assist in the total synthesis of alkaloid natural products is a viable goal. 
1.2 Frog Toxins 
 Aposematism, as an evolutionary adaptive trait transpires when conspicuous appearance, 
serves to advertise potential risk of a prey to potential predator, for instance, anti-predator 
warning coloration.
2,328
 The best known examples are the neo-tropical poison dart frogs of the 
genus Dendrobatidea (meaning ant specialists). The common name for these miniature 
amphibians (one and a half to six centimeters long and weighing about two grams)
3
 was derived 
from indigenous use of their toxic secretions in the tips of blow darts and poison arrows. These 
frogs are endemic to humid, tropical environments of Central and South America (Bolivia, Costa 
Rica, Brazil, Colombia, Ecuador, Venezuela, Suriname, French Guiana, Peru, Panama, Guyana 
and Nicaragua)
4
 and prefer to live on or close to the ground.
5
  
Dendrobatides are characterized by vivid coloration patterns and variable toxicity 
dependent upon species, and this is directly linked to lipophilic alkaloids excreted from skin 
glands.
6
 Originally, it was believed that toxins were biosynthesized inherently in frogs.
7
 
However, further research in frog diet and habits resulted in a “dietary hypothesis” that the 
majority of frog alkaloids are actually sequestered from dietary sources.
7
 It was observed that 
while in captivity, poison dart frogs had a decreased quantity of alkaloids and captivity-bred 
frogs had almost no toxins whatsoever.
8-11
 This observation was originally attributed to lack of 
natural stress that might turn off biosynthetic machinery as a defense mechanism against 
predators.
 8-11 
In addition, experiments attempting to demonstrate biosynthetic synthesis of 
alkaloids in Phyllobates aurotaenia proved unproductive as injection of radioactive acetate, 
mevolonate, cholesterol, and serine into the frogs did not result in noticeable incorporation into 
secreted toxins.
12,13,14
 The quest for a reasonable answer to this puzzling observation linked 
variation in alkaloid profiles to variation in diet, normally consisting of ants, mites and other 
arthropods found in leaf-litter.
15,16
 To test this hypothesis, J. W. Daly, a pioneer in  
Dendrobatides alkaloid research, set up a series of lab and field based experiments.
7
  
Captive-raised and wild dendrobatid frogs were fed an alkaloid-rich diet based on fruit flies 
containing several alkaloids.
17-20
 The findings unequivocally proved that indeed the majority of 
toxins present in dendrobatid frogs do come from a leaf-litter diet supporting the original  
“dietary hypothesis”.7,19 To date, more than 800 alkaloids, derived from dietary sources  
(leaf-litter arthropod diet), have been detected in amphibian skin, representing over 28 structural 
groups in 11 major classes (Figure 1).
12,21-24
 Approximately 300 frog alkaloids have been directly 
linked to dietary sources (mites, ants, beetles and millipedes).
7
 The remaining 500 or so alkaloids 
still do not have confirmed point of origin.
3,7,21
 This “dietary hypothesis” has now been widely 
accepted but is not necessarily exclusive of alternate routes; for instance, in vivo alkaloid 
modifications or de novo biosynthesis.
7
 
 
 
Figure 1. Dendrobatides alkaloids arranged by structural class.
7
 
 
 
Many Dendrobatides alkaloids exhibit valuable and unique pharmacological properties.  
Lipophilic secretions can serve as muscle relaxants, heart stimulants or appetite suppressants as 
they affect conductance of mono-sensitive and voltage-sensitive channels of nerves and 
muscles.
25-28
 One such example is ()-Gephyrotoxin 287C, or ()-GTX 1 (C19H29NO;  
287.4397 g/mol). Synthetic studies toward this alkaloid are the main focus of this dissertation 
(Figure 1).   
 
 
 
Figure 2. Structure of (+)-GTX 1 derived from Dendrobates histrionicus.326 
 
 
1.3 ()-Gephyrotoxin 287C 
1.3.1 Discovery and Isolation 
Gephyrotoxin was originally described by Daly and Witkop in 1974.
29
 It was first 
isolated from the skin of the southwestern Columbian poison arrow frog  
Dendrobates histrionicus.
29 
Methanol extracts from frog skin were washed with an acidic 
solution and extracted with chloroform, followed by column chromatography over silica gel. 
1100 frog skins afforded a mere 1.2 g of alkaloids.
29
 
The alkaloid’s name is derived from the Greek word “gephyra” meaning bridge27;  
it bridges two subclasses of dendrobatid alkaloids (Figure 3): the decahydroquinoline system of 
pumiliotoxin C or PTX 2 (in red) and the vinylacetylene side chain of histrionicotoxin 283A 3  
(in blue).
30 
Thus, the GTX’s name literally suggests marriage between the fused-core nitrogen 
functionality and an unsaturated five-carbon side chain.
30
 
 
 
Figure 3. Structures of Pumiliotoxin C and Histronicotoxin 283A. 
 
 
1.3.2 Structure Elucidation by X-Ray Crystallography 
 The overall structure was initially determined by X-ray crystallography in 1977
30 
from 
frog samples collected from Guayacana, Colombia in 1971 and further revised by Fujimoto and 
Kishi in 1981.
31 
It was established that ()-GTX 1 crystalized in primitive orthorhombic space 
group P212121 where primitive lattice consists of two-fold screw axis (21) along a,a two-fold 
screw axis (21) along b and a two-fold screw axis (21) along c; it is a cubic lattice stretched along 
two of its orthogonal pairs by two different factors generating a cube (Figure 4).
30,32
 
 
 
Figure 4. Primitive orthorhombic Bravais lattice. 
 
 
The absolute configuration (Figure 5) was accomplished with anomalous bromide anion 
scattering by molybdenum K-alpha emission (MoK - high energy incoming electrons displace 
an electron from L to K shell).
33 
However, some doubt remains as to whether the described 
stereoisomer was the major one secreted from the frog skin.
34
 
 
 
Figure 5. Absolute configuration of ()-GTX 1 as determined by x-ray diffraction analysis with torsional angles. 
 
 
The initial X-ray analysis by Daly
30 of (+)-GTX 1 sample obtained in 1971 suggested that the 
absolute configuration was levorotatory (Figure 5) but the actual optical rotation on that specific 
sample from 1971 was never measured.
34
 Skin extracts from 1974 obtained from the same 
population of Dendrobates histrionicus revealed levorotatory ([]D – 51.5) optical rotation.
34
 
However, first total synthesis of this specific enantiomer by Kishi et al.,
31
 starting from  
L- pyroglutamic acid 4, afforded product that had dextrorotatory optical rotation (Scheme 1).
34
 
This proved that the initial (+)-GTX 1 structured proposed by Daly was erroneous and possessed 
the opposite absolute configuration. 
 
 
Scheme 1. Revised structure of naturally occurring ()-GTX 1. 
 
 
Possible reasons related to confusion pertaining to actual absolute configuration of naturally 
occurring (–)-GTX 1 could stem from misinterpreted X-ray data, error in enantioselective 
synthesis, improper assignment of optical rotation sign or possibility that the naturally occurring 
enantiomer was subjected to X-ray analysis not as a signal crystal.
34,35 
1.3.3 Structure Elucidation by NMR Techniques 
 Further evidence of (+)-GTX 1 absolute configuration came from detailed and complete 
assignment of 
1
H and 
13
C spectra employing novel 2D NMR techniques.
25 
Nonetheless, 
characterization by NMR of the alkaloid 1 proved rather troublesome especially with assigning 
signals to multiple methylene units and also the low abundance of the natural product.
25  
The 
1
H ambiguity was resolved with a then-novel HOHAHA relay experiment  
(Homonuclear-Hartmann-Hahn)
36 
combined with standard homo- and heteronuclear  
2D correlation techniques.
25
 
 (+)-GTX 1 NMR analysis began with establishing a 
1
H – 1H connectivity map utilizing 
double-quantum filtered COSY (DQCOSY) where peaks with no double-quantum transitions 
(for instance, singlets) are suppressed, producing cleaner spectra than with standard COSY 
experiments (Figure 6). 
 
 
 
Figure 6. 500 MHz DQCOSY of high-field region of (+)-GTX 1. 
 
Standard 
1
H NMR, though informative, depicted severe overlap in 1.3 – 1.8 ppm region 
inhibiting proper peak assignment and thus required techniques that could reveal connectivity 
through more than three bonds.
25 
Phase-sensitive 
1
H – 13C correlation spectrum, even though 
performed on a low sample amount (8 mg) and at low NMR resolution, allowed for all  
13
C resonances to be assigned to 
1
H signals (Figure 7).
25
 
 
 
 
Figure 7. 
1
H & 
13
C Heteronuclear chemical shifts for (+)-GTX 1. 
The final perplexing 
1
H assignments were done via HOHAHA relay experiments – 1D 
homonuclear correlation (TOCSY1D).
36 
This particular approach is based on the concept of spin 
propagation via a homonuclear Hartmann-Hahn coherence transfer process
35,37 – resonance 
inversion of an isolated spin multiplet with 180 pulse and subsequent propagation through the 
1
H coupling network.
35,38,39 
The first set of 
1
H peaks analyzed by this new technique is shown in 
Figure 8. 
 
 
 
Figure 8. HOHAHA spectrum for H6, H7, H8, H13 transfers with various durations of propagation. 
 
 
 
 
Inversion of resonance for H13 signal (2.37 ppm) with 21 ms spin-lock (Figure 9) caused 
magnetization to propagate to its geminal partner (2.37 ppm) and to vicinal protons H14  
(5.98 ppm) and H6 (1.71 ppm) only.
25 
As mixing times were increased to 45 ms, multiplet H7 
appeared and at 120 ms two peaks at 1.52 ppm and 1.62 ppm and assigned to H8 signal.
25
 
 A second set of 
1
H peaks was analyzed in similar fashion (Figure 9). The focused was 
placed on transfer from H1.
25 
Short lock-spin (9 ms) revealed couplings of H1 to H11, H11, H2 
and H2.25 As propagation period was increased to 21 ms, methane protons for H12  
(3.65 ppm and 4.00 ppm) appeared. Further propagation to 33 ms revealed methine proton 
appearing at 2.55 ppm which was assigned to H3a as well as peak at 1.36 ppm attributed to H3.
25
 
The logic behind this assignment came from the fact that magnetization relay should occur via 
the geminal protons.
25
 Since peaks for H1, H2 and H2 were already described, the next relay 
connection must have been H3 multiplets at 1.35 ppm and 1.79 ppm.
25
 With signals for H3 and 
H3a known, H4 peaks were assigned by the previously established 
1
H – 1H connectivity map 
from COSY experiments.
25
 
 
 
Figure 9. HOHAHA spectrum for H2, H3, H3a, H11 and H12 transfers with various durations of propagation. 
 
 
NMR spectral assignment for (+)-GTX 1 was completed with the third set of HOHAHA 
experiments. The focused was placed on the transfer from H9a (3.33 ppm).
25
 Short lock-spin  
(9 ms) transferred magnetization to H5a and geminal protons H9 (1.45 ppm and 1.62 ppm) and 
this was further confirmed by COSY (Figure 10).
25 
As propagation periods were increased to  
21 ms, 33 ms, and 45 ms, resonances of H8 and H7 appeared in agreement with the first set of 
HOHAHA experiment.
25
 As before, the remaining signals of H5 (1.37 ppm and 1.71 ppm) were 
assigned based on previous COSY experiments.
25
 
 
 
Figure 10. HOHAHA spectrum for H7, H8, H9 and H5a transfers with various durations of propagation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The full spectral assignment for 
1
H and 
13
C resonances is presented in Table 1 and Figure 11. 
 
  position 
13
C shift (ppm) 
1
H shift (ppm)   
 
1 55.36 3.26 
 
 
2 26.26 1.72; 1.80 
 
 
3 30.93 1.36; 1.79 
 
 
3a 55.95 2.55 
 
 
4 32.16 1.18; 1.86 
 
 
5 26.01 1.37; 1.71 
 
 
5a 41.17 1.67 
 
 
6 39.34 1.71 
 
 
7 24.37 1.37; 1.50 
 
 
8 20.04 1.52, 1.62 
 
 
9 16.47 1.45; 1.62 
 
 
9a 50.33 3.33 
 
 
11 30.28 1.36; 2.07 
 
 
12 59.53 3.65; 4.00 
 
 
13 33.42 2.37; 2.67 
 
 
14 145 5.98 
 
 
15 109.32 5.49 
 
 
16 80.31 
    17 81.41 3.08   
 
Table 1. ()-GTX 1 1H & 13C chemical shifts. 
 
 
 
Figure 11. Structure of ()-GTX 1. 
1.3.4 Biological Activity 
 ()-GTX 1 possesses weak antimuscarinic activity and has been shown to interact with 
nicotinic acetylcholine receptor (NAChR) complex by interrupting neuromuscular transmission 
at neuromuscular junctions (Figure 12). This occurs by two discrete mechanisms: (a) blockage of 
potassium conductance of chemo- and voltage sensitive receptor-gated channels in its open 
conformation;
27,40
 (b) increasing affinity of nicotinic receptor for AChR leading to 
desensitization of the receptor-channel complex.
41,42
 
 
 
Figure 12. Structures of acetylcholine and nicotine. 
  
 
NAChR channels occur in electrically excitable membranes of nerves (neurons), ganglia 
and muscle.
40
 Muscle NAChR is comprised of two α-subunits and single β-,γ-,δ-subunits that are 
arranged to form a trans-membrane pore, conducting properties of which are governed by the 
binding of nicotinic agonists to a site at each of the two α-subunits (Figure 13).40,43 
 
 
Figure 13. Mode of operation of NAChR complex. Adapted from [44]. 
 
 
Evidence of neuromuscular transmission interruption by ()-GTX 1 came from end-plate 
currents (EPC) experiments to Rana pipiens frog sciatic nerve in muscles.
42
 The sartorius 
muscles were stimulated both indirectly via the sciatic nerve (0.05 ms and 0.2 ms supramaximal 
rectangular  pulses) and directly (1 ms and 2 ms supramaximal rectangular pulses) at a rate of  
0.2 Hz.
42
 Action potential was measured with a microelectrode located 100 µm from the 
recording electrode by passing 30 ms depolarizing pulses.
42
 It was concluded that exposure of 
()-GTX 1 to sciatic nerve in sartorius muscle specimens decreased both the peak and amplitude 
of the EPC and τEPC (the channel's lifetime) by blocking the indirect muscle twitch  
(Figure 13).
42,45,46
 Specifically, a ()-GTX 1 concentration of 20 µM completely inhibited 
muscle twitch in approximately 30 minutes (Figure 14).
42
 Interference with potassium 
conductance in a concentration-dependent manner progressively blocked the AChR complex ion 
channel resulting in desensitization of the receptor-channel complex and establishment of a 
gigaohm seal (a high electrical resistance seal).
42,47,48,49
 
 
 
Figure 14. Effect of ()-GTX 1 on evoked twitch of the frog’s sciatic nerve in sartorius muscle. 
 
 
Interestingly, ()-GTX 1 did not penetrate into the channel to cause its blockage suggesting that 
the active form of the alkaloid was neutral.
42
 
 Further evidence supporting neuromuscular transmission interruption by desensitization 
came from studies on chronically denervated (deprivation of nerve supply by chemical or 
surgical means)  rat and frog soleus muscles as well as frog cutaneous muscle by measuring 
depolarization induced by microiontophoretically (locally) applied acetylcholine.
41
 It was 
determined that ()-GTX 1 facilitated formation of a desensitized state of AChR complex by 
increasing the alkaloid's affinity for the receptor.
41,50,51
 Again, ()-GTX 1 effect was determined 
to be dependent on agonist concentration as well as duration of exposure and frequency of 
stimulation.
41
 Specifically, exposure to 20 µM ()-GTX 1 caused a 18-fold reduction of 
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acetylcholine sensitivity in rat soleus muscle to 28.1 ± 3.8 mV/nC, as compared to a control 
value of 514 ± 44 mV/nC.
41
 Similar experiments on AChR complex were conducted on  
Torpedo californica (the pacific electric ray) organs using radio-labeled probes.
27
 Denervated 
striated muscle has a high concentration of nicotinic receptors and its biochemical properties 
resemble those found at the neuromuscular junction.
27
 It was verified that exposure to ()-GTX 1 
did indeed result in allosteric (non-competitive) alteration of receptor-gated channels in a 
concentration-dependent manner.
27,52,53
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
2. Previous Synthetic Work 
2.1 Total Synthesis 
This intriguing activity coupled with the scarcity of natural gephyrotoxin  
(15 mg from 3200 frogs)
54 
rendered it an attractive target for the synthetic community. The first 
total synthesis of racemic ()-GTX 1 was accomplished by Yoshito Kishi at Harvard University 
in 1980
55
 followed by an enantiospecific variant of the (+)-form in 1981.
31
 Immediately prior to 
this, both David Hart at Ohio State University
26
 and Larry Overman at the University of 
California, at Irvine
56
 published model studies toward related systems. Subsequent successful 
individual approaches were reported by Hart
26 
and Overman
53 
both in 1983. The last total 
synthesis was accomplished by Noritaka Chida from Keio University,  Japan in 2014.
57 
To date, 
seven formal synthesis have followed – by Hart (1981)58, Ito (1983)59, Pearson (2000)60, Hsung 
(2001)
61
, Lhommet (2008)
62
, Trudell (2010)
63 
and more recently by Spino (2013).
64
 A review is 
presented herein. 
 
2.1.1 Total Synthesis of ()-Perhydrogephyrotoxin  Prelude to ()-Gephyrotoxin 
Overman’s successful stereospecific total synthesis of ()-Pumiliotoxin C 265 established 
a simplified general entry to alkaloids containing cis-decahydroquinoline scaffolds such as those 
found embedded within tricyclic gephyrotoxin (Scheme 2). cis-decahydroquinoline 7 scaffold 
was derived from hydrogenation of imine 8 generated from cyclization of alkene 9 obtained from 
Diels-Alder reaction of N-acylamino-1,3-diene 10 and trans-crotonaldehyde 11.
65
 
 
 
Scheme 2. Construction of cis-decahydroquinoline core of 7. 
  
 
Overman’s initial approach to ()-perhydrogephyrotoxin 12, however, did not include 
imine 8 but N-acyliminium ion 14 (Scheme 3).
66
 
 
 
Scheme 3. Retrosynthetic analysis of ()-perhydrogephyrotoxin 12. 
 
 
During the initial phase of synthesis, it was discovered that addition of Grignard reagents to 
establish the correct stereochemistry at C3a position occurred from undesired, more sterically 
hindered concave -face (Scheme 4).66 
 
 
Scheme 4. Undesired axial attack conundrum.  
 
 
The undesired stereochemical outcome was attributed to interplay of stereoelectronic control  
(a preference for initial trans-axial alignment between approaching nucleophile and newly 
developing lone pair on nitrogen) and allylic A
(1,2)
 strain.
66,67,68
 Hence, a modified approach was 
developed relying on formation of the C3 – C3a bond via a 2-azonia-[3,3]-sigmatropic 
rearrangement in which iminium ion did not undergo re-hybridization.
66,69,71
 
The total synthesis commenced from Diels-Alder reaction of diene 19
71
 and dienophile
72 
20 to furnish a 10:1 mixture of endo and exo cycloadducts, 23 and 24, respectively, via 21 and 22 
transition states (Scheme 5).
66 
Consequent Wittig extension
73
 followed by acetalization
74 
afforded alkene 25.
66 
Hydrogenation over Pd/C furnished acetal 26 which was subjected to 
reductive amination
69
 to furnish amine 28 as a 1:1 mixture of distereoisomers.
66
 
 
 
Scheme 5. Synthesis of B-ring precursor 28. 
 
 
Exposure of amine 28 (Scheme 6) to heat in the presence of PTSA resulted in 2-azonia-[3,3]-
sigmatropic rearrangement
69,70
 of amine 28 via intermediates, 29, 30 and 31, to yield a 3:2 
mixture acetyl epimers 32.
66
 
 
 
Scheme 6. 2-azonia-[3,3]-sigmatropic rearrangement of amine 28. 
  
 
Following this, synthesis of ()-perhydrogephyrotoxin 12 ensued (Scheme 7). Tricyclic 
ketone 32 was dismembered to enone 33 in two step sequence and subsequently subjected to 
reduction and ortho ester Claisen rearrangement
75
 to afford ester 34.
66 
Selective O-debenzylation 
followed by Gilman’s extension76 allowed introduction of the n-pentyl side chain. Subsequent  
N-debenzylation and re-protection as a Troc-group furnished ester 35.
66 
A five-step sequence 
converted ester 35 into cyclic carbamate 36.
66 
Selenoxide elimination
77
 to introduce the  
,-unsaturated ester was followed by allylic reduction with concomitant carbamate removal 
generated amine 38 via intermediate 37.
66 
The final step involved generation of an  
,-unsaturated ester under basic conditions which underwent 1,4-Michael addition and further 
ester hydrolysis to yield a 8:1 mixture of  and  epimers of ()-perhydrogephyrotoxin 12, 
respectively.
77
 
 
 
Scheme 7. Finalizing synthesis of ()-perhydrogephyrotoxin 12. 
 Overman’s key strategy to ()-perhydrogephyrotoxin 12 approach was strengthened by a 
previously released model study on A
(1,3)
 strain in N-acyliminium ion cyclizations by Hart.
78 
This 
approach had been shown to be a strategic method in olefin cyclizations to establish a various 
scaffolds in alkaloid synthesis.
79-83
 
 Hart’s model study involved conversion of alkene 39 to tricyclic amides 41 – 44  
(Scheme 8). During the course of this investigation it was determined that only structure 41 
could adopt a conformation that would explain observed proton couplings between C4 and C5a 
hydrogens.
78
 
 
 
Scheme 8. Acid mediated N-acyliminium cyclization. 
 
 
 
It was concluded that two main factors may explain observed result: conformational preference 
and minimization of A
(1,3)
 strain.
78 
Conversion of alkene 39 to tricyclic amide 41 could proceed 
via two different chair-chair conformations 45 and 46 (Scheme 9) via common intermediate 40.
78 
Given the fact the vinyl group on alkene 41 occupies the axial site (as determined from 
1
H 
NMR), conversion of 45 to 47 would have a lower Eact and minimized A
(1,3)
 strain compared to 
conversion of 46 to 48 where a severe A
(1,3)
 would develop impeding the conversion.
78,84,85,86
  
 
 
Scheme 9. Minimization of A
(1,3) 
strain in N-acyliminium ion cyclization. 
 
 
To further evaluate effects of A
(1,3)
 strain on N-acyliminium ion cyclizations a supplementary 
study was conducted involving simplified carbinolamides (Scheme 10).
78 
Thus, two distinct 
alkenes 49 and 56 with two different substituents (phenyl and allyl groups) were subjected to 
acidic conditions (formic acid) to generate the quinolizidinones 54 and 61, respectively.  
Anew, A
(1,3)
 strain proved to be the driving force. Upon departure of water, both phenyl and allyl 
groups preferred to occupy axial positions in intermediates 50 and 57 versus equatorial positions 
in intermediates 51 and 58 in order to minimize allylic strain thus generating intermediates 52 
and 59 and not intermediates 53 and 60.
78 
The stereochemistry of 54 was established by 
conversion to a known structure 55
87,88,89
 and the stereochemistry 61 was confirmed by 
conversion to 62.
78
 In both instances, it was shown that that alkenes 49 and 56 with either phenyl 
and allyl groups underwent N-acyliminium ion cyclizations by adopting chair conformations 
wherein the C4 substituent occupied the axial position; this is contrary to olefin cyclizations 
where equatorial tethers were preferred in transition states resembling chair conformations of 
cyclohexanes.
90-95
 
 
 
 
Scheme 10. Effects of A
(1,3) 
strain on N-acyliminium ion cyclization. 
 
 
 
2.1.2 Kishi’s Racemic Approach (1980) 
Kishi’s approach expanded Overman’s total synthesis of  
()-perhydrogephyrotoxin 1266 and Hart’s model study for the ring construction of the same 
alkaloid.
78 
The overall retrosynthesis of Kishi’s approach is presented in Scheme 11.  
()-GTX 1 could be derived from Corey’s enyne extension96 of alcohol 63 resulting from 
reduction of ester 64. This was expected from a Grignard addition to ketone 65.  
The unique feature of this synthesis was the stereoselective introduction of five asymmetric 
centers via hydrogenation reactions. The key tactic employed the hydroxyethyl side chain as the 
stereochemical director in hydrogenation of vinylogous amide 66 in turn derived from ester 67,  
a simple derivative of protected succinimide obtained from amide 68.
55
 
 
 
Scheme 11. Kisih’s retrosynthesis of ()-GTX 1. 
  
The total synthesis commenced from amide 68 furnishing diester 67 (Scheme 12).  
The first two stereogenic centers (C1 and C3a) were introduced in 67 via hydrogenation over 
Pd/C catalyst with a 12:1 ratio of cis and trans pyrrolidines.
55 
Reduction and mono-benzylation 
of pyrrolidine 69 generated alcohol 70 as a racemic mixture; no attempt to desymmetrize was 
made at this time. Subsequent coupling of 70 to cyclohexane-1,3-dione 71 furnished ketone 72 
which was converted to key tricycle 66 (the so-called “Kishi’s intermediate”). The overall yield 
of 66 from 68 was reported as roughly 16% over 12 steps.
55
 
 
 
Scheme 12. Synthesis of Kishi’s intermediate 66. 
 
Initial hydrogenation of enaminone 66 (Scheme 13) over 10% Pd/C resulted in over-reduced 
alcohol 73 in 51% yield and deoxygenated amide 74 in 19% yield.
55 
However, a change of 
catalyst to Pt/Al2O3 (followed by primary alcohol acetylation) proceeded with reversal of the 
stereoselectivity to furnish mono esters, with a ratio of 1:12 for 75 and 73, respectively.
55 
Swern 
oxidation
97,98,99
 followed by Grignard addition and acetal de-protection generated ester 76, E/Z 
ratio of 1:1.
55
 
 
 
Scheme 13. Generation of enyne precursor 76. 
 
Hydrogenation of ester 76 posed yet another stereoselectivity problem (Scheme 14).
55 
Acetylation of ester 76 was followed by hydrogenation (4.1 atm) over 5% Rh/Al2O3 and 
subsequent reduction with Li/NH3, protection of the C12 hydroxy and ester reduction furnished a 
1:35 mixture of alcohols 77 and 78, respectively.
55
 Reversal of this undesired stereoselectivity 
was surprisingly achieved by first protecting C12 hydroxy with the bulky silyl group  
(this blocked the convex -face of ester 76 promoting concave -face hydrogenation as 
illustrated by structure 79) followed by hydrogenation at 1 atm versus 4.1 atm. Subsequent ester 
reduction generated a 10:1 mixture of alcohols 77 and 78, respectively, but with a 3.5 fold loss of 
diastereoselectivity.
55
 
 
 
 
Scheme 14. Overriding stereoselectivity with flanking effect. 
 
 
 
 
This stereochemistry was confirmed by known conversion of alcohol 77 to  
()-perhydrogephyrotoxin 12 and NMR, IR, MS and TLC comparisons (Scheme 15). 
 
 
Scheme 15. Conversion of alcohol 77 to ()-perhydrogephyrotoxin 12. 
 
 
Following this, synthesis of ()-GTX 1 ensued. Alcohol 77 was oxidized to an aldehyde, 
extended by Wittig protocol and hydrolyzed to yield unstable aldehyde 80 which was 
subsequently converted to cis-enyne via Corey’s method96 to yield ()-GTX 1 (Scheme 16).55 
The first total synthesis of alkaloid 1 was thus obtained in 26 steps with overall yield of less than 
3.9% (three conversions from ester 76 to alcohol 77 had no reported yields) with 14 steps to 
construct Kishi’s intermediate 66 with 16% yield.55 
 
 
Scheme 16. Finalizing the synthesis of ()-GTX 1. 
 
2.1.3 Kishi’s Asymmetric Approach (1981) 
The first total synthesis of ()-GTX 1 raised some questions about its true absolute 
configuration.
31 
The original stereochemistry assigned by Daly and Wiktop
30 
arose from studies 
of the HBr salt and utilized anomalous scattering of bromide anion. Thus, presumably, naturally 
occurring ()-GTX 1 as presented in Figure 15.  
 
 
Figure 15. Proposed structure of naturally occurring ()-GTX 1. 
 
 
To put the absolute configuration dilemma to rest, Kishi revisited his original synthesis of  
()-GTX 1 but utilized an optically active starting material with known absolute configuration to 
obtain Kishi’s intermediate 66.31,55 
This commercially available optically active starting material of choice was  
L-pyroglutamic acid 4 which was converted to nitrile 81
100
 in 4 steps (Scheme 17).
31
 Conversion 
of nitrile 81 to thiolactam, followed by an Eschenmoser sulfide contraction
101
 and  
de-acetylation
102
 yielded ester 82.
31 
Hydrogenation over 5% Pt/C furnished a 2.3:1 ratio of  
cis/trans pyrrolidines 83 (desired) and 84, respectively. Compound 83 was cyclized in 3 steps to 
85, then reduced to amine 86.
31 
As previously described,
55  
transformation of amine 86 to Kishi’s 
key intermediate 66 took 4 steps.
31 
Conversion of ketone 66 to (+)-GTX 1 in 15 steps
55  
afforded 
the target alkaloid 1 in its dextrorotatory form [D +50.0, c = 1.0 (EtOH)] where by naturally 
occurring ()-GTX 1 was deduced to be levorotatory [D -51.5, c = 1.0 (EtOH)].
31
 Kishi’s 
intermediate 66 was obtained in 19 steps but no yields were reported. 
 
 
Scheme 17. Finalizing synthesis of Kishi’s intermediate 66.  
 
 
 
 
 
 
 
 
 
 
2.1.4 Hart’s N-acyliminium Ion Approach (1983) 
The second total synthesis of ()-GTX 1 was reported by David J. Hart in 1983.26  
It followed his previous formal synthesis of the same alkaloid 1 in 1981
58
; an initial model study 
had yielded nor-pentylperhydrogephyrotoxin 87 (Figure 16) based on his previously established 
methodology.
103
 
 
 
Figure 16. Structure of nor-pentylperhydrogephyrotoxin 87. 
 
 
Hart’s approach tackled the question of stereocontrol by first establishing the relative 
stereochemistry at C6, C5a and C9a centers (Scheme 18); transposing appropriate 
stereochemistry to C3a using an N-acyliminium ion cyclization;
78,104
 and attaching the C1 tether 
in a stereo-controlled fashion.
26,58,103
 
 
 
Scheme 18. Hart’s retrosynthesis of ()-GTX 1. 
 
 
Model studies towards ()-GTX 158 and nor-pentylperhydrogephyrotoxin 87103 established that 
utilization of an N-acyliminium ion cyclization (e.g. compound 89) could provide a general route 
to bi- and tricyclic lactams 88 containing trans-2,6-dialkyl-N-acyl piperidines as subunits.
26 
Previous studies on Lythraceae alkaloids
105
 and indolizidines
106
 had shown that the preferred 
conformation of 2-substituted N-acylpiperidines set the C2 substituent axially to minimize A
(1,3)
 
strain
68
 making lactam 88 with its cis hydrogens more thermodynamically stable than its trans 
counterpart.
26
 
 Total synthesis of ()-GTX 1 commenced with commercially available cyclohexenone 90 
which was subjected to Diels-Alder cycloaddition with 1,3-butadiene in the presence of 
aluminum trichloride (AlCl3) as described by Wenkert
107
 and followed by reduction at low 
temperature to furnish a 9.2:1 ratio of alcohols 91 (desired) and 92, respectively (Scheme 19).
26
 
Subsequently Mitsunobu reaction
108 
generated axial imide 93 in which installation of three 
stereogenic centers (C6, C5a and C9a) was accomplished.
26
 
 
 
Scheme 19. Installation of three stereogenic centers in imide 93. 
 
 
Ozonolysis of imide 93 followed by reduction furnished diol 94 (Scheme 20).
26 
NMR studies of 
compound 94 showed that it adopted a chair conformation 95 with both alcohol tethers 
occupying axial positions, thus minimizing chances of oxepane formation.
26  
Bisdehydration of 
diol 94 utilizing Grieco’s protocol109,110 was followed by selective reduction to carbinolamide 
96.
26
 
 
 
 
Scheme 20. Assembly of key N-acyliminium precursor 96. 
 
 
Treatment of carbinolamide 96 with formic acid afforded lactam 99 via intermediates 97 and 98 
(Scheme 21).
26 
As previously noted,
78,103
 allylic strain effects and conformational preferences of 
cyclohexane were expected to reinforce each other in order during cyclization of N-acyliminium 
ion 97 to generate lactam 99.
26 
Removal of formic acid residue by saponification followed by 
xanthate formation and reduction yielded lactam 100.
26
 
 
Scheme 21. Formation of the key lactam 100 via N-acyliminium cyclization. 
Treatment of lactam 100 with Lawesson’s111 reagent and subsequent alkylation afforded iminium 
salt 101 which upon treatment with triethyl amine and triphenylphosphine afforded urethane 102 
(Scheme 22).
26 
Reduction of ester double bond by sodium cyanoborohydride was predicted to 
generate mostly ester 103 due to stereoelectronic effect associated with known stability of  
trans-indolizidines.
26,112 
However, reduction gave a disappointing stereoselective control 
resulting in 2.8:1 ratio of esters 103 and 104, respectively.
26
 
 
 
Scheme 22. Synthesis of ABC framework 103. 
 
 
This undesired stereoselectivity was reversed by employing Kishi’s findings in his approach to 
()-GTX 155 where utilizing a remote functionality (C1 tether with bulky TBDPS group) 
controlled stereochemistry during reduction of a double bond (Scheme 23).
26
 Thus, urethane  102  
was converted to alcohol 105 and its protected version 108 and subjected to reduction using 
either sodium cyanoborohydride (NaBH3CN) or hydrogenation over 5% Pt/Al2O3.
26 
For the case 
of unprotected alcohol 105, it was determined that the tether at C6 had very little stereoselective 
effect (or remote control) on reduction of the double bond with either NaBH3CN or 
hydrogenation over 5% Pt/Al2O3 yielding roughly 1:2 or 2:1 ratio of ester 106 to 107, 
respectively.
26 
However, reduction of TBDPS-protected alcohol 108 did prove extremely 
effective under hydrogenolysis yielding a 24:1 ratio of esters 109 and 110, respectively. In 
contrast, bulky C6 tether had no practical effect on additional discernable effect on reduction 
when NaBH3CN was utilized, yielding ~ 2:1 ratio of esters 109 and 110, respectively.
26
 
 
 
Scheme 23. Reversal of undesired stereoselectivity by utilizing remote functionality (TBDPS group). 
 
 
The synthesis of ()-GTX 1 was completed by introduction of cis-enyne moiety utilizing 
Yamamoto protocol (Scheme 24).
113
 Deprotection
114
 of silyl ether 109 followed by Swern 
oxidation
97,98,99
 afforded aldehyde 111.
26  
Installation of TMS-protected enyne proceeded to yield 
a 9:1 ratio of cis/trans enynes 113 and 114, respectively. Final reduction of the ester and removal 
of the silyl group furnished ()-GTX 1.26 The second total synthesis of alkaloid 1 was thus 
completed in 24 steps with an overall yield of 0.9%.
26
 
 
 
Scheme 24. Finilizing synthesis of ()-GTX 1.  
 
 
2.1.5 Overman’s Iminium Ion Approach (1983) 
A third total synthesis was achieved by Larry E. Overman in 1983
56 
based on methodology 
previously applied to his earlier synthesis of ()-perhydrogephyrotoxin 12 in 1980.66,115  
()-GTX 1 was ultimately derived from decahydroquinoline 115.56 The key step was reduction 
of bicyclic iminium ion 116 from the sterically more congested concave -face in order to 
minimize A
(1,2)
 interactions
68
 between the C6 tether and C9.
56 Overman’s approach focused on 
the interplay of stereoelectronic and allylic conformational effects in octahydroquinolinium 116 
directing the steric course of the reaction of cyclic iminium ions
116
 with nucleophiles  
(Scheme 25).
56
 Such an arrangement forced the approaching hydride (intermediate 117) into a 
trans-diaxial alignment with the developing lone pair on nitrogen leading to decahydroquinoline  
115.
56
 Finally, iminium ion 116 was derived from an initial Diels-Alder reaction of diene 118 
and dienophile 119.
56
 
 
 
Scheme 25. Overman’s retrosynthetic approach to ()-GTX 1. 
 
 
Thus, the total synthesis of ()-GTX 1 commenced with commercially available  
2-pentyn-1-ol 120 which was extended to alcohol 121 and the alkyne subsequently partially 
reduced and oxidized
117
 to aldehyde 119 (Scheme 26).
56 
Thermal Diels-Alder cycloaddition of 
dienophile 119 and diene 118
118
 afforded a 9:1 mixture of desired endo-aldehyde 122 and 
undesired exo-product 123, respectively.
56
 
 
 
Scheme 26. Establishing pre-cis configuration of AB ring system. 
 
 
Aldehyde 122 was extended by reaction with sodium salt of ketophosphonate 124
119
 to furnish 
enone 125 (Scheme 27).
56 
Reduction of alkene 125 required copious amounts of trifluoroacetic 
anhydride (TFAA) in order to avoid hydrogenation from undesired convex face
65 
yielding 
intermediate salt 126 which under basic conditions afforded imine 127.
115
  
 
 
Scheme 27. Formation of hydroquinoline 127. 
 
 
Overman’s next key step was reduction of bicyclic imine 127 (Scheme 28).56 It was assumed that 
the nucleophilic species would be delivered preferably from more congested concave -face due 
to a preference for initial trans-axial alignment between approaching hydride and newly 
developing lone pair on nitrogen (Section 1.4.1.1).
66 
Stereoelectronically controlled delivery of a 
nucleophile could occur via two conformers 128 and 129 to furnish amines 130 and 131, 
respectively. Addition of a nucleophile to conformer 129 to furnish amine 131 would occur from 
less sterically congested convex -face in axial fashion in order to avoid severe A(1,2) interaction 
between Li and C9.
56 
Conversely, addition of a nucleophile to conformer 128 to furnish amine 
130 would occur from more congested concave -face in spite of unfavorable  
1,3-diaxial interaction developing  between C9 and approaching nucleophile as this is less severe 
than the A
(1,2)
 interaction
 
between Li and C9.
56
 A variety of reducing agents were tested under 
different conditions (solvents and temperatures) to achieve desired stereoselectivity.
56
  
It was determined that bulky (i.e. NaEt3BH) and weak (i.e. NaBH4) reducing agents preferred 
less the congested convex -face attack whereas LiAlH4 favored more congested concave -face 
if right reaction conditions were chosen (dr = 9:1 to 16:1 for 130 to 131, respectively).
56
 
 
 
Scheme 28. Contrasteric iminium 127 reduction to furnish amine 132. 
 
 
Installation of the C-ring with C1 side chain was achieved by a Michael-type protocol 
(Scheme 29).
56
 Amine 132 was protected by a Troc group 133 allowing hydrolysis of ketal and 
Wittig extension to enal 134.
56 
Protection of newly formed enal
74 
134 followed by removal of the 
amine protecting group under basic conditions
120 
furnished amine 135. This was subsequently 
hydrolyzed under acidic conditions to regenerate enal which, upon treatment with a base, 
underwent a Michael addition to generate the pendant aldehyde. This was reduced in situ to yield 
a 20:1 ratio of desired alcohol 136 and its epimer 137, respectively.
56 Overman’s synthesis of  
()-perhydrogephyrotoxin 12 had already established that formation of the C-ring via Michael 
addition of an enal gave greater stereoselectivity (dr = 20:1)
115
 than cyclization of an  
,-unsaturated ester which only proceeded with moderate stereoselectivity  
(dr = 8:1).
66 
Alcohol 136 was protected with a silyl group followed by cleavage of the MOM 
ether and subsequent Swern oxidation
97,98,99
 to aldehyde 138.
56 
Introduction of the cis-enyne 
moiety was accomplished by Corey and Rücker’s protocol121 upon which removal of both silyl 
groups afforded a 9:1 ratio of Z/E ()-GTX 1.56 The third total synthesis of alkaloid 1 was thus 
obtained in 22 steps with overall yield of 3.8%.
56
 
 
 
Scheme 29. C-ring formation and endgame. 
 
 
2.1.6 Chida’s Amide-Selective Nucleophilic Addition (2014) 
The most recent total synthesis of ()–GTX 1 was achieved by Noritaka Chida et al. in 
2014.
57 
This unique approach avoided numerous protecting group manipulations that plagued his 
predecessors, in order to establish desired stereogenic centers. Chida envisaged 
()-GTX 1 to be derived from intramolecular Michael addition on ester 140 in turn established 
via a key Kulinkovich-type procedure
122
 of amide 141 (Scheme 30).
57 
 
The cis-decahydroquinoline core of 141 would be established via radical cyclization of ester 142 
generated via another key Hosomi-Sakurai cyclization
130
 of amide 143 derived from carboxylic 
acid 144 via Grubbs metathesis.
57,123
 Chida’s approach was based on amide-selective 
nucleophilic addition previously developed by De Meijere et al.
124
 employing a key 
Kulinkovich-type
122
 cyclopropanation.
57  
 
 
 
Scheme 30. Chida’s retrosynthetic approach to ()-GTX 1. 
 
 
De Meijere et al. expanded this methodology to explore a range of tertiary amides as well 
as additional metals (zirconium) (Scheme 31).
124 
Subjecting Weinreb amide 145
125 
to Schwartz 
reagent
126,127 
resulted in formation of a five-member ring complex 146 which collapsed, upon 
treatment with acid, to iminium 147 that was subsequently attack by a Grignard reagent to yield 
acetamide 148.
57
 
 
 
Scheme 31. Conversion of amide to oxime employing zirconium species.  
 
 
Chida’s approach to Kulinkovich-type reductive allylation57,122 utilized modified version 
of De Meijere et al.
124 
methodology. Subjecting acetamide 145 to reductive allylation to furnish 
alkene 149 did not utilize a highly reactive Grignard reagent but rather a Lewis acid  
(to enhance electrophilicity of N-oxyiminium ion) that could be coupled with a milder 
nucleophile thus, providing better functional group compatibility (Scheme 32).
57
 Additionally, 
the choice of methoxy substituent on acetamide nitrogen 145 was deliberate as it was shown to 
act as a reactivity control element by increasing the nucleophilicity of the nitrogen atom.
57
 
 
 
Scheme 32. Kulinkovich-type rearrangement to generate key intermediate 149. 
 
Once key synthetic steps were established, synthesis of ()–GTX 1 commenced. 
Coupling of carboxylic acid 144 with N-methoxyamine gave amide 150 which was subsequently 
converted to alkene via cross metathesis
128,129
 to afford an E/Z mix of 151 (Scheme 33).
57 
Addition of bromo aldehyde generated intermediate 152 which in the presence of a Lewis acid 
underwent intramolecular Hosomi-Sakurai cyclization
130 
to furnish amide 154. Thus, the desired 
AB-cis-ring junction was established.
57 
Ozonolysis of alkene 154 to aldehyde 155 and extension 
to desired Z-enoates 157 and 158 was achieved via modified Ando et al. protocol.
131
 
 
Radical 
cyclization of Z-enoates 157 and 158 was an important step if desired ester 159 was to be 
obtained as a single diastereoisomer.
57 
Unpublished studies showed that employing E-enoate  
(not shown) variant afforded ester without diastereoselectivity (1:1) whereas Z-enoate provided a 
single diastereoisomer exclusively.
57
 
 Scheme 33. Synthesis of cis-AB ring framework 159. 
 
 
Establishment of the cis-decahydroquinoline core in 159 allowed for the key chemoselective 
reductive allylation.
57 
Ester 159 was subjected to Schwartz reagent
126,127
 to obtain a five-member 
chelate 160; this underwent subsequent tin-mediated allylation catalyzed by a Lewis acid via 
intermediate 161 to furnish alkene 162 in a chemo- and stereoselective manner (Scheme 34).
57 
Hydroboration of the resulting terminal alkene afforded alcohol 163 which was converted to  
E-enoate 164 via one-pot homologation employing Parikh-Doering oxidation
132
 and the Wittig 
olefination.
 
Removal of methoxide from nitrogen with zinc
56
 allowed for intramolecular  
aza-Michael addition to form pyrrolidine 165.
57 
The drawback of the last step, however, was 
poor diastereoselectivity (dr = 1.8:1).
57
 
 
 
 
Scheme 34. Synthesis of ABC ring system 165. 
 
 
Once the ABC ring system was established, efforts were directed at the end game (Scheme 35). 
Methyl ester on pyrrolidine 165 was selectively reduced in the presence of tert-butyl ester with 
sodium diisobutyl-t-butoxyaluminum (SDBBA)
134 
to afford aldehyde 166. This was further 
extended via Wittig chemistry
135,136
 to furnish alkene as a single stereoisomer 167.
57  
Sonogashira coupling
137
 installed the Z-eneyne moiety stereospecifically to generate alkyne 168, 
which underwent a final ester reduction to yield the target alkaloid 1.
57
 
 
 
Scheme 35. Finalizing synthesis of ()-GTX 1. 
 
The fourth total synthesis of alkaloid 1 was thus obtained in 20 steps with overall yield of 
17.8%.
57
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Four successful syntheses of ()-GTX 1 are summarized in Scheme 36.  
 
 
Scheme 36. Total syntheses of ()-GTX 1. 
 
 
 
 
 
 
 
2.2 Formal Synthesis 
2.2.1 Hart’s N-acyliminium Ion Cyclizatin (1981) 
 The first formal synthesis of ()-GTX 1 was proposed by David J. Hart in 1981.58  
It comprised of his previous model study of A
(1,3)
 strain effects in N-acyliminium ion 
cyclization
78
 and his synthetic approach to nor-pentylperhydrogephyrotoxin 12
78 
and thus served 
as a prelude to his own total synthesis of ()-GTX 1 in 1983.26 
Hart’s approach tackled the question of stereochemistry by first establishing the relative 
relationship of the C6, C5a and C9a centers (Scheme 37); transferring appropriate 
stereochemistry to C3a using an N-acyliminium ion cyclization;
78,104
 and attaching the C1 tether 
in a stereocontrolled fashion.
58,103 
Hart envisaged alcohol 77 to be derived from 
hydroboration/hydrogenolysis of alkene 102 obtained from N-acyliminium ion cyclization of 
amide 96.
58 
This in turn was generated from enone 169 furnished via Diels-Alder reaction of 90 
and 170 followed by epimerization.
58
 
 
 
Scheme 37. Hart’s retrosynthetic approach to ()-GTX 1. 
 
 
First formal synthesis of ()-GTX commenced with the Diels-Alder reaction of diene 170 
and enone 90 in the presence of a Lewis acid (with epimerization) and subsequent stereoselective 
reduction afforded alcohol 91 (Scheme 38).
58 
Subsequent Mitsunobu addition of succinimide 
furnished amide 93.
58 
Alkene ozonolysis coupled with reductive workup allowed furnished diol 
94.
58
 Introduction of bis-selenide, followed by dual elimination under peroxide conditions and 
reduction generated bis-alkene 96.
58
 Exposure to acidic conditions afforded N-acyliminium ion 
97 that underwent cyclization to amide 99.
58
 Removal of formic acid residue by saponification 
followed by xanthate formation and its reduction generated alkene 100.
58
 Treatment with 
Lawesson’s reagent furnished thiolactam 171.58 Subsequent alkylation in a two-step process 
yielded vinylogous ester 103 (no E/Z ratio reported).
58
 
 
 
Scheme 38. Synthesis of ester 103. 
 
With tricyclic scaffold 103 at hand, it was subjected to succeeding double bond/ester reduction 
and protection of resulting alcohol to afford alkene 172 (Scheme 39).
58 
Final hydroboration and 
oxidation resulted in alcohol 77 as previously synthesized by Kishi.
55,58
 
 
 
Scheme 39. Synthesis of Kishi’s alcohol 77.   
 
 
The first formal synthesis of Kishi’s alcohol 72a was obtained in 22 steps with an overall yield 
of 3.6%. 
2.2.2 Ito’s Intramolecular [4 + 2] Cycloaddition Approach (1983) 
The second formal synthesis of ()-GTX 1 was reported by Yoshikatu Ito in 1983.59 Ito’s 
approach was based on a Diels-Alder cycloaddition to establish an ABC ring system analogous 
to Kishi’s intermediate 66.59 This in turn was generated by hydrogenation of amine 173 derived 
from a cycloaddition reaction of alkene 174 generated from fluoride-anion induced  
1,4-elimination of ammonium salt 175 (Scheme 40).
59
 
 
Scheme 40. Ito’s retrosynthetic approach to ()-GTX 1. 
Thus, formal synthesis of Kishi’s intermediate 66 commenced with commercially 
available aniline 176 which was converted to amine 178 in three steps (Scheme 41).
59  
O-silylation followed by quaternization afforded quinone 179.
59 In the key step of Ito’s approach, 
a fluoride-induced 1,4-elimination yielded intermediate 174 which underwent subsequent 
intramolecular hetero Diels-Alder addition to furnish a 5:1 ratio of amines 173 and 181, 
respectively via transition state 180.
59
 
 
 
Scheme 41. Synthesizing ABC ring precursor 173. 
 
 
 
Desired amine 174 was converted to Kishi’s intermediate 66 (Scheme 42).59 Initial attempts to 
reduce the benzene ring employing Birch reduction with either Li or Na surprisingly returned 
unreacted starting material.
59 Adopting Kishi’s steps of the first total synthesis66, Ito utilized 
hydrogenation over Rh/Al2O3 catalyst to afford a 14:1:2 mixture of Kishi’s intermediate 66, its 
epimer 182 and alcohol 87, respectively.
59
 
 
 
Scheme 42. Synthesizing Kishi’s intermediate 66. 
 
 
The formal synthesis of Kishi’s intermediate 66 was thus obtained in 7 steps with overall yield of 
34.3%.
59
 
2.2.3 Pearson’s Intramolecular Schmidt Rearrangement (2000) 
The third formal synthesis of ()-GTX 1 was reported by William H. Pearson in 2000.60 
Pearson’s approach involved interception of Ito’s intermediate 174 by stereoselective reduction 
of iminium ion 183 as derived from Schmidt rearrangement reaction of the azido-alkene 184 
(Scheme 43).
60 
Generation of iminium ion 183 proceeded through a 1,2 aryl migration via 
intermediate 184.
60 
Obtainment of alkene 185 would arise from commercially available indanone 
186.
60 The attempt to efficiently synthesize Ito’s intermediate 174 was accompanied with 
rigorous studies of the stereoselectivity of iminium ion reduction as well as the regioselectivities 
of the both Schmidt reaction and indanone alkylation.
60
 
 
 
Scheme 43. Pearson’s retrosynthetic approach to ()-GTX 1. 
 
 
Formal synthesis of Ito’s intermediate 174 commenced with commercially available  
4-methoxyindan-1-one 186 (Scheme 44).
60 
Grignard addition, followed by 
mesylation/elimination and regioselective Brown oxidation
138
 afforded a 1.3:1 ratio of alkenes 
187 and 188, respectively.
60 
Swern oxidation employing Ireland’s protocol133 followed by 
Grignard addition furnished alcohol 189 as a single isomer.
60 
Generation of azide 190 was 
accomplished by standard SN2 reaction on mesylated alcohol 189.
60
 
 
 
Scheme 44. Generation of azido-alkene 190. 
 
 
The key reaction was conversion of azide 190 to amine 194 (Scheme 45).
60 
Intramolecular 
Schmidt’s rearrangement was initiated with triflic acid and proceeded via intermediate 191, 
involving the migration of the m-methoxyaryl group to generate a mixture of iminium ions 192 
and 193. These were subsequently reduced to furnish a 2:1 inseparable mixture of amides 194 
and 195, respectively as well as regiomeric amide 196.
60 
This results proved that Schmidt 
reaction could be efficiently applied to establish the ABC ring system of ()-GTX 1 but a bulkier 
group would be required to increase regioselectivity of the processes involved.
60
 
 
 
Scheme 45. Schmidt’s reaction to establish precursor to ABC ring system. 
 
 
This search for a more robust side chain resulted in a 2-bromoethyl group, predicted to withstand 
the high acidity of Schmidt reaction easily converted to a hydroxyl group without oxidation.
60 
Thus, 4-methoxyindan-1-one 186 was transformed to bromide 197 employing Taguchi
139
 and 
Williams
140
 protocols (Scheme 46).
60 
Inseparable mixture of Z/E = 2:1 bromides was converted 
to a Grignard species and added to an epoxide utilizing Kocienski protocol
141 
to afford alcohol 
199 as an inseparable mixture.
60 
Displacement of the 2 hydroxyl by azide and deprotection of 
the silyl ether furnished azide 200 once again as an inseparable mixture.
60 
Substitution of the  
1 hydroxyl group generated both bromide 201.60 
 
Scheme 46. Synthesizing Schmidt’s precursor 201. 
 
 
Once again, the key reaction was conversion of azide 201 to amine 203 (Scheme 47).
60
 Schmidt 
reaction was initiated with triflic acid and proceeded via intermediate 202 involving the 
migration of m-methoxyaryl group to generate a mixture of iminium ions 203 and 204 that were 
subsequently reduced under various conditions followed by acetylation and reduction to furnish 
alcohols 173, 181 and 205.
60 
In spite of changing a tether from alkene to bromide group, did not 
result in enhanced stereoselectivity of iminium ion reduction as envisaged.
60 
The best result was 
achieved with L-Selectride with the highest stereoselectivity for alcohol 173 but the lowest 
overall yield.
60
 
 
 
 
Scheme 47. Finalizing synthesis of Kishi’s intermediate’s precursor 173. 
 
 
The third formal synthesis of Kishi’s intermediate 66 was obtained in 14 steps with overall yield 
of 18%.
60
 
2.2.4 Hsung’s Asymmetric Intramolecular Formal [3 + 3] Cycloaddition Approach (2001) 
The fourth formal synthesis of ()-GTX 1 was reported by Richard P. Hsung in 2001 
(Scheme 48).
61
 A new methodology was proposed involving intramolecular formal [3 + 3] 
cycloaddition reaction of vinylogous amide with an enal, as in enal 206, thus intercepting Kishi’s 
intermediate 66.
61 
This approach is based on a sequence of reactions involving Knoevenagel 
condensation followed by electrocyclic ring closure (stereoselective intramolecular formal  
[3 + 3] cycloaddition
142
).
61 
ABC core precursor 206 was obtained from coupling of diketone 71 
with amine 207.
61
 
 
 
Scheme 48. Hsung’s retrosynthetic approach to ()-GTX 1. 
 
 
This formal synthesis of Kishi’s intermediate 66 commenced with commercially 
available ethyl 8-((tert-butyldimethylsilyl)oxy)-3-oxooct-6-enoate 208 which was converted to 
chiral amine 207 in four steps (not listed) (Scheme 49).
61
 Enamine formation with diketone 186 
followed by allylic oxidation and silyl protection afforded enal 189.
61 The key step of Hsung’s 
approach was conversion of enal 209 to Kishi’s intermediate 66 via intermediates 210, 211 and 
212, employing piperidinium acetate
143,144
 to promote intramolecular formal [3 + 3] 
cycloaddition. Subsequent hydrogenation and deprotection of the silyl group furnished a 3:2 
mixture of Kishi’s intermediates 66 and 182, respectively.61 
 
 
Scheme 49. Synthesizing Kishi’s intermediate 66. 
 
 
Despite this low selectivity, the fourth formal synthesis of Kishi’s intermediate 66 was 
thus completed in 10 steps with overall yield of 11.5%.
61
 
2.2.5 Lhommet’s Distereoselective Reduction of Chiral -Amino Ester (2008) 
 The fifth formal synthesis of ()-GTX 1 was reported by Gerard Lhommet in 2008 
(Scheme 50).
62 
The key aspect of this approach was interception of Kishi’s cis-2,5-disubstituted 
pyrrolidone 213 (precursor to Kishi’s intermediate 66). This was obtained by distereoselective 
reduction of chiral -amino ester 214, as generated from ketone 215 and chiral amine 216.62 
 
 
Scheme 50. Lhommet’s retrosynthetic approach to (+)-GTX 1. 
 
 
The synthesis commenced with commercially available methyl acetoacetate 215 (Scheme 
51).
62 
Alkylation of ester 215 with bromide 217 was achieved by Weiler’s protocol (proceeding 
with a dianion formation)
145
 to afford ester 218 which upon hydrolysis and protection with  
2-tetrahydropyranyl (THP) furnished ketone 219.
145  
Distereoselective condensation of ketone 
219 and (S)-phenylglycinol was accomplished under zinc chlorate catalyst in the presence of a 
drying agent
146
 to yield bicyclic chiral pyrrolidine -enamino ester 214 in moderate yield.62 
 
 
Scheme 51. Synthesizing key intermediate 213. 
The key step was diastereoselective reduction of pyrrolidine 214 following a previously 
developed protocol.
147 
This employed in situ generation of NaBH(OAc)3 which after reduction 
released 2 amine that was protected with a BOC group to generate amine 220 (Scheme 52).62 
Ester reduction was followed by benzylation then hydrolysis of the remaining protecting groups 
to yield amine 66.
62
 
 
 
Scheme 52. Diastereoselective reduction to form amine 213. 
 
 
Kishi’s intermediate 66 was finalized by condensation of amine 213 and cyclohexane-1,3-dione 
to afford enamine 72
66 
followed by intramolecular cyclization to furnish amine 221  
(Scheme 53).
62 Final hydrogenolysis generated desired Kishi’s intermediate 66.62 
 
 
Scheme 53. Finalizing synthesis of Kishi’s intermediate 66.  
 
The fifth formal synthesis of Kishi’s intermediate 66 was obtained in 13 steps with overall yield 
of 18%.
66
 
2.2.6 Trudell’s Distereoselective Reduction of Tropinone (2010) 
 The sixth formal synthesis of (+)-GTX 1 was reported by Mark L. Trudell in 2010.
63 
Once again, Trudell’s approach envisaged interception of Kishi’s intermediate 66, this time 
streaming from cis-2,5-disubstituted pyrrolidine 222 as obtained from tropinone derivative 223 
(Scheme 54).
63,148 
Interestingly, ketone 223 was readily available via degradation of cocaine 
224.
63,148,149
 
 
 
Scheme 54. Trudell’s retrosynthetic approach to (+)-GTX 1. 
 
 
The synthesis commenced with degradation product of cocaine 225 which was converted 
to silyl enol ether 223 (Scheme 55).
150 
Ozonolysis followed by reductive work-up and 
estrification afforded desired cis-2,5-disubstituted pyrrolidine 222 with the correct 
stereochemistry at C1 and C3a.
63
 
 
 
Scheme 55. Synthesis of cis-2,5-disubstituted pyrrolidine 222. 
 
 
Pyrrolidine 222 was first O-protected, then the ester 226 which underwent partially reduction to 
aldehyde 227 (Scheme 56).
63 
A one-carbon homologation generated aldehyde 228 which was 
coupled with a diketone utilizing Kishor and Ramachary’sprotocol151 to furnish pyrrolidine 
229.
63 
Subsequent hydrogenolysis over Pd/C allowed for simultaneous N-deprotection, 
cyclization and enamine formation to yield an inseparable 9:1 mixture of diastereoisomers 230 
and 231, respectively.
63 
Final desilylation afforded desired Kishi’s intermediate 66.63 
 
 
Scheme 56. Synthesis of Kishi’s intermediate 66. 
 
 
The sixth formal synthesis of Kishi’s intermediate 66 was thus obtained in 11 steps with 
overall yield of 22.1%.
63
 
2.2.7 Spino’s Photochemical Rearrangement of N-activated Lactam (2013) 
The seventh formal synthesis of (-)-GTX 1 was proposed by Claude Spino in 2013.
64 
Spino’s approach was based on photochemical and/or thermal rearrangement of N-activated 
lactams such as 232 to a new carbamate 233 or a new N-heterocycle 234 (Scheme 57), thus 
complementing Pearson’s formal synthesis60 which included Schmidt-type rearrangement 
(Lossen,
152,153,154
 Hofmann
155
 and Curtis
156
 rearrangements). 
 
 
Scheme 57. Rearrangement of activated lactams
.
 
 
 
Spino envisaged interception of Kishi’s intermediate (–)-66 by condensation of pyrrolidine  
235 obtained from ring cleavage of amide 236 (Scheme 58).
64
 The key step would be 
photochemical ring contraction of chloride amide 237 to generate alkene 236. This in turn, would 
be obtained from sequential [4 + 3] cycloaddition and Beckmann ring expansion
157
 on Favorskii 
intermediate generated from chloropentanone 238.
64
 
 
 
Scheme 58. Spino’s retrosynthetic approach to ()-GTX 1. 
 
 
The synthesis of Kishi’s intermediate (–)-66 commenced with commercially available 
chloropentanone 238 (Scheme 59). Conversion to a Favorskii intermediate 239, employing 
Föhlisch’s and Joachimi’s protocol158, which underwent [4 + 3] cycloaddition to afford ketone 
240.
64 
A Beckmann ring expansions
157 
generated lactam 241 which was N-chlorinated to yield 
237.
64  
Irradiation at low temperature allowed for desired ring contraction to furnish carbamate 
236
159,160 
through intermediates 242, 243 and 244.
64 
 
 
Scheme 59. Synthesizing key intermediate 236. 
 
 
Ozonolysis of carbamate 236 and subsequent reduction afforded diol 245 (Scheme 60).
64  
The next step involved enzymatic desymmetrization
161,162,163 
to furnish mono-protected 
pyrrolidine 235. This was achieved with Pseudomonas fluorescens (PFL) after a series of 
optimizations involving different enzyme systems.
64
 
 
 
Scheme 60. Ozonolysis and enzymatic desymmetrization. 
 
 
Oxidation of 235 under Swern conditions
97
 afforded aldehyde 246 which was coupled to  
1,3-cyclohexadione employing Trudell’s protocol63 to furnish diketone 247 (Scheme 61).64 
Hydrogenolysis of the Cbz group allowed for intramolecular condensation to generate 
enaminone 248 which after diestrification yielded desired Kishi’s intermediate (–)-66.64 
 
 
Scheme 61. Finalizing synthesis of epimer of Kishi’s intermediate (–)-66. 
 
The seventh formal synthesis of Kishi’s intermediate (–)-66 was obtained in 13 steps with 
overall yield of 1.3%.
64
 
 
 
These formal syntheses are summarized in Scheme 62.  
 
Scheme 62. Formal syntheses of ()-GTX 1 to Kishi’s intermediate 66. 
Chapter 3 
3. Synthesis of ()-Gephyrotoxin 287C 
3.1 Overall Retrosynthetic Approach 
The goal of this dissertation is to develop an alternative approach to the total synthesis of 
()-Gephyrotoxin 1. In doing so, we hope to demonstrate the utility of oxazolone as the 
dienophilic component in intramolecular Diels-Alder reactions with long lasting applications to 
suitable alkaloid targets.  
Our initial retrosynthetic approach is shown in Scheme 63. This study will be crucial in 
determining the final overall route to accomplish a later enantioselective synthesis of ()-GTX 1 
based on our racemix model study. 
Disconnection of the enyne side chain would lead to tricycle 249 as the final advanced 
intermediate in our route. It would contain the completed skeleton and necessary functionalities 
for further conversion to the final product. This system would be derived from carbamate 250 
which would undergo CO2 excision following intramolecular 1,4-Michael cyclization to form the 
pyrrolidine C-ring. Michael acceptor 250 would arise from standard oxidation/Wittig chemistry 
of alcohol 251. The desired stereochemistry at C6 would be installed by stereo- and 
regioselective scission of the corresponding cyclopropane 252 as derived from -facial selective 
cyclopropanation of alkene 253. Thus, cis-decahydroquinoline core 253 would be the expected 
product of intramolecular Diels-Alder cycloaddition (IMDA) of triene 254 presumably via an 
endo transition state 255 wherein C3a group would be held pseudo-axially in order to minimize 
allylic type-strain. 
 
 
 
 
Scheme 63. Retrosynthetic approach to ()-GTX 1. 
 
 
3.2 Synthesis of ()-2-epi-Pumiliotoxin C – The Precedent 
This overall synthetic strategy to (+)-GTX 1 is derived from the recent precedent
164 
from 
our laboratory based on our approach to decahydroquinoline alkaloid ()-2-epi-Pumiliotoxin C 2. 
These efforts delivered the unexpected result during the key IMDA with oxazolone as the 
dienophilic component as shown in Scheme 64. PTX 2 was envisaged to arise from excision of 
carbamate functionality preceded by face-selective cyclopropanation and subsequent 
regioselective rupture of alkene 256. We expected the desired cis-decahydroquinoline core of 
PTX 2 would result from IMDA of triene 258 via endo transition state 257 with C3a group held 
pseudo-equatorially in order to minimize 1,3-diaxial interactions. 
 
 
Scheme 64. Retrosynthetic approach to PTX 2. 
 
 
In fact, previous studies involving the unsubstituted heptadienyl parent system
165
 showed that 
IMDA did indeed favor the cis-cycloadduct (cis/trans = 3.8:1) via an endo transition state and we 
hoped to establish 3 of the 4 desired stereocenters of the final target in a single step.
165
 
 This approach, as developed by Dr. Thongsornkleeb, a post-doc in our laboratory,  
commenced with synthesis of triene 258 (Scheme 65). Commercially available divinylcarbinol 
259 was converted to aldehyde 261 via Marbet-Saucy-type rearrangement
166,167
 followed by 
Grignard addition to afford alcohol 262.
164 
A three-step protocol developed by Shibuya was 
employed
168 
to install oxazolidinedione 263 furnished carbamate 264 which underwent 
chemoselective reduction then elimination to generate desired alkene 258.
164
 
 
 
Scheme 65. Synthesis of key triene 258. 
 
 
With triene 258 at hand, investigation of the key cycloaddition ensued (Scheme 66). Thermal 
activation under rather harsh conditions (reflux at 182 C) due to poor dienophilic properties of 
oxazolone moiety, furnished two major cycloadducts cis-265 and trans-266 in 3.7:1 ratio and 
81% overall yield (best yield and selectivity).
164 
Detailed proton NMR analysis  
(decoupling experiments) revealed that two major cycloadducts 265 and 266 both have C3a 
groups axial instead of equatorial as originally predicted and cycloadducts 256 and 267 did form 
but in miniscule quantities. Further X-ray of cis-cycloadduct 265 analysis confirmed that indeed 
the C3a propyl group was axial.
164
 
 
 
Scheme 66. IMDA of triene 258. 
 
 
Analysis of transition states suggested that C3a group may actually prefer to be placed  
pseudo-axially (268 and 269) to the carbonyl group on oxazolone in order to minimize A
(1,3)
 
strain (Scheme 67). Thus would give rise to cycloadducts 265 and 266 via endo and exo 
transition states, respectively. On the other hand, transition states with C3a group placed  
pseudo-equatorially 270 and 271 would actually increase allylic strain minimizing formation of 
cycloadducts 256 and 267.
164
 
 
 
Scheme 67. Transition states of endo and exo IMDAs. 
 
 
In spite of these intriguing findings, this ultimately blocked our planned route to PTX 2. 
However, this approach was used to prepare a member of Pumiliotoxin C family,  
()-2-epi-Pumiliotoxin C 272 (Scheme 68). 
 
 
Scheme 68. Modified route to synthesize ()-2-epi-Pumiliotoxin C 272. 
 
 
Hence, cycloadduct 265 was cyclopropanated employing modified Denmark conditions
169 
with a  
high degree of -facial control to yield a mixture of cyclopropanes 273 and 274 in 9:1 ratio 
(Scheme 69).
164 
Given the topology of 273, its rupture by hydrogenolysis was predicted to occur 
from more sterically accessible C7 edge. An unusual hydrogenolysis over  
super-stoichiometric Adam’s catalyst170 afforded an inseparable mixture of carbamates 275 and 
276 in 5.5:1 ratio.
164 
Cleavage of oxazolidinone with methyllithium (MeLi)
171
 furnished alcohol 
277 which allowed for easy separation from its C7 regioisomer but left amine protected as an 
acetamide.
164 
Deoxygenation via a modified Barton-McCombie protocol
172,173 
generated 
acetamide 279 via xanthate 278.
164 
The final step involved removal of the stubborn acetyl group 
under Pearson’s dissolving metal conditions174 to yield the desired ()-2-epi-Pumiliotoxin C 
272.
164 
These results, thus, laid the foundations for our approach to (+)-GTX 1.  
 
 
Scheme 69. Synthesis of ()-2-epi-Pumiliotoxin C 272. 
 
 
 
 
 
 
 
 
 
 
Chapter 4 
4. Results & Discussion 
4.1 Synthesis of the Key Triene 
Construction of cis-decahydroquinoline core 253 was to be analogous to our  
()-2-epi-Pumiliotoxin C 272 synthesis and thus required analog of triene 258 (Scheme 70).164 
As before, commercially available 1,4-pentadien-3-ol 259 was converted to aldehyde 261 via 
Marbet-Saucy-type rearrangement.
166,167 
Addition of in situ-generated organolithium 282
175,176 
afforded alcohol 283. A three-step protocol as developed by Shibuya
168 
was employed to 
introduce the oxazolidinedione moiety via Mitsunobu protocol
177,178
 reaction
 
and furnished 
carbamate 284, which underwent consecutive chemoselective reduction and elimination to 
generate desired triene 285. 
 
 
Scheme 70. Synthesis of the key triene 285. 
 
 
4.2 Intramolecular [4 + 2] Diels-Alder Cycloaddition of Key Triene Intermediate 
 With triene 285 at hand, investigation of the key cycloaddition ensued. We anticipated 
the desired cis-fused decahydroquinoline core to arise from a thermally activated intramolecular 
[4+2] Diels-Alder cycloaddition as based on the precedent above.
164
 Initial studies in refluxing 
(182 C)  o-dichlorobenzene afforded both cis-287 and trans-289 cycloadducts with 3.73:1 ratio, 
respectively, and 67% overall yield (Scheme 71). As expected, major cis-cycloadduct 287 arose 
from endo transition state 286 and minor trans-cycloadduct 289 arose from exo transition state 
288 with C3a side chain held pseudo-axially to minimize A
(1,3)
-type strain.
164
 
 
 
Scheme 71. IMDA of key triene 285. 
 
 
These results closely mirrored the yields and cis/trans ratios obtained in  
()-2-epi-Pumiliotoxin C 272 studies with the corresponding propyl side chain.164 However, it 
was speculated that bulkier terminal propylsilyl group on triene 285 may influence cis/trans ratio 
to a greater extent than the unadorned propyl group on triene 258. Thus, a series of optimizations 
was performed by varying the temperature at which IMDA took place. A general trend was 
determined (Table 2) that lowering reaction temperature from 182 C (entry 1) to  
152 C (entry 4) (all reactions in o-DCB) and extending reaction time from 72 h to 168 – 336 h 
not only increased selectivity from 3.73:1 to 4.97:1 but also improved overall isolated yields 
from 67% to 74%.  
 
 
# T ( °C ) Time ( h ) cis / trans Yield (287 & 289) 
1 182 168 3.73 : 1 67% 
2 175 168 4.11 : 1 75% 
3 166 210 4.24 : 1 73% 
4 152 210 4.97 : 1 74% 
5 140 336 4.74 : 1 71% 
 
Table 2. Thermal optimization of IMDA. 
 
 
Suitably encouraged, further studies were launched to increase endo selectivity. Firstly, the 
effects of solvent in the total synthesis of  ()-neovibsanin B, Nishizawa et al.179 showed that 
incorporating high polarity 1,3-dimethyl-2-imidazolidinone (DMI) as solvent in IMDA increased 
selectivity, shortened reaction times and improved yields (Scheme 72). This enhancement was 
attributed to the solvophobic packing effect of 1,3-dimethyl-2-imidazolidinone associated with 
its polar aprotic properties.
179
 
 
 
Scheme 72. Effects of DMI on IMDA. 
 
 
 
However, in our case, numerous attempts actually decreased yields (~ 28%) and  
selectivity (~ 1:1) as presented in Scheme 73.  
 
 
Scheme 73. Failed attempt to improve yields and selectivity employing DMI. 
 
 
Next, attempts were made to utilize Lewis acid catalysts. Et2AlCl and EtAlCl2 were selected in 
order to determine if they could favor greater endo selectivity as described by Evans et al.
180 
Exposure of dienophile 293 to diene 294 led to formation of a Lewis acid complex 295 that 
underwent IMDA to form two endo-296 and exo-297 cycloadducts (Scheme 74). Et2AlCl was 
found to be the superior to EtAlCl2 catalyst as it better coordinated to two carbonyl groups in 
intermediate 295 without a loss of a substituent (Cl in EtAlCl2).
180
 
 
 
Scheme 74. Effects of Lewis acids on IMDA. 
 
 
Following the same overall reaction conditions for intramolecular Diels-Alder reaction as 
described in Table 2, triene 285 was treated with 1.3 equiv of selected Lewis acid. Surprisingly, 
higher order of selectivity was not achieved (cycloadducts 287 and 289) and yields were 
drastically reduced (Scheme 75). It was determined that at elevated temperatures, expeditious 
deprotection of the TBS group resulted in rather disappointing results (alcohols 298 and 299).  
 
 
Scheme 75. Utilization of Lewis acid is IMDA. 
 
 
4.3 Structure Elucidation by NMR Analysis 
4.3.1 Structure Elucidation of Major cis-Cycloadduct 
Structure elucidation achieved by multiple NMR techniques (
1
H, 
13
C, DEPT, gDQCOSY, 
1D & 2D NOESY, zTOCSY, HOMODEC, gHSQC, gH2BC and gHMBC). 
In the case of cis-287 cycloadduct, its formation in 
1
H NMR was manifested by 
disappearance of the characteristic methylene and methine signals in triene 285 and formation of 
only two methine signals in cis-287. Additionally, mass spectrometry data revealed conservation 
of mass (352.2309 g/mol for 285 and 352.2303 g/mol for cis-287) suggesting successful [4 + 2] 
cycloaddition (Scheme 76).  
 
 
Scheme 76. 
1
H NMR analysis of IMDA leading to cis-287. 
 
 
Having established IMDA has proceeded satisfactorily, we moved to determine the 
stereochemistry of the ring junction. 2D gDQCOSY abreast with decoupling of the CDCl3 
solution proved very useful as the important diagnostic signals were kindly resolved. The key 
diagnostic signals, H5a and H9a, had J = 4.1 Hz and J = 4.5 Hz corresponding to dihedral angel 
of ~ 60 which is typical of cis-fused rings. Additional coupling constants are presented in Figure 
17. 
 Further evidence of a cis-ring junction and its conformation came from 1D and 2D 
NOESY experiments (Figure 18). It was revealed that the A-ring adopted a boat conformation 
based on observed nÖe’s between H5a and H8ax across the A-ring. Ring B, on the other hand, 
adopted chair-like conformation based on observed nÖe’s between H6 and H4ax and H6 and 
H5eq.  
 Finally, the position of the C3a group was also revealed through multiple NMR 
experiments. Firstly, H3a signals is an obscured signal suggesting equatorial position with  
J = 4.6 Hz coupling to H4ax and J = 9.8 Hz coupling to H3. If it were in an axial position, it 
would have had large trans-axial coupling constant (~ J = 15 Hz) to H4ax which was not 
observed. However, what was noticed was nÖe’s between H9a and H3, H9a and H2 suggesting 
that C3a group was indeed axial otherwise it would have not been able to “talk” to H9a on the 
cis-ring junction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Diagnostic coupling constants for cis-287 in CDCl3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18. Diagnostic nÖe’s for cis-287 in CDCl3. 
 
 
 
 
 
4.3.2 Structure Elucidation of Minor trans-Cycloadduct 
Similarly, identity of trans-289 cycloadduct was confirmed. Formation of minor 
cycloadduct in 
1
H NMR was manifested by disappearance of the characteristic methylene and 
methine signals in triene 285 and formation of a single peak in trans-289 in alkene region 
integrating for two protons. Additionally, mass spectrometry data revealed conservation of mass 
(352.2309 g/mol for 285 and 352.2307 g/mol for trans-289) suggesting successful [4 + 2] 
cycloaddition (Scheme 77).  
 
 
Scheme 77. 
1
H NMR analysis of IMDA leading to trans-289. 
 
 
Having established IMDA has proceeded satisfactorily, we moved to determine the 
stereochemistry of the ring junction. 2D gDQCOSY abreast with decoupling of the CDCl3 
solution proved very useful as the important diagnostic signals were kindly resolved. The key 
diagnostic signals, H5a and H9a had J = 10.0 Hz corresponding to dihedral angel of ~ 180 
which is typical of trans-fused rings. Additional coupling constants are presented in Figure 19. 
 Further evidence of a trans-ring junction and its conformation came from 1D and 2D 
NOESY experiments (Figure 20). It was revealed that the A-ring adopted an inverted boat 
conformation based on observed nÖe’s between H5a and H8ax across the A-ring. Ring B, on the 
other hand, adopted chair-like conformation based on observed nÖe’s between H5a and H4ax.  
 Finally, the position of the C3a group was also revealed through multiple NMR 
experiments. Firstly, H3a signals is an obscured signal suggesting equatorial position with  
J = 5.2 Hz coupling to H4ax and J = 10.4 Hz coupling to H3. If it were in an axial position, it 
would have had large trans-axial coupling constant (~ J = 15 Hz) to H4ax which was not 
observed. However, what was noticed was nÖe’s between H9a and H3, and H9a and H2 
suggesting that C3a group was indeed axial otherwise it would have not been able to “talk” to 
H9a. 
 
 
 
Figure 19. Diagnostic coupling constants for trans-289 in CDCl3. 
 
 
 
 
Figure 20. Diagnostic nÖe’s for trans-289 in CDCl3. 
 
 
 
 
4.4 Computational Studies on Intramolecular [4 + 2] Diels-Alder Cycloaddition 
One key issue to be resolved is the actual nature and origin of the observed 
stereoselectivity of these cycloadditions. Our original hypothesis was that the C3a side chain is 
held pseudo-axially to avoid A
(1,3)
-type strain, as in the transition state 286. However, this 
assumes the tether would adopt a chair-like conformation during closure. In order to verify, 
quantum calculations of transition states employing Density Function Theory (DFT) were 
performed using Gaussian 2009 software
181
 (Computational Clusters at York College and 
College of Staten Island).
182
 
We started with major cis-cycloadduct 287. We initially supposed that this product arose 
from an endo transition state such that ring A (in blue) would adopt a boat conformation and ring 
B (in green) would adopt a chair conformation with C3a side chain (in red) held pseudo-axially 
(Scheme 78). Additionally, detailed NMR analysis also indicated presence of miniscule amounts 
of cycloadduct 301 which presumably arose from endo transition state 300 where the C3a side 
chain was held pseudo-equatorially. This particular compound was later isolated in desilylated 
form as 304. What was not isolated but was observed in NMR analysis, when large batches when 
undergoing IMDA (> 5 g), was cycloadduct 303 which presumably arose from exo transition 
state 302 where the C3a side chain was held pseudo-equatorially. 
 
 
Scheme 78. Presumed transition states for cis-287 and trans-289 cycloadducts. 
 
 
 
Thus, the structure was optimized with Molecular Mechanics (MM2), followed by DFT 
calculations (6-31+G(d)), and finally, quantum transition state (QTS3) calculations  
(DFT 6-31+G(d)). Once transition state energies were obtained, their validities were verified 
with Internal Reaction Coordinate (IRC) calculations [DFT 6-31+G(d)] in forward and reverse 
directions in order to substantiate that calculated transition states (a single imaginary frequency) 
were indeed the actual global minima.
183-189
  
As expected, DFT calculations of the transition state geometry returned the predicted 
structure in which ring A was an endo-boat and ring B was a chair with the C3a side chain in the 
axial position (Figure 21).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21. Calculated endo transition state for formation of cis-287 cycloadduct. 
 
 
Calculated transition state 286 was further substantiated by IRC calculations in order to validate 
that indeed it represented a global, not a local minima. Figure 22 shows the pathway that triene 
285 may take to furnish desired cis-287 via calculated transition state 286 confirming that indeed 
QTS3 calculation yielded correct state.  
 
 
Figure 22. IRC reaction pathway to cis-287 cycloadduct. 
 
 
Similarly, minor trans-cycloadduct 289 was modeled in exactly the same fashion. DFT 
calculations of the trans transition state geometry returned the same result as for cis state where 
ring A was an exo-boat (inverted compared to the endo-boat) and ring B was a chair with the C3a 
side chain in the axial position (Figure 23).   
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Figure 23. Calculated exo transition state for formation of trans-289 cycloadduct. 
 
 
Calculated transition state 288 was further substantiated by IRC calculations in order to validate 
that indeed it represented a global, not a local minima. Figure 24 shows the pathway that triene 
285 may take to furnish desired trans-289 via calculated transition state 288 confirming that 
indeed QTS3 calculation yielded correct state (Figure 24). 
 
 
 
 
Figure 24. IRC reaction pathway to trans-289 cycloadduct. 
 
 
Both these results revealed a pattern - that the tether would naturally prefer a chair-like aspect. In 
order to further substantiate the computational data, we extended our calculations to compare and 
contrast: both (1) endo/exo modes of cycloaddition; containing (2) chair or boat-like tethers; with 
(3) axial/equatorial C3a side chains accordingly. 
 Triene 285, when subjected to IMDA, can yield four different products adopting, in 
principle, eight major different conformations (Figure 25). 
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Figure 25. Possible products and their conformations of triene 285 undergoing IMDA. 
 
Following the same calculation methods as before (QTS3 and IRC in gas phase), we obtained 
results for each of these possible scenarios that both appear to validate our initial hypothesis and 
support observed experimental data. Table 3 consists of calculated G of formation for triene 
285 undergoing IMDA to form either endo cycloadducts (287, 301, 305, 307) or  
exo-cycloadducts (289, 303, 306, 308) along with calculated G‡ for possible transition state 
energies (Figures 26 and 27).  
# conformer G (kcal/mol) TS conformer G‡ (kcal/mol) 
305 cis endo bb ax -31.870585 314 26.650961 
307 cis endo bb eq -32.073271 316 25.95819 
301 cis endo bc eq -36.065035 312 23.914391 
287 cis endo bc ax -36.480899 310 22.953674 
285 triene 0 285 0 
289 trans exo bc ax -32.796162 311 24.79667 
306 trans exo bb ax -30.789418 315 26.1131848 
303 trans exo bc eq -30.148373 313 27.12207595 
308 trans exo bb eq -29.014162 317 26.3585411 
 
Table 3.Calculated G and G‡ for possible transition state conformations. 
 
 
 
Figure 26. Free energy diagrams for calculated G and G‡ for possible transition state conformations. 
 
 
The lowest calculated G and G‡ was attributed to the transition state leading to  
cis cycloadduct 287 (entry #1) (Table 4). This was an anticipated result as alkene 287 was the 
major product of IMDA arising from hypothesis – now proven endo-boat/chair-axial transition 
state. The next experimentally obtained cycloadduct was trans-cycloadduct 289, which had its 
transition state destabilized by +1.84 kcal/mol (entry #3). However, according to DFT 
calculations, the actual second lowest G and G‡ was not attributed to trans-cycloadduct 289, 
but to cis-cycloadduct 301 with C3a tether in equatorial position. The calculated destabilization 
energy was +0.96 kcal/mol. In fact, this particular compound was observed in NMR when IMDA 
was done on a large scale (> 5 g) but it was present in very minute quantities and had to be 
desilylated (304) in order to facilitate purification.  
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 # # conformer G‡ (kcal/mol)
 1 287 (310) cis endo bc ax 0 
 2 301 (312) cis endo bc eq 0.96 outlier? 
3 289 (311) trans exo bc ax  1.84 
 4 307 (316) cis endo bb eq 3.01 
 5 306 (315) trans exo bb ax 3.16 
 6 308 (317) trans exo bb eq 3.41 
 7 305 (314) cis endo bb ax 3.7 
 8 303 (313) trans exo bc eq 4.17 
  
 
 
Table 4. Calculated G‡ energies for possible transition states. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. Calculated transition states of 285 undergoing IMDA. 
 
 
 
 
 
Given this unexpected result, a deeper level of theory (6-311 basis set and inclusion of 
polarizibility) might resolve this discrepancy. Additionally, all presented calculations were 
calculated in the gas phase. Modeling in actual solvent (1,2-dichlorobenzene) would allow to 
calculate reaction rates (k) needed to extrapolate whether calculated transition states 
corresponded to actual reaction temperatures and experimental cis/trans ratios. However, due to 
limited computational abilities and time restrictions solution-phase calculations were not 
completed on time.   
All in all, DFT calculations of free energies and transition states energies did reveal an 
inherent favoritism for endo pathways over exo and chair-like tethers over boats, even if an axial 
substituent was required. This overall tendency matched the experimental results where  
cis-cycloadducts were favored over trans-cycloadduct and axial placement of C3a group lead to 
minimization of A
(1,3)
 strain. 
One other piece of supporting evidence comes from the crystal structure of a key  
cis-cycloadduct obtained during our ()-2-epi-Pumiliotoxin C synthesis (Figure 28).164 This 
clearly indicates that in the solid state the preferred low energy conformation for the major  
cis-cycloadduct 244a, as arising from an endo transition state, is boat/chair in which the side 
chain is placed axially.  
 
 
Figure 28. Crystal structure of ()-2-epi-Pumiliotoxin C key precursor 265. 
 
 
4.5 Formation of C-Ring  via Tandem Elimination/Ring Closure – A Model Study 
Once in possession of sufficient amounts of cis-fused decahydroquinoline 287, efforts 
were directed to construct the C-ring via a tandem elimination/ring annulation. Previously, the  
C-ring has been assembled by standard 1,4-Michael addition as demonstrated by Overman in his 
pursuit to synthesize ()-perhydrogephyrotoxin 1266 and ()-GTX 156 as well as by Ybuka et al. 
in his quest for alkaloid 12 (Scheme 79).
54
 
 
 
Scheme 79. Previous approaches to the C-ring formation. 
 
 
Following a simple model study (Scheme 80), we foresaw conversion of cis-cycloadduct 287 to 
,-unsaturated ester 319 which under basic conditions could eliminate oxazolidinone with 
concomitant loss of CO2 to yield secondary amine anion 320. This was expected to undergo 
spontaneous Michael addition to afford diene 321. Padwa et al. demonstrated this concept while 
investigating new strategies in intramolecular cycloaddition/rearrangement cascades in 
indoles.
190 
Subjecting alkaloid 322 to a strong base (DBU) allowed for excision of CO2 molecule 
and liberation of secondary amine 323 (Scheme 81).
190
 
 
 
Scheme 80. C-ring formation via a tandem elimination/ring annulation. 
 
 
Synthesis of Michael acceptor 319 was achieved as follows. The cis-cycloadduct 287 was 
desilylated under acidic conditions to afford alcohol 298 which was oxidized with  
Dess-Martin Periodinane (DMP)
191,192
 to generate aldehyde 324 (Scheme 81). Standard 
Wittig
135,136
 extension with stabilized ylide furnished desired ,-unsaturated tert-butyl ester 
319.  
 
 
Scheme 81. Synthesis of Michael acceptor 319. 
 
 
This Michael acceptor 319 was then subjected to base-promoted elimination/cyclization  
(Scheme 82). This was to take advantage of the -allylic hydrogen at C8. Modelling and X-ray 
data indicated this was close to antiperiplanar to the C-O bond on oxazolidinone. It was hoped 
that subjecting it to basic conditions would promote excision of CO2 in order to liberate aza-
anion intermediate 320. Two bases were selected; potassium tert-butoxide (pKa = 19) in either 
tetrahydrofuran or tert-butanol, and the non-nucleophilic, strong Schwesinger phosphazene base 
P4-
t
Bu (pKa = 42.6).
193,194 
Unfortunately, treatment of Michael acceptor 319 with potassium  
tert-butoxide failed to generate quinoline 321. Multiple trials were attempted under varying 
solvent conditions: tetrahydrofuran and tert-butanol; base equivalences (1 – 5 equiv) and 
temperature (addition at - 78 C, 0 C, 25 C and subsequent reflux). In each case, initial NMR 
analysis showed disappearance of characteristic oxazolidinone and ,-unsaturated ester signals 
along with formation of putative diene. However, all resulted products were neither discernible 
by initial NMR nor isolable by column chromatography. Furthermore, running this tandem 
elimination-ring annulation reaction in an NMR tube, as followed by frequent proton 
acquisitions, did not provide any meaningful suggestions as to what may have happened once 
putative amide 320 was generated. Disappointed but not defeated, a different base was 
employed; phosphazene base P4-
t
Bu, which is non-nucleophilic in nature. Its large size would 
promote deprotonation at desired C8 and not attack tert-butyl ester on alkene 319.  
However, once again, multiple trials were attempted with various base equivalences (1 – 5 equiv) 
and temperatures (addition at -78 C, 0 C, 25 C and subsequent reflux) resulting in product that 
was undistinguishable by NMR and column chromatography. 
 
 
Scheme 82. Unsuccessful C-ring construction via a tandem elimination/ring annulation 
 
 
All in all, this was a major concern as Overman
56
 had successfully closed the C-ring 
under Michael-type conditions. Therefore, we surmised the problem was with our particular 
substrate and the over-ambitious tandem cascade; “asking too much to go in one pot”.  
One possible concern was the ,-unsaturated ester itself. Also, while we had selected  
a tert-butyl ester in order to avoid problems with transestrification and E2 elimination as the  
tert-butyl group could affect deprotection and release free acid. This itself had acidic protons at 
the -position. 
Seeing as our tandem one-pot approach was unsuccessful, a more defined step-wise 
strategy was adopted (Scheme 83). This helped identify any problem-variables in systematic 
fashion by focusing the investigation on (1) feasibility of E2-elimination of the allylic C8 proton 
with various bases; (2) stability of the resulting diene under basic/acidic conditions; and  
(3) subsequent formation of the C-ring via Michael pathway.
56,66,115
 Thus step-wise strategy as 
devised was also aimed at avoiding problems with the ,-unsaturated ester.  
Therefore, Michael acceptor 319 was reduced to allylic alcohol 325 and oxidized with 
DMP
191,192
 to enal 326; this was protected as acetal 327. Excision of CO2 under basic conditions 
afforded amine 328, which upon acidic deprotection and treatment with a base, cyclized to a 
mixture of hexahydroquinolines 329 and 320 with dr = 7.5:1, respectively (based on NMR). 
 
Scheme 83. C-ring formation via modified Overman’s approach. 
 
 
 
 
4.6 Installation of C6 Side Chain 
With a viable route to the ABC ring system in quinoline 329 established, we turned our 
efforts for installation of the C6 enyne moiety. This was envisaged by conversion of cycloadduct 
287 to diester 331 and/or mono ester 333 and rupturing them under various conditions to 
generate cis-decahydroquinoline 332 and/or 334 (Scheme 84). Such systems have been shown to 
be easily cleaved on several occasions
195,196
 and would thus provide a functional group that could 
be further modified to generate an eneyne moiety. Synthesis of mono- (333), and di-substituted 
(331) cyclopropane esters was attempted in order to investigate whether double activation of 
cyclopropane ring with electron withdrawing groups would aid in swifter rupture compared to 
mono activated ring.  
 
 
Scheme 84. C6 enyne installation via concomitant cyclopropanation/rapture approach. 
 
 
 
 
4.6.1 Cyclopropanation with Ester-Stabilized Diazo Reagents 
4.6.1.1 Synthesis of Ester-Stabilized Diazo Reagent 
Cyclopropanation employing ester-stabilized diazo species is a well-established 
methodology.
197 
Common choices include dimethyl 2-diazomalonate (must be prepared fresh) 
and ethyl 2-diazoacetate (commercially available). Typically, cyclopropanation with diazo 
species is mediated via a transition metal catalyst such as rhodium
198,199
, palladium
200
, or 
copper
201-204
 to generate reactive carbenoid. Heat
205
 and light
206
 have also been shown to promote 
displacement of nitrogen and generation of reactive carbenoid.  
Diazo 338, not commercially available, was prepared according to the known procedure 
(Scheme 85).
207
 Tosyl chloride 335 was converted to azide 336 which was subsequently 
transferred to dimethyl malonate 337 to form diazo 338 [CAUTION! This experiment should be 
conducted behind an auxiliary safety shield in a closed fume hood because of the explosive 
nature of diazo and azide compounds].   
 
 
Scheme 85. Preparation of dimethyl 2-diazomalonate 338. 
 
 
A literature search revealed a plethora of protocols for cyclopropanation with diazo 
species utilizing palladiumacetate
208,209
, dirhodium tetraacetate
210,211,212 
or copper 
catalysts.
201,203,204,213
 
Wicha et al.
200
 showed that installation of monoester cyclopropane on alkene 339 
employing palladium acetate and various alkyl 2-diazoacetate 340 led to formation of 
cyclopropanes 341 – 343 and 344 – 345 with excellent yields and epimer ratios (Scheme 86).200 
 
 
Scheme 86. Cyclopropanation utilizing Pd(OAc)2. 
 
 
Similarly, van Boom et al.
198
 showed that installation of monoester cyclopropane employing 
dirhodium tetraacetate and ethyl 2-diazoacetate 347 led to formation of D-glucal cyclopropane 
348 with excellent yield from alkene 346 (Scheme 87).
198
 
 
 
Scheme 87. Cyclopropanation utilizing Rh2OAc4. 
 
 
 
4.6.1.2 Synthesis of Diester 
Adopting these methods, alkene 287 was subjected to cyclopropanation utilizing freshly 
prepared diazo 338 and commercially available diazo 347 employing either palladium acetate or 
dirhodium tetraacetate in dichloromethane at room temperature (Scheme 88). Surprisingly, initial 
attempts did not yield any cyclopropanes 331 and 333. 
 
 
Scheme 88. Initial failed cyclopropanation attempts to construct diester 331 and monoester 333. 
 
Therefore, a systematic study was launched to investigate the effects of solvents and temperature 
(Table 5). However, after numerous attempts neither palladium acetate nor dirhodium 
tetraacetate mediated installation of a cyclopropane ring on alkene 287. Instead, copious amounts 
of diazo dimers (349 and 350) and trimmers (351 and 352) (Figure 29) were recovered along 
with unreacted cycloadduct 287. 
  
Figure 29. Undesired dimer and trimer by-products of alkene 287 cyclopropanation. 
 
# catalyst (10 mol%) solvent T ( C) 331 &  333 
1 Rh2(OAc)4 CH2Cl2 25 no reaction 
2 
 
THF 25 no reaction 
3 
 
toluene 25 no reaction 
4 
 
CH2Cl2 40 no reaction 
5 
 
THF 66 no reaction 
6 
 
toluene 111 no reaction 
 
7 Pd(OAc)2 CH2Cl2 25 no reaction 
8 
 
THF 25 no reaction 
9 
 
toluene 25 no reaction 
10 
 
CH2Cl2 40 no reaction 
11 
 
THF 66 no reaction 
12 
 
toluene 111 no reaction 
 
Table 5. Attempted optimization for cyclopropanation of 287. 
 
 
Unsuccessful cyclopropanations raised questions as to why literature methods failed. One reason 
is progressive degradation of the catalyst due to ligand exchange. For instance, Rh2(OAc)4 
undergoes structural changes as soon as the reaction is initiated. Acetate ligands are weak 
linkers, due to their small size, to prevent catalyst degradation by dissociation of link rhodium 
atoms. 
214 
Secondly, excessive dimer and trimer formation suggested that alkene 287 was either 
inaccessible for the carbenoid or not electronically activated (there was no observed difference 
between neat and dropwise addition).  
Revisiting the literature, revealed a modified rhodium catalyst, bis[rhodium(,,,-
tetramethyl-1,3-benzenedipropionic acid)] [Rh2(esp)2], which has been shown to perform 
exceptionally well when coupled with malonate-derived carbenoids such as diazo 338  
(Figure 30).
215
 The active species is presumably mixed valence complex 
[Rh2(esp)2]  [Rh2(esp)2]
+
 which is kinetically stable.
216
 One Rh serves as carbenoid biting site 
and the other Rh as electron sink in order to increase electrophilicity of carbenoid moiety. 
Additionally, Rh binds carbenoid through strong -acceptor interactions and weak -back-
donation
217
 Presence of carboxylate ligands as electron withdrawing groups and strong linkers 
results in electron deficient dirhodium core as well as prevents breakage or Rh-Rh bond.
218
 
 
 
Figure 30. Structure of bis[rhodium(,,,-tetramethyl-1,3-benzenedipropionic acid)]. 
 
 
Its utilization, as described by Gonzales-Bobes et al.
215
, eliminated high reaction 
temperatures that may lead to excessive dimerizations of diazo species and avoided the usual 
large excess of olefins that in some cases were used as solvents in order to increase overall 
yields.
219-222
 Additional advantages of employing [Rh2(esp)2] catalyst included small catalyst 
loading (0.1 – 2 mol%), mild temperature (usually rt), one molar equivalence of olefin and slight 
excess of diazo species (~ 1.3 equiv).
215 
A specific example includes cyclopropanation of  
1,2-dihydronaphthalene 354 under mild conditions to obtain cyclopropane 355 (Scheme 89).
215 
We chose this approach to introduce cyclopropane moiety onto alkene 287. 
 
 
Scheme 89. Cyclopropanation of dihydronaphthalene 354. 
 
 
Initial attempts to generate cyclopropane 331 were rather discouraging especially in 
terms of yield (Scheme 90). Additionally, NMR analysis revealed formation of what appeared to 
be minor cyclopropane 356 which had been anticipated to some extent. 
 
 
Scheme 90. Initial cyclopropanation attempt of alkene 287. 
 
 
Therefore, a test reaction was performed to test the quality of reagents. Utilization of 
styrene 357 under standard conditions described by Gonzales-Bobes et al.
215
, resulted in nearly 
quantitative conversion (as analyzed by NMR) of olefin 357 to cyclopropane 358 (Scheme 91) 
verifying that both the Rh-catalyst and diazo 338 were active. 
 
 
Scheme 91. Control reaction to test quality of the catalyst and diazo species. 
 
It was deduced that the topology of alkene 287 was to be blamed as installation of dimethyl 
malonate on the double bond was sterically demanding but not impossible. Thus, after a series of 
optimizations (Table 6), involving catalyst loadings (0.5 – 10 mol%), various temperatures  
(rt – 120 ºC), equivalents of dimethyl diazomalonate (1 – 20 equiv), reaction times (8 – 72 h), 
and dropwise versus one-portion additions, a particular set of reaction conditions was found to 
give decent yields of desired cyclopropane 331 (entry #13). 
# Rh (mol/%) N2 (equiv) t (h) T (ºC) yield (331 & 356) ratio (331 & 356) 
1 0.5 1.5 
neat
 18 25 20% - 
2 2 2.0
 neat
 18 40 23% 8  :  1 
3 5 2.0
 neat
 24 120
st
 26% - 
4 5 10.0
 neat
 18 120
st
 61% - 
5 2 10.0
dp
 10 40 65% - 
6 2 2.0
dp
 10 40 18% - 
7 5 10.0
 neat
 18 40 64% - 
8 10 10.0
 neat
 18 40 60% - 
9 5 10.0
 neat
 18 25 59% - 
10 2 10.0
 neat
 18 25 40% - 
11 5 5.0
 neat
 18 40 49% - 
12 5 20.0
dp
 10 25 35% - 
13 2 5.0
 neat
 72 25 67% 36 : 1 
 
Table 6. Optimization of cyclopropanation: CH2Cl2 (solvent), 
dp
drop-wise, 
st
sealed tube. 
 
The outcome of this extensive cyclopropanation study showed that the optimal catalyst 
loading was 2 mol% of Rh2(esp)2 with 5 equivalents of diazo 338 being sufficient to convert 
most of alkene 287 to desired cyclopropane 331 and undesired 356 (entry #13). Moreover, there 
was not much difference between drop-wise versus one-portion addition; however, extending the 
reaction time (up to 72 h) did help to improve the overall yield of the reaction. Furthermore, 
elevated temperatures did not have a significant impact on product formation but did affect the 
ration of cyclopropanes 331 and 356 and led to excessive formation of alkene dimers. Given 
steric considerations, diazo 338 preferred to add from the -face rather than the -face as 
predicted. Additionally, it was observed that reactions that were run at rt showed mostly  
 product (36:1 ratio by NMR of 331 to 356, respectively) but this ratio dropped as temperature 
was increased (with lowering of the yields as well). Moreover, unreacted diazo 338 (due to high 
loadings) and its dimerized forms interfered with purification of cyclopropane 331 from the 
reaction mix. Thus, while there was still a lot of room for improvement in this particular 
cyclopropanation reaction, we moved forward in our study.  
4.6.1.3 Structure Elucidation of -Diester by NMR Analysis 
Structure elucidation achieved by multiple NMR techniques (
1
H, 
13
C, DEPT, gDQCOSY, 
1D & 2D NOESY, zTOCSY, HOMODEC, gHSQC, gH2BC and gHMBC). 
In the case of cyclopropane 331, its formation in 
1
H NMR was manifested by conversion 
of the obscure and characteristic alkene signals in cycloadduct 287 and formation of two broad 
and nicely resolved doublets of doublets leaning towards each other in cyclopropane 331. 
Moreover, two distinct methoxy peaks of the malonate diester appeared suggesting successful 
cyclopropanation of alkene 287. Further evidence came from mass spectrometry data which 
revealed that presumed cyclopropane 331 (exact mass 482.2574 g/mol) gained 130.0271 mass 
units from cycloadduct 287 (352.2303 g/mol) which corresponded to the exact mass of malonate 
diester carbenoid.  
Having established cyclopropanation has proceeded satisfactorily, we moved to 
determine the stereo- and regiochemistry of attached cyclopropane. 2D gDQCOSY abreast with 
decoupling of the C6D6 solution proved very useful as the important diagnostic signals were 
kindly resolved. The key diagnostic signal for the cis-ring junction H9a but not H5a (overlap),  
C-O bond (H9) and side chain attachment (C3a) were very similar to 
1
H NMR of cycloadduct 
287 (Figure 31). The -facial position of the cyclopropane ring was initially deduced from 
coupling constants for signals H8eq, H7 and H6 which were very similar (J = 7.6 Hz to  
J = 9.4 Hz) suggesting a dihedral angel of ~ 0. Additionally, H5a signal had a J = 7.6 Hz to H6 
signal suggesting trans alignment because J = 9.2 Hz and J = 9.4 Hz was observed between H6 
and H7 signals suggesting cis position. In a cyclopropane ring, cis coupling constants are larger 
than trans coupling constants. 
 Further evidence of -position of cyclopropane ring and its conformation came from 1D 
and 2D NOESY experiments (Figure 32). It was presumed that the A-ring retained its boat 
conformation (as in cycloadduct 287) due to the presence of -cyclopropane. This would have 
been obvious if there were nÖe between H8ax and H5a (tips of the boat). However, those two 
signals were merged. Ring B also retained its chair-like conformation based on observed nÖe’s 
between H6 and H4ax and H9a and H5ax signals.  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31. Diagnostic coupling constants for 331 in C6D6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32. Diagnostic nÖe’s for 331 in C6D6. 
 
 
 
 
 
 
4.6.1.4 Synthesis of Monoester 
These Lessons learned from the synthesis of cyclopropane 331 were applied to the 
synthesis of cyclopropane 333 utilizing Rh2(esp)2 and commercially available diazo 347 
(Scheme 92).  
 
 
Scheme 92. Cyclopropanation of alkene 287. 
 
 
However, as showed by Wicha et al.
200
, this particular cyclopropanation was more efficient than 
installing a diester cyclopropane when diazo 347 is added drop-wise due to its instability under 
to prolonged exposure to light. Moreover, formation of exo-cyclopropane 333 was a cleaner 
reaction than cyclopropane 331 and yielded only cyclopropane 333. Endo products 359 and  
-product 360 were not observed. 
4.6.1.5 Structure Elucidation of exo--Monoester by NMR Analysis 
Structure elucidation achieved by multiple NMR techniques (
1
H, 
13
C, DEPT, gDQCOSY, 
1D & 2D NOESY, zTOCSY, HOMODEC, gHSQC, gH2BC and gHMBC).  
In the case of cyclopropane 333, its formation in 
1
H NMR was manifested by conversion 
of the obscure and characteristic alkene signals in cycloadduct 287 and formation two obscure 
signals whereas only H7 was distinct and H6 overlapped with other signals. Further evidence 
came from mass spectrometry data which revealed that presumed cyclopropane 333 (exact mass 
438.2672 g/mol) gained 86.0369 mass units from cycloadduct 287 (352.2303 g/mol) which 
corresponded to the exact mass of ethyl 2-diazoacetate carbenoid.  
Having established cyclopropanation has proceeded satisfactorily, we moved to 
determine the stereo- and regiochemistry of attached cyclopropane. 2D gDQCOSY abreast with 
decoupling of the C6D6 solution proved very useful even though most of the diagnostic signals 
were not kindly resolved. The key diagnostic signal for the cis-ring junction H9a but not H5a 
(overlap), C-O bond (H9) and side chain attachment (C3a) were very similar to 
1
H NMR of 
cycloadduct 287. The -facial position of the cyclopropane ring was initially deduced from 
coupling constants for signals H7, H8eq and H8ax. H7 signal had J = 7.4 Hz and J = 7.7 Hz to 
H8eq and J= 9.1 Hz to H6 suggesting a dihedral angel of ~ 0 and placing these three signals 
roughly in the same plane. Additionally, H7 had J = 3.5 Hz to H13 signifying that C13 proton 
was positioned trans to H7 and therefore pointing above the A-ring and forcing ester group into 
exo position. Moreover, H8ax had J = 8.2 Hz to H7 suggesting trans alignment. Since H6 
overlapped with H5, H2, and H3 no coupling constants were extracted to describe position of H6 
with respect to H13 which overlapped with H5a and methoxy on ethyl ester. Additional coupling 
constants are presented in Figure 33. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33. Diagnostic coupling constants for cyclopropane 333 in CDCl3. 
 
 
Further evidence of -position of cyclopropane ring and its conformation came from 1D and 2D 
NOESY experiments (Figure 34). It was presumed that the A-ring retained its boat conformation 
(as in cycloadduct 287) due to the presence of -cyclopropane. This would have been obvious if 
there were nÖe between H8ax and H5a (tips of the boat). However, H5a overlapped with H13 
and methoxy signal on the ester group and no clear distinction was observed. However, the exo 
position of the ethyl ester was verified by nÖe between H8ax and H13. Ring B also retained its 
chair-like conformation based on observed nÖe’s between H6 and H4ax and H9a and H5ax 
signals. Additional nÖe’s are presented in Figure 31. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34. Diagnostic nÖe’s for cyclopropane 333 in CDCl3. 
 
 
4.7 Cyclopropane Rupture 
Armed with novel cyclopropane systems 331 and 333, the necessary task of ring rupture 
was initiated. Extensive literature review suggested fairly effortless ring rupture under a variety 
of conditions including metal-mediated hydrogenolysis (Pt and Pd)
170,223-230
 radical-mediated 
rupture (SmI2 and n-Bu3SnH),
195,228,231-238
 cleavage under acid
239,240,241
 and basic 
conditions,
242,243
 radical anion-metal-mediated rupture (Li and Mg),
200,244-252
 homoconjugate 
addition/cleavage (PhS
-
 and H
-
 )
253-265 
and thermal rearrangement.
266 
These methods are 
portrayed in Scheme 93 using diester 331 as an example. 
 
Scheme 93. Possible routes to rupture cyclopropane ring in diester 331. 
 
 
 
 
4.7.1 Metal-Mediated Hydrogenolysis 
Given the fact that cyclopropane ring is on the -face with bulky ester group(s), the 
catalyst for metal-mediated hydrogenolysis could approach from less sterically hindered -edge 
and mediate rupture of the ring at either C7 (preferred) or C6 position generating esters 332 and 
361, respectively (Figure 35). In the case of (±)-2-epi-Pumiliotoxin C 272 the ratio was  
5.5:1
164
 and it is expected to be improved based on the topology and steric congestion of ester 
331. 
 
 
Figure 35. Accessible sites for cyclopropane rupture on diester 331. 
4.7.1.1 Adam’s Catalyst (PtO2  xH2O) 
 The preferred mode of cyclopropane rupture was utilization of Adam’s catalyst 
(PtO2H2O)
267,268 
in super-stoichiometric quantity (2.0 equiv) which performed exceptionally 
well in our precedent (Scheme 94).
164
 
 
 
Scheme 94. Rupture of cyclopropane ring with Adam’s catalyst 
 
 
This idea had further support from Rigby et al.
170
 and his work on 9-epi-pentalenic acid.  
While attempting to rupture acid 366 under conditions such as hydrogenolysis, dissolving metal 
reduction or trimethylsilyl iodide activation, only starting material could be recovered. However, 
an observation was made that during aqueous work-up, acid 366 was converted to lactone 367 
and unintended cyclopropane rupture occurred to generate iodide 368 in minuscule yield 
(Scheme 95).
170
 
 
Scheme 95. Unexpected one-pot lactonization and cyclopropane cleavage. 
Conversion of acid 366 to lactone 367 appeared to increase strain on cyclopropane 367 as well as 
provide an electron withdrawing group that could aid in ring rupture.
170
 Indeed, subjecting 
lactone 367 to standard hydrogenolysis conditions over Adam’s catalyst resulted in decent yield 
but undesired regioselectivity to generate two esters 369 and 370 in 
1:6 ratio, respectively (Scheme 96).
170 
Conversely, a complete reversal of regioselectivity was 
achieved with utilization of Pearlman’s catalyst (Pd(OH)2/C)
269 
which afforded the same two 
esters 369 and 370 but with 5.7:1 ratio, respectively.
170
 Surprisingly, no explanation was 
provided as to why reversal of regioselectivity was observed or if solvent had any role in it.  
 
 
Scheme 96. Utilization of Adam’s catalyst in cyclopropane ring rupture 
 
 
Hydrogenolysis of esters 331 and 333 employing Adam’s catalyst267,268, however, failed 
wretchedly (Scheme 97). The first set of conditions employed (Table 7) followed our 
precedent.
164
 Portion-wise addition of PtO2 did not result in any cyclopropane rupture as verified 
by initial NMR analysis and complete recovery of starting material. 
 
 
Scheme 97. Failed hydrogenolysis of esters 331 and 333 utilizing Adam’s catalyst. 
 
 
Secondly, utilization of Rigby’s protocol170 with 0.8 equiv of Adam’s catalyst at elevated 
pressure (4.1 atm) yet again did not result in cyclopropane rupture and recovery of starting 
materials (Table 7). Finally, an increase in pressure (6.1 atm) and catalyst loading (2 equiv) 
resulted once more in negative results and also partial loss of silyl protecting group presumably 
due to formation of a platinic acid.  
# equiv t (h) T (
o
C) H2 (atm) solvent yield (332 & 334) 
 1 0.8+0.4+0.4+0.4 144 rt 1 EtOAc no rupture 
 2 0.8 72 rt 4.1 EtOAc no rupture 
 3 2 70 rt 6.1 EtOAc no rupture, partial desilylation 
 
Table 7. Hydrogenolysis conditions utilizing Adam’s catalyst. 
 
 
4.7.1.2 Pearlman’s Catalyst (Pd(OH)2) 
Failure of Adam’s catalyst267,268 to rupture cyclopropane ring of esters 331 and 333 
prompted utilization of alternative catalyst such us Pearlman’s catalyst269 which was successfully 
used by Rigby et la.
172
 as previously described.  
Hydrogenolysis of esters 331 and 333 employing Pearlman’s catalyst, however, failed 
miserably yet again. The first set of conditions employed (Table 8) were taken from Rigby’s 
paper
170,269
. Incubation at rt for 6 days under hydrogen atmosphere (1 atm) resulted in no 
cyclopropane rupture as verified by NMR analysis and recovery of starting material. Increasing 
pressure to 4.1 atm not only failed to improve matters but it was also observed that the silyl 
protecting group was being cleaved. Finally, full increase in pressure (6.1 atm) resulted once 
more in no desired reaction. Only significant loss of silyl protecting group presumably due to 
formation of metallic acid was observed. 
# mol% t (h) T (
o
C) H2 (atm) solvent yield (332 & 334) 
 1 20 144 rt 1 EtOH no rupture 
 2 20 72 rt 4.1 EtOH no rupture, desilylation 
 3 20 70 rt 6.1 EtOH no rupture, desilylation 
 
Table 8. Hydrogenolysis conditions utilizing Pearlman’s catalyst. 
 
 
4.7.1.3 Palladium on Charcoal (Pd/C) 
The failure of cyclopropane rupture in esters 331 and 333 using either Adam’s 
catalyst
267,268
  and Pearlman’s catalyst was concerning since those two catalysts are standard 
methods for cyclopropane rupture widely used in the literature. An additional catalyst 
investigated was palladium on charcoal (Pd/C).
270
 Fox et al.
228
 utilized this catalyst in the 
synthesis of ()-pentalenene (Scheme 98). Subjecting enone 372 to hydrogenolysis on palladium 
support, allowed for clean conversion to ketone 373 with an exclusive regioselectivity.
228
 
 
 
Scheme 98. Utilization of Pd/C in cyclopropane ring rupture. 
Hydrogenolysis of esters 331 and 333 employing Pd/C,
270
 however, failed once yet again. The 
first set of conditions employed (Table 9) were taken directly from Fox et al.
223,224
 Incubation at 
rt for 6 days under hydrogen atmosphere (1 atm) resulted in no cyclopropane rupture as verified 
by NMR analysis and recovery of starting material. Increasing pressure to 4.1 atm as described 
by Fox et al.
228 
not only gave no desired reaction but it was observed that silyl group was being 
cleaved. Finally, an increase in pressure (6.1 atm) resulted once more in negative results and also 
in significant loss of silyl protecting group presumably due to formation of metallic acid. 
# mol% t (h) T (
o
C) H2 (atm) solvent yield (332 & 334) 
 1 10 144 rt 1 MeOH no reaction 
 2 10 72 rt 4.1 MeOH no reaction, desilylation 
 3 10 70 rt 6.1 MeOH no reaction, desilylation 
 
Table 9. Hydrogenolysis conditions utilizing Pd/C. 
 
 
A subsequent literature review
271,272
 revealed that indeed under certain conditions where 
polar protic solvents (methanol, ethanol, tert-butanol, etc.) are used, silyl groups  
(tert-butyldimethylsilyl, triisopropylsilyl and triethylsilyl) can undergo metal-mediated cleavage 
to corresponding alcohols which in turn can possibly interfere with the catalyst.  
The disastrous hydrogenolysis results were speculated to arise from severe steric 
congestion due to the diester moiety (and mono ester as well) preventing the catalyst from 
interacting with the cyclopropane ring. One such possibility could be lack of precise alignment 
of the C=O moiety with the adjacent ring.  
4.7.2 E2 Elimination 
 Though used only sporadically, cyclopropane rings can be ruptured via E2 elimination 
with a strong base. Yates et al. demonstrated this principle in the synthesis of cedranoid 
sesquiterpenes (Scheme 99).
242 
Upon treatment of ketone 374 with  
1,8-diazabicycloundec-7-ene (DBU), enone 375 was generated in excellent yield.  
 
 
 
Scheme 99. Cyclopropane rupture via E2 elimination. 
 
 
However, in this special case, deprotonation occurred at an already activated site ( to a ketone) 
and the regioselectivity of cyclopropane rupture was directed towards two electron withdrawing 
groups (ketone and ester) at the other vertex of the cyclopropane ring. Cyclopropane 331, on the 
other hand, did not possess highly acidic hydrogen but is doubly activated by two electron 
withdrawing ester groups. This should be the driving force governing regioselectivity of 
elimination (Scheme 100). Nevertheless, two outcomes are possible when cyclopropane 331 is 
subjected to E2 elimination: (a) deprotonation of the equatorial C8 hydrogen, which is 
antiperiplanar to the cyclopropane ring, would lead to diester 363 and installation of the C6 
group with the correct stereochemistry. This newly generated double bond, in turn, could be 
transposed to excise the carbamate moiety affording amine 376. Alternatively, (b) deprotonation 
of the axial C8 hydrogen, which is antiperiplanar to the oxazolone moiety, would lead to 
excision of the carbamate moiety affording amine 362. This newly generated double bond, in 
turn, could be transposed to rupture the cyclopropane ring, furnishing diester 377. 
 
 
Scheme 100. Possible products for E2 elimination. 
 
 
4.7.2.1 Phosphazene Base (P4-
t
Bu) 
In either case, rupturing cyclopropane under E2 conditions should require a powerful base. From 
our earlier approach to PTX 2,
164
 an unpublished findings revealed that simple inactivated 
cyclopropane 273 underwent clean base-mediated excision of the carbamate moiety and 
generated amine 378 (Scheme 101).  
 
 
Scheme 101. Attempted cyclopropane rupture under E2 conditions. 
The base of choice was phosphazene P4-
t
Bu 379 (Figure 36) developed by Schwesinger.
193 
Such 
bases are uncharged, non-nucleophilic and kinetically highly active towards even weak protons 
with pKa = ~ 42 (in acetonitrile).
193
 
 
 
Figure 36. Structure of P4-
t
Bu base 379. 
 
 
Unfortunately, subjecting activated cyclopropane 331 to phosphazene base, however, was 
fruitless (Scheme 102). Multiple attempts generated undesired mixtures of products that could 
not be separated by column chromatography or discernible by NMR analysis. 
 
 
Scheme 102. Failed cyclopropane rupture by P4-
t
Bu. 
 
 
Plausible causes of unsuccessful base-mediated cyclopropane rupture included zwitter-ion 
formation that complicated work-up and possible multiple deprotonation sites leading to 
undesired intermediates. 
 
 
4.7.2.2 Potassium tert-Butoxide (KO
t
Bu) 
 This unsuccessful application of phosphazene base prompted us to consider a milder base 
that had been previously used (vide supra) to excise carbamate moiety en route to C-ring 
formation (Scheme 103). In this instance, potassium tert-butoxide proved to be a useful, 
moderate base (pKa = ~ 19) capable of eliminating oxazolone from alkene 327 and generating 
amine 328 in excellent yield.  
 
 
Scheme 103. Excision of carbamate moiety by 
t
BuOK. 
 
 
Treating cyclopropane 331 with potassium tert-butoxide, however, did not result in elimination 
but rather in transestrification to afford diester 380 where both methyl groups were replaced with 
tert-butyl moieties (Scheme 104). Consequently, exposure of this cyclopropane 380 to the base 
once again under harsher conditions (0 C to ) generated complex mixtures products that could 
not be separated by column chromatography or discernible by NMR analysis. 
 
 
Scheme 104. Failed excision of carbamate moiety by 
t
BuOK. 
 
 
Plausible causes of unsuccessful base-mediated cyclopropane rupture included zwitter-ion 
formation that complicated work-up, hydrolysis of the carbamate moiety leading to formation of 
secondary alcohol and tert-butyl amide and elimination of tert-butyl groups from esters leading 
to carboxylic acids.  
4.7.3 Radical Cleavage by Radical Anion 
 Radical-mediated ring rupture is an alternative approach to hydrogenolysis. Such 
reactions are known for a high degree of regioselective control. However, they usually require 
formation of a radical on an adjacent atom which then propagates as it ruptures the ring. This 
methodology applies well to small rings, such as cyclopropane, as the process is extremely fast 
(Scheme 105).
234
 This has been referred to as radical clock. Radical initiators commonly utilized 
are samarium diiodide (SmI2)
232
 and stannanes (n-Bu3SnH).
233
 
 
 
Scheme 105. Radical cyclopropane cleavage. 
 
 
 
Larger rings, in contrast, undergo rupture at much slower rate unless radical formation can be 
stabilized by adjacent substituents.
234
 
 Several moieties can be employed to promote cyclopropane cleavage by such radical 
clock. The most common functional group that aids in ring rupture is a carbonyl group. Fox et 
al.
228
 demonstrated this concept in the synthesis of (-)-pentalenene (Scheme 106). Monoester 
cyclopropane 372 was ruptured with SmI2 in excellent yield to furnish ketone 373 via 
intermediate 383 with complete regioselectivity.
228
 
 
 
Scheme 106. SmI2-mediated cyclopropane rupture monoester. 
 
 
Similarly, Ohta et al. presented a detailed study of homobenzylic diester 384 cyclopropanes 
witch ruptured regioselectively to diester 385 in excellent yields utilizing SmI2 with (Scheme 
107).
195
 
 
 
Scheme 107. SmI2-mediated cyclopropane rupture of diester 385. 
 
 
 
 
 
4.7.3.1 Samarium Diiodide (SmI2) 
This futile attempt with tin hydride mandated utilization of a more robust radical initiator, 
such as SmI2 as demonstrated by Ohta et al.
195
 However, there were concerns with respect to 
overall regioselectivity.  
In practice, radical rupture of ester 331 with SmI2 proved partially successful but not 
regioselective (as determined by NMR analysis of the crude mixture) (Scheme 108). The 
reaction yielded an inseparable mixture (~ 1:1 by NMR) of two regioisomers 332 and 361 with 
very low yield, along with indiscernible side products.  
 
 
Scheme 108. Partial successful SmI2-mediated cyclopropane rupture of diester 331.  
 
 
In contrast, subjecting mono ester 333 to the same reaction conditions resulted in recovery of 
starting material (Scheme 109).   
 
 
Scheme 109. Unsuccessful SmI2-mediated cyclopropane rupture of monoester 333. 
 
 
SmI2 reaction was peculiar. It did partially work for diester 331 but not for monoester 333 even 
though the same commercial batch was used. Firstly, it was expected that the outcome of 
cyclopropane rupture would lack regioselectivity. Secondly, the quenching agent  
(
t
BuOH or MeOH) may have had a crucial role in this reaction. Procter et al.
273
 experimented 
with lactone radical cyclizations cascades mediated by SmI2 and came to the conclusion that 
quenching reagent (in Procter’s case it was H2O) had a vital role; water molecule (~ 100 equiv) 
would coordinate to Sm(II) and increase its reducing potential as well as providing a proximal 
proton source to quench intermediates.
273
 Thus, further studies would be conducted to investigate 
this particular method of ring rupture. 
4.7.4 Homoconjugate Addition 
Less common methods for rupturing cyclopropane rings were also attempted with a main 
focus placed on homoconjugate addition employing strong nucleophiles. The key arguments for 
this was esters 331 and 333 have bent sp
3 – sp3 bonds that are subjected to electron withdrawal 
by adjacent ester group(s), reminiscent of an atypical ,-unsaturated diester (Michael acceptor) 
(Figure 37). 
 
 
Figure 37. Pseudo-Michael acceptor. 
 
 
Numerous nucleophiles have been shown to undergo homoconjugate addition to activated 
cyclopropanes. Taber
255
 demonstrated utilization of in situ generated benzenethiolate to rupture 
mono substituted cyclopropane ring 390 en route to prostaglandin 391 (Scheme 110). 
 
 
Scheme 110. Cyclopropane rupture with sodium benzenethiolate. 
 
 
Similarly, Kocienski et al.
257
 utilized benzeneselenolate to rupture a simple cyclopropane 392 to 
diester 393 with excellent yields en route to talaromycin B (Scheme 111). 
 
 
Scheme 111. Homoconjugate addition of benzeneselenolate to 392. 
 
 
There was, however, an inherent risk of using nucleophiles to undergo homoconjugate addition. 
The danger involved possible transestrification. Even though it was not reported in presented 
literature
253-265
, unsuccessful attack at the 4-position of a pseudo-Michael acceptor could result in 
strong nucleophile attacking elsewhere such as a carbonyl of an ester group.  
4.7.4.1 Sodium Benzenethiolate (PhSNa) 
 The first nucleophile utilized was in situ generated sodium benzenethiolate 
(Scheme 112). However, after several attempts esters 331 and 333 failed to undergo  
pseudo-Michael addition with no rupture of the cyclopropane ring.  
 
 
Scheme 112. Failed homoconjugate addition of benzenethiolate to diester 331 and monoester 333. 
 
 
It was speculated that the failure to rupture the cyclopropane ring in our case was not due to 
insufficient nucleophilicity of benzenethiolate 399 but rather its size and the topology.  
Cyclopropane ring in esters 331 and 333 leans away from the cis-ring junction (Figure 38). 
Therefore, intermediate’s 398 vacant * orbitals on C6 and C7 point towards the concave cavity, 
add in homo-Michael fashion. In addition, the adjacent -system of the C=O may not have 
activated the ring as required. 
 
 
Figure 38. Hindered trajectory for homoconjugate addition of benzenethiolate. 
 
 
4.7.4.2 Stryker’s Reagent (PPh3CuH]6) 
 Given the bulky benzenethiolate failed to undergo homoconjugate addition in order to 
rupture cyclopropane ring. However, a smaller nucleophile could have less hindered trajectory 
and be able to reach the vacant * orbitals on C6 and C7, thus leading to ring rupture. A novel 
nucleophile, Stryker’s reagent274 ([PPh3CuH]6) 400 (Figure 39), used primarily in reduction of 
double bonds in ,-unsaturated ketones275, was then selected for cyclopropane rupture. The 
only concern was the hydride and is proximity to copper and how it could affect the delivery of 
that hydride (possible steric congestion of the complex to properly reach * orbitals).  
 
Figure 39. Structure of (triphenylphosphine)copper hydride hexamer (Stryker’s reagent) 400.321 
 
 
Even though Stryker’s reagent has been shown to be inert towards inactivated cyclopropane 
rings
276 
(as a mild source of hydride), in principle it could undergo 1,4-addition to pseudo-, 
unsaturated Michael acceptor (vide supra) to furnish a ruptured product. A successful cleavage 
would be a worthy achievement. However, after several attempts both esters 331 and 333 failed 
to undergo pseudo-Michael hydride addition to rupture cyclopropane ring (Scheme 113). 
Stryker’s reagent is a mild hydride donor, its hulking structure might have been too sterically 
congested to properly or efficiently delivery hydride in the necessary fashion.  
 
 
Scheme 113. Failed homoconjugate addition of hydride to diester 331 and monoester 333. 
 
 
4.8 Alternative Model Study 
Thus far, all studies had failed to provide a successful approach to cyclopropane ring 
rupture. Hence, a modified approach was adopted to shed some insights into these repeated 
failures and thus provide a suitable solution. 
During the course of our cyclopropane rupture studies, it was observed that C3a group 
with silyl group was labile under many conditions, thus rendering any interpretation difficult. 
Therefore, a simplified model system was envisaged in order to reduce any unnecessary 
variables (Scheme 114). Naked cycloadduct 401 could not only provide additional details into 
cyclopropane formation and rupture but also simplify NMR analysis. 
 
Scheme 114. Proposed modification of the key cycloadduct 287 to troubleshoot failed ring ruptures.   
4.8.1 Synthesis of Naked cis-decahydroquinoline - A Key Intermediate 
The synthetic steps that lead to the generation of the key scaffold 401 were adapted from 
our established precedent
164
 with slight modifications (Scheme 115). A known aldehyde
166 
261 
was reduced to an alcohol (volatile) 402 which was quickly converted to tosylate 403. 
Introduction of oxazolone 404 under standard SN2 reaction afforded triene 405. Intramolecular 
Diels-Alder cycloaddition at elevated temperature afforded cis-401 and trans-406 cycloadducts 
in a ratio of 4.4:1, respectively.  
 
 
Scheme 115. Synthesis of the key cycloadduct 401. 
 
 
4.8.2 Structure Elucidation by NMR Analysis 
4.8.2.1 Structure Elucidation of Major cis-Cycloadduct 
As predicted, NMR spectra for cis-cycloadduct 401 were significantly simplified. 
Structure elucidation achieved by multiple NMR techniques (
1
H, 
13
C, DEPT, gDQCOSY,  
1D & 2D NOESY, zTOCSY, HOMODEC, gHSQC, gH2BC and gHMBC).  
In the case of cis-401 cycloadduct, its formation in 
1
H NMR was manifested by 
disappearance of the characteristic methylene and methine signals in triene 405 and formation of 
only two methine signals in cis-401. Additionally, mass spectrometry data revealed conservation 
of mass (180.1034 g/mol for 405 and 180.1036 g/mol for cis-401) suggesting successful [4 + 2] 
cycloaddition.  
Having established IMDA has proceeded satisfactorily, we moved to determine the 
stereochemistry of the ring junction. 2D gDQCOSY abreast with decoupling of the CDCl3 
solution proved very useful as the important diagnostic signals were kindly resolved and very 
similar to spectra of cis-287. The key diagnostic signal, H5a and H9a, had J = 4.3 Hz 
corresponding to dihedral angel of ~ 60 which is typical of cis-fused rings. Additional coupling 
constants are presented in Figure 40.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 40. Diagnostic coupling constants for cis-401 in CDCl3. 
 
 
Further evidence of a cis-ring junction and its conformation came from 1D and 2D 
NOESY experiments (Figure 41). It was revealed that the A-ring adopted a boat conformation 
based on observed nÖe’s between H5a and H8ax across the A-ring. Ring B, on the other hand, 
adopted chair-like conformation based on observed nÖe’s between H6 and H4ax, H9a and H3aax, 
H9a and H5ax. cis-401 NMR spectra was closely analogous to cis-287 cycloadduct (Figure 42). 
 
 
 
 
 
 
 
 
 
Figure 41. Diagnostic nÖe’s for cis-401 in CDCl3. 
 
 
 
 
Figure 42. Comparison of 
1
H NMR spectra of cycloadducts 287 and 401. 
 
 
4.8.2.2 Structure Elucidation of Minor trans-Cycloadduct 
Similarly, identity of trans-406 cycloadduct was confirmed. Formation of minor 
cycloadduct in 
1
H NMR was manifested by disappearance of the characteristic methylene and 
methine signals in triene 405 and formation of a single peak in trans-406 in alkene region 
integrating for two protons. Additionally, mass spectrometry data revealed conservation of mass 
(180.1034 g/mol for 405 and 180.1025 g/mol for trans-406) suggesting successful [4 + 2] 
cycloaddition.  
Having established IMDA has proceeded satisfactorily, we moved to determine the 
stereochemistry of the ring junction. 2D gDQCOSY abreast with decoupling of the CDCl3 
solution proved very useful as the important diagnostic signals were kindly resolved. The key 
diagnostic signals, H5a and H9a had J = 9.8 Hz and J = 9.9 Hz corresponding to dihedral angel 
of ~ 180 which is typical of trans-fused rings. Also, signal H5ax had a J = 13.2 Hz to H5a, 
suggesting trans-orientation. Additional coupling constants are presented in Figure 43. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 43.  Diagnostic coupling constants for trans-406 in CDCl3. 
Further evidence of a trans-ring junction and its conformation came from 1D and 2D NOESY 
experiments (Figure 44). It was revealed that the A ring adopted an inverted boat conformation 
based on observed weak nÖe’s between H5a and H8ax across the A-ring. Ring B, on the other 
hand, adopted chair-like conformation based on observed weak nÖe’s between H5a and H4ax.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 44. Diagnostic nÖe’s for trans-406 in CDCl3. 
 
4.8.3 Cyclopropanation of Model cis-decahydroquinoline Core 
Armed with the major cis-401, efforts were directed to install C6 eneyne moiety with 
both regio- and stereocontrol. It was predicted that cyclopropanation with a malonate carbenoid 
or equivalent would proceed with correct -facial selectivity allowing subsequent regioselective 
rupture. Employing conditions previously optimized for cyclopropanation of cycloadduct 287, 
monoesters 407 and 408 were generated with a exo/endo ratio of 1.2:1, respectively  
(Scheme 116).  
 
 
Scheme 116. Cyclopropanation of cycloadduct 401. 
 
 
This outcome was rather unexpected as there was no observed addition from the -face; in 
addition cyclopropanation from the -face now yielded exo-407 and endo-408 esters instead.  
It was proposed that the axial C3a substituent may indeed affect installation of endo ester due to 
sterics (flanking effect). Previously, only exo-333 had been observed (Scheme 117). 
 
 
Scheme 117. Effects of C3a side chain on cyclopropanation of cis-cycloadduct 287. 
A similar observation was made by Kishi
55
 when an attempt was made to hydrogenate 
,-unsaturated ester 78 (Scheme 118). The initial effect involved hydrogenation of ester 76 to 
set the C6 stereocenter. Protection of 1 alcohol with acetate followed by hydrogenation revealed 
a 1:35 ratio of 409 and 410, respectively, clearly favoring incorrect stereochemistry at C6. 
However, when the overall order of these events was reversed – C12 silylation then 
hydrogenation – 411 and 412 were generated in 10:1, respectively, now favoring the correct 
stereochemistry at C6. Kishi believed this was a long-range (“flanking”) steric effect in which 
the bulky TBDPS ether, though remote, presumably remained proximal to the -face of the 
olefin.
55
   
 
 
 
 
Scheme 118. Blocking effect of bulky TBDPS group on hydrogenation. 
 
 
 
 
 
 
4.8.4 Structure Elucidation by NMR Analysis 
4.8.4.1 Structure Elucidation of exo--Monoester 
Structure elucidation achieved by multiple NMR techniques (
1
H, 
13
C, DEPT, gDQCOSY, 
1D & 2D NOESY, zTOCSY, HOMODEC, gHSQC, gH2BC and gHMBC).  
In the case of cyclopropane 407, its formation in 
1
H NMR was manifested by conversion 
of the obscure and characteristic alkene signals in cycloadduct 401 and formation of two broad 
and nicely resolved doublets of doublet and doublet of triplet of doublet leaning towards each 
other in cyclopropane 407. As a matter of fact, all signals were individually resolved expect for 
H13 which overlapped with CH3 of ethyl group. Further evidence came from mass spectrometry 
data which revealed that presumed cyclopropane 407 (exact mass 266.1370 g/mol) gained 
86.0368 mass units from cycloadduct 401 (180.1036 g/mol) which corresponded to the exact 
mass of ethyl 2-diazoacetate carbenoid.  
Having established cyclopropanation has proceeded satisfactorily, we moved to 
determine the stereo- and regiochemistry of attached cyclopropane. 2D gDQCOSY abreast with 
decoupling of the C6D6 solution proved very useful as the important diagnostic signals were 
kindly resolved due to lack of H3a side chain. The key diagnostic signal for the cis-ring junction, 
H9a, H5a, C-O bond (H9), were very similar to 
1
H NMR of cyclopropane monoester 333  
(Figure 45). The -facial position of the cyclopropane ring was initially deduced from coupling 
constants for signals H8eq, H7 and H6 which were very similar (J = 7.4 Hz to J = 9.3 Hz) 
suggesting a dihedral angel of ~ 0. Additionally, H5a had a J = 7.3 Hz to H6 signal suggesting 
trans-alignment because in a cyclopropane ring, cis coupling constants are larger than trans 
coupling constants. Furthermore, H13 (tip of cyclopropane) had J = 3.7 Hz to both H6 and H7 
suggesting pointing trans to H6 and H7 and above ring A placing ester group away from the ring 
in exo position. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 45. Diagnostic coupling constants for exo-407 in C6D6. 
 
 
Further evidence of -position of cyclopropane ring and its conformation came from 1D and 2D 
NOESY experiments (Figure 46). It was presumed that the A-ring retained its boat conformation 
(as in cycloadduct 401) due to the presence of -cyclopropane. This is supported by weak nÖe 
(1.6%) between H8ax and H5a (tips of the boat) and, more convincingly, nÖe between H13 and 
H8eq and H5a. Ring B also retained its chair-like conformation based on observed nÖe’s between 
H6 and H4ax. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 46. Diagnostic nÖe’s for exo-407 in C6D6. 
 
 
4.8.4.2 Structure Elucidation of endo--Monoester 
Similarly, in the case of cyclopropane  408, its formation in 
1
H NMR was manifested by 
conversion of the obscure and characteristic alkene signals in cycloadduct 401 and formation of 
two broad and nicely resolved quartet and pentet leaning towards each other in cyclopropane 
407. As a matter of fact, all signals were individually resolved except for H13 which overlapped 
with H5eq and H8eq which overlapped with H8ax. Further evidence came from mass spectrometry 
data which revealed that presumed cyclopropane 408 (exact mass 266.1378 g/mol) gained 
86.0342 mass units from cycloadduct 401 (180.1036 g/mol) which corresponded to the exact 
mass of ethyl 2-diazoacetate carbenoid.  
Having established cyclopropanation has proceeded satisfactorily, we moved to 
determine the stereo- and regiochemistry of attached cyclopropane. 2D gDQCOSY abreast with 
decoupling of the C6D6 solution proved very useful as the important diagnostic signals were 
kindly resolved due to lack of H3a side chain. The key diagnostic signal for the cis-ring junction 
H9a, H5a, C-O bond (H9) were clearly distinct but not similar (in terms of shifts) to 
cyclopropane 407 (Figure 47). The -facial position of the cyclopropane ring was initially 
deduced from coupling constants for signals H6 (quartet), H7 (pentet) and H13 (m) which had 
basically the same J = 8.3 Hz suggesting a dihedral angel of ~ 0. Hence, all three signals must 
have been in the same plane otherwise, one signal would have had a smaller coupling constant as 
it was seen in exo-407. Additionally, having H13 in the same plane as H6 and H7 would place 
ester group above the A-ring, this in endo position.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 47. Diagnostic coupling constants for endo-408 in C6D6. 
Further evidence of -position of cyclopropane ring and its conformation came from 1D and 2D 
NOESY experiments (Figure 48). It was presumed that the A-ring retained its boat conformation 
(as in cycloadduct 407) due to the presence of -cyclopropane. This is supported by weak nÖe 
(1.0%) between H8ax and H5a (tips of the boat) and, more convincingly, nÖe between H13 and 
H8eq and H5a. Ring B also retained its chair-like conformation based on observed nÖe’s between 
H6 and H4ax. Furthermore, endo-position of the ester group is supported by lack of nÖe between 
H13 and either H8ax or H5a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 48. Diagnostic nÖe’s for endo-408 in C6D6. 
4.8.5 Naked Cyclopropane Rupture 
Armed with novel cyclopropane systems 407 and 408 to hand, studies of ring rupture 
were re-initiated employing a survey of conditions as previously described in Section 4.7.1.  
A few additional approaches were also attempted and are discussed below.  
4.8.5.1 Metal-Mediated Hydrogenolysis 
First, cyclopropanes exo-407 and endo-408 were subjected to standard metal-mediated 
hydrogenolysis (Scheme 119). Compared to methods described in Section 4.7.1, however, 
catalysts loading were modified from mole percent (mol%) to percent by weight (%/wt) (adopted 
from literature) to ensure faster and complete cyclopropane rupture. However, after multiple 
attempts employing four different catalysts, excess catalysts loadings (up to 215% by weight) 
and elevated pressure, both cyclopropanes resisted rupture (Table 10). This was in direct contrast 
to literature examples. 
 
Scheme 119. Unsuccessful hydrogenolysis of esters 407 and 408. 
 
 
 
 
 
 
# % / wt t (h) T (
o
C) p (atm) solvent yield (407 & 408) 
Adam's  37 56 rt 1 EtOAc no rupture 
  215 24 rt 6.1 EtOAc no rupture 
20% Pd/C 37 48 rt 1 EtOH no rupture 
  215 24 rt 6.1 EtOH no rupture 
20% Pearlman's  37 168 rt 1 EtOH no rupture 
  215 24 rt 6.1 EtOH no rupture 
5% Pt/C 37 56 rt 1 EtOAc no rupture 
  215 24 rt 6.1 EtOAc no rupture 
 
Table 10. Hydrogenolysis conditions to rupture cyclopropanes 407 and 408. 
 
 
These failed hydrogenolysis results were contradictory to literature examples. As to why, no 
clear indication was evident. Subtle steric effects might have played a significant role; however, 
there were also clear electronic differences.  The ester group, being so bulky, may be preventing 
proper coordination to the metal catalyst’s surface, precluding hydride transfer. In addition, 
incorrect alignment of the ester sp
2 
center with the cyclopropane ring system may have prevented 
rupture.   
4.8.5.2 Dissolving Metal Reduction 
 Hydrogenolysis failure prompted utilization of alternative approaches such as dissolving 
metal reduction employing lithium metal.
200
 Wicha et al. presented this methodology while 
building the CD ring system of 17-epi-calcitriol derivatives.
250 
Subjecting cyclopropane 415 to 
lithium metal in refluxing ammonia resulted in regioselective cyclopropane rupture (Scheme 
120). However, under these same conditions, the methyl ester suffered reduction to the primary 
alcohol and had to be re-oxidized under Jones conditions back to methyl ester 416.
250
 
Nonetheless, the overall yield was excellent.  
 
 
Scheme 120. Li-mediated cyclopropane ring rupture. 
 
 
Inspired by this result, we subjected cyclopropane exo-407 to lithium metal in refluxing 
ammonia yet obtained surprising results (Scheme 121). Instead of two ruptured products 417 and 
418, respectively, NMR analysis of the crude mixture revealed that ester exo-407 did undergo 
ring rupture, along with reduction of the ethyl ester but also removal of the carbamate moiety. 
This was ammonolysed presumably yielding alcohols 419 and 420 along with some other 
indiscernible products.  
 
 
Scheme 121. Uncontrolled rupture/excision of ester 407 by lithium metal.  
 
Multiple attempts to separate generated products failed, however. Carbamate cleavage may have 
resulted from excess of lithium used (20 equiv) which is typical for this type of cyclopropane 
rupture.  
4.8.5.3 Homoconjugate Addition 
Previous attempts, described in Section 4.7.4, to rupture doubly activated cyclopropane 
ring under homoconjugate conditions had proven unsuccessful. However, additional literature 
review
248,277
 searches revealed more unorthodox approaches that could lead to desired ring 
rupture.  
4.8.5.3.1 Metal Activated Hydride (NiCl2  NaBH4) 
The first method follows the concept of homoconjugate addition of a nucleophile to 
cyclopropane ring activated by an ester group which could act as a pseudo-Michael acceptor 
(Section 4.7.4). The nucleophile is a hydride anion from sodium borohydride which are known 
to reduce double bonds (and carbonyl moieties) in ,-unsaturated systems. However, by 
coupling the hydride with a transition metal, for instance, nickel, it selectivity can be modified to 
favor soft (double bond) rather than hard (carbonyl group) addition.
278,279  
Mori et al.
280
 applied 
this methodology in total synthesis of (–)-stemoamide (Scheme 122). Treatment of amide 421 
with nickel-activated hydride resulted in 1,4-reduction to generate lactone 422.
280
 
 
 
Scheme 122. Cyclopropane rupture with nickel-activated hydride. 
 
 
 
In our case, the goal was to force an attack onto * of the cyclopropane ring at C7 (and/or C6). 
Nevertheless, after several attempts esters exo-407 and endo-408 failed to undergo any  
pseudo-Michael hydride addition to rupture cyclopropane ring with starting material recovered 
(Scheme 123). 
 
 
Scheme 123. Unsuccessful ring rupture with nickel-activated hydride. 
 
 
It was speculated that that ester-activated cyclopropane ring was too weak of a pseudo-Michael 
acceptor to undergo 1,4-addition utilizing soft hydride species. Whether this is steric or 
electronic in origin remains to be discerned.   
4.8.5.3.2 Magnesium Metal 
An alternative method to nickel chloride-mediated Michael addition of a hydride is 
magnesium mediated methanolysis.
248 
Deslongchamps et al. demonstrated this methodology in 
novel synthesis of 14--hydroxysteroids related to batrachotoxin and ouabain (Scheme 124).249 
Simply subjecting ketoester 423 to magnesium turnings in refluxing methanol resulted in rupture 
of cyclopropane ring and addition of methoxide to yield ketone 424. 
 
Scheme 124. Cyclopropane rupture with magnesium. 
 
 
This selectivity of cyclopropane ring rupture via methoxide was speculated to arise from the 
necessary alignment of C=O -orbitals with the breaking cyclopropane bonds.248 In this 
particular case, only the carbonyl on ketone group can be aligned with -bonds on cyclopropane 
ring (due to its rigidity) as carbonyl on ester has restricted rotation in space.
248 
Additionally, the 
active species is believed to be Mg(OCH3)2 as a source of methoxide which should be formed 
prior to addition of the cyclopropane substrate.
248 
Alternatively, addition of mercuric chloride 
activates magnesium to act as a single electron transfer agent as a capable reducing agent.
281,282
 
 We applied this method to our system. Upon generation of an active magnesium species 
(Mg(OCH3)2), esters exo-407 and endo-408 were subjected to methanolysis in order to rupture 
the cyclopropane ring (Scheme 125). However, once again ring cleavage did not occur (419 and 
420 not observed) even if the reaction mixture was subjected to elevated temperatures.  
 
Scheme 125. Unsuccessful ring rupture with magnesium. 
Two reasons can be used to explain lack of ring rupture. Firstly, insufficient nucleophilicity of 
methoxide anion and its size prevented proper attack on vacant * orbitals on C6 and C7 
carbons. Secondly, there may be lack of proper alignment of -bonds in the cyclopropane with 
the -orbital on the ester carbonyl group. Misalignment of orbitals could be due to the fact that 
ester group is rigid and/or stationary and cannot rotate in space (pointing in the wrong direction) 
reducing chances of proper orbital overlap.  
4.8.5.4 Meldrum’s Acid 
The issue of improper orbital overlap between the cyclopropane ring and the carbonyl 
group on the activating ester moieties a cause of failed ring rupture was an intriguing aspect 
worth exploring further. What if there existed a system that would inherently align -bonds in 
cyclopropane with -orbital on ester carbonyl group as the three member ring is being assembled 
such as Meldrum’s acid moiety. Danishefsky and Singh explored such systems focusing on 
homoconjugate addition in order to rupture a cyclopropane ring formed with Meldrum’s acid 
(Scheme 126).
283
 
 
 
Scheme 126. Cyclopropane ring rupture installed on Meldrum’s acid framework.  
 
 
The rationale of these homoconjugate ring ruptures [427 to 428, 427 to 429 and 427 to 430] 
stems from the observation that alkoxycarbonyl groups on Meldrum’s acid can participate in 
delocalization of developing carbanion only if the plane of cyclopropane is perpendicular to the 
O=C-OR planes of both esters (Figure 49).
283
 
 
Figure 49. Restricted rotation of alkoxycarbonyl groups in Meldrum’s installed on a cyclopropane ring. 
 
 
Motivated to test the viability of this approach, cycloadduct 401 was subjected to standard 
cyclopropanation conditions utilizing freshly prepared diazo Meldrum’s acid 431.207  
However, the reaction revealed formation of only dimer instead of cyclopropanated product 432 
(Scheme 127).  
 
 
 
 
 
 
 
 
 
Scheme 127. Unsuccessful installation of diazo Meldrum's acid onto alkene 401. 
 
 
Though only attempted once, the failure of this particular cyclopropanation was probably due to 
severe steric hindrance associated with formation of the spirocenter at the alkene. 
4.8.5.5 Metal Insertion/Hydrogenolysis 
Disappointed with lack of progress, a decision was made to revisit metal-mediated 
hydrogenolysis but on our model bicyclic system (Scheme 128). In addition, as the ester group 
attached to the cyclopropane ring, being so bulky, may have prevented proper coordination to the 
metal catalyst’s surface, precluding hydride transfer. An exposed hydroxy group (434 and 436) 
was considered for haptophilic delivery of the hydride source
284,285 
or metal-mediated insertion 
into the cyclopropane bond followed by hydrogenation of the resulting metalocycle to generate 
alcohols 435 and 437.
286,287
 
 
Scheme 128. Reduction of steric hindrance around cyclopropane moiety. 
 
 
Ester reduction, a presumably simple task, was not so trivial due to somewhat hindered 
access to cyclopropane esters. Reduction with DIBAL at low temperature not only reducing ethyl 
esters exo-407 and endo-408 but also the carbamate moiety to yield amines 438 and 439, 
especially at elevated temperatures (~ 0 C) (Scheme 129). This problem was overcome by 
utilization of a milder reducing agent – lithium borohydride (LiBH4) which has been shown to 
tolerate the carbamate moiety.
288 
However, overall yields for generated alcohols 434 and 436 
were rather disappointing, especially for endo alcohol 436 which required additional equivalents 
of the reducing agent and extended reaction times.  
 
 
Scheme 129. Chemoselective reduction of esters 407 and 408. 
 
 
4.8.5.5.1 Metal-Mediated Hydrogenolysis 
Once alcohols exo-434 and endo-436 were generated in sufficient quantities, 
investigation of ring rupture was re-initiated employing same conditions as previously described 
(Section 4.7.1). Compared to these methods, however, catalysts loading were modified from 
mole percent (mol%) to percent by weight (%/wt) to ensure faster and complete cyclopropane 
rupture (Scheme 130). However, after multiple attempts employing three different catalysts, 
excess catalysts loadings (up to 215% by weight) and elevated pressure, both cyclopropanes 
resisted rupture with full recovery of starting materials (Table 11). 
 
 
Scheme 130. Failed hydrogenolysis of alcohols 434 and 436.  
 
 
# % / wt t (h) T (
o
C) p (atm) solvent yield (434 & 436) 
Adam's  37 56 rt 1 EtOAc no rupture 
  215 24 rt 6.1 EtOAc no rupture 
Pd/C 37 48 rt 1 EtOH no rupture 
  215 24 rt 6.1 EtOH no rupture 
Pearlman's  37 168 rt 1 EtOH no rupture 
  215 24 rt 6.1 EtOH no rupture 
Pt/C 37 56 rt 1 EtOAc no rupture 
  215 24 rt 6.1 EtOAc no rupture 
 
Table 11. Conditions for hydrogenolysis of alcohols 434 and 436. 
 
 
Any potential modification of steric hindrance and adjusting electronic effects seemed to have no 
positive influence on cyclopropane rupture. Even without the sp
2
 C=O of ethyl ester groups, 
steric hindrance around cyclopropane moiety still may have been too congested to allow for 
metal coordination.  
 
 
 
4.8.5.5.2 Haptophilic Delivery – Crabtree’s Catalyst 
These failed hydrogenolysis outcomes were not a complete surprise, taking into 
consideration our previous failures, but it did open up both esters to additional chemistry that 
could lead to desired cyclopropane rupture.  
One such method involved intramolecular directed delivery of hydrogen via a metal 
coordination to a proximal hydroxyl group – a haptophilic effect. This concept was originally 
described by Thompson et al. who showed that certain moieties, for instance, a hydroxyl group, 
can direct homogeneous hydrogenation from the face containing the ligating group.
284,285,289
 The 
first catalyst used was the lithium salt of alcohol with RhCl(PPh3)3 which was later modified to 
more complicated systems such as [(nbd)Rh(dppb)]PF4 as developed by Brown and Naik.
290
 
However, the true efficacy of haptophilic delivery was unlocked with the development of 
[Ir(cod)(PCy3)py]PF6 440 as developed by Crabtree (Figure 50).
291
 
 
 
Figure 50. Structure of Crabtree’s catalyst. 
 
 
Crabtree et al. presented the effectiveness of the novel catalyst system in homogenous 
hydrogenation of various allylic, homoallylic, and bishomoallylic alcohols and their derivatives 
(Scheme 131).
292 
Subjecting alkene 441 to hydrogenolysis (Pd/C and Ir) resulted in two alkanes 
443 and 445 with different yields and selectivities. Crabtree's catalyst results, compared to Pd/C, 
showed excellent facial selectivities (structures 442 and 444) even if the directing group 
(hydroxy, methoxy or ester moiety) was up to three carbon centers away from the double 
bond.
292
 
 
 
Scheme 131. Advantage of Crabtree's catalyst over standard Pd/C hydrogenation. 
 
 
Subjecting alcohols exo-434 and endo-436 to similar conditions, however, did not result in 
cyclopropane rupture to generate alcohols 435 and 437 (Scheme 132). Even at elevated pressure 
and extended reaction time, only starting material was recovered.  
 
 
Scheme 132. Failed haptophilic hydrogen delivery to rupture cyclopropane ring. 
 
 
4.8.5.5.3 Metal Insertion – Zeise’s Dimer 
 Unsuccessful haptophilic delivery of hydrogen to rupture the cyclopropane ring was yet 
another battle lost but capitulation was not an option. Especially, as reduced steric congestion 
around the cyclopropane ring in alcohols exo-434 and endo-436 allowed for additional 
methodologies to be tested, one of them being brute insertion of a metal into the cyclopropane 
ring followed by rupture of the resulting cyclometallobutane. Jennings et al. illustrated this 
methodology by inserting stoichiometric salts of platinum metal (Zeise’s dimer (C2H4)2Pt2Cl4)
293
 
into cyclopropane rings (Scheme 133).
287 
Insertion  of a metal into naked cyclopropane 446 
resulted in unstable intermediate 447 which upon heating underwent rearrangements to 
compounds 448-456.
287
 
 
 
Scheme 133. Diversity of Zeise's dimer. 
 
 
Additionally, the unstable intermediate 447 could be converted to a stable species 457 by 
addition of pyridine.
287
 Later that year, Jennings et al. expanded his methodology to include 
substituted cyclopropane rings mounted on a norborane framework (Scheme 134). Alcohols 458 
and 459 were treated with Zeise’s dimer and ligated with pyridine to afford stable intermediates 
460 and 461.
294,295
 Subsequent addition of methanol under acidic conditions resulted in ring 
expansion to furnish a five-member ring platinum salts 462 and 463.
294,295
 
 
 
Scheme 134. Insertion of Zeise’s dimer into cyclopropane ring. 
 
 
However, what was missing in these studies as presented was removal of pyridine-stabilized 
platinum from the complex. As in the case of unstabilized metal complex 457, exposure to heat 
would lead to ,-eliminations/rearrangement (Scheme 134 above) but the same has not been 
observed (or studied) when pyridine occupied vacant sides on the metal. It might be that 
additional catalyst system may be needed in order to excise the metal.  
 Jenning’s initial studies were later adopted by Snyder et al. where secondary alcohols or 
their derivatives were treated with catalytic amounts of Zeise’s dimer in order to 
rearrange/rupture cyclopropane ring (Scheme 135).
296,297 
Once such instance involved addition of 
Zeise’s dimer to alcohol 464 where hydroxyl directed Pt insertion (465 and 466) from the upper 
face was followed by hydride transfer, resulting in platinum enolate 467. Upon tautomerization 
this released platinum to yield ketone 468.
296,297
 
 
 
Scheme 135. Cyclopropane rearrangement induced by Zeise's dimer. 
 
 
Armed with new methodology, alcohols exo-434 and endo-436 were subjected to catalytic  
(10 mol%) Zeise’s dimer in refluxing toluene (Scheme 136). However, after two days at reflux, 
NMR analysis revealed no products (469 and 470) formation and only starting materials were 
recovered. 
 
 
Scheme 136. Failed cyclopropane rearrangement induced by Zeise's dimer. 
 
 
Nonetheless, switching to stoichiometric amounts of Zeise’s dimer gave completely different 
results. Thus, alcohols exo-434 and endo-436 were treated with a full equivalent of platinum 
catalyst and the complex was stabilized with deuterated pyridine (for NMR analysis) to yield 
salts 414 and 416 (Scheme 137). The addition of labeled pyridine increased electron density 
around the complex and stabilized it. In order to force reductive elimination, platinum complexes 
414 and 416 were subjected to harsh hydrogenolysis conditions involving elevated pressure  
(6.1 atm) and excessive catalyst loading (215 % Pd/C by wt). As a result, both platinum 
complexes 414 and 416 desired yet non-regioselective rupture to furnish an inseparable mixture 
of alcohols 415 and 417 with an approximate ~ 2:1 ratio (as determined by NMR).  
 
 
Scheme 137. Successful cyclopropane rupture with Zeise's dimer. 
 
 
This partial victory was indeed a much yearned success though required serious improvement to 
progress. Judging by significant recovery of the starting alcohols exo-434 and endo-436, 
improved insertion conditions would have to be developed, coupled with better choice of catalyst 
to improve hydrogenolysis outcome. Finally, the question of proper regioselectivity (rupture at 
C7 not C6 position) was going to be difficult to answer due to unselective insertion of platinum. 
Literature review
298-301
 was somehow helpful to tackle cyclopropane rupture, but conditions 
described there must be modified to fit our unique system. Low de, additional synthetic steps and 
poor selectivity forced us to seek a more viable route.   
 
4.9 Crowbar Approach – A Model Study 
This partial victory with Zeise’s dimer, even though a fractional success, could not be 
considered a desirable synthetic approach due to additional steps and lack of desired 
regioselectivity. It was already established, through multiple failures, that steric hindrance and/or 
electronic factor around mono-, and di-substituted cyclopropane rings presented an 
unsurmountable obstacle to affect rupture. Therefore, a different approach that bypassed these 
issues altogether would be in order; a tactic to pry out the ring instead of rupturing it. This notion 
came to mind while attempting to rupture cyclopropane ring under radical anion conditions  
(Section 4.7.3.1). In this particular case, carbonyl group on either ester would accept a radical 
from SmI2 and undergo radical clock cleavage (intermediates 473 – 475 and 474 – 476) to 
generate either diester 332 or 361 but in a non-regioselective manner (Scheme 138). 
 
 
Scheme 138. Cyclopropane rupture under radical conditions. 
 
 
Regioselectivity could be completely controlled with a modified system 477 where C6 group is 
installed via cyclopropane rupture mediated by a radical generated at C8 478. This upon 
collapsing would rupture the ring in a regiospecific manner to afford desired alkene 479  
(Scheme 139).  
  
 
Scheme 139. Radical clock reaction to rupture cyclopropane ring on ester 477. 
 
 
In the case when the handle (radical precursor) consist of a halide, Danishefsky et al. utilized 
iodide 480 in the -position to cyclopropane ring and converted it to a radical with SmI2 en route 
to () – Aplykurodinone-1 to furnish ester 481 (Scheme 140).232 
 
 
Scheme 140. SmI2-mediated radical cyclopropane ring rupture.  
 
Similarly, Shishido et al. used analogous methodology in the fragmentation reaction of optically 
active trisubstituted cyclopropylcarbinyl radicals (Scheme 141).
237
 Ester 482 was treated with  
n-tributyltin hydride to generate a radical 483 that would undergo radical clock ring opening 
(intermediate 484) to generate alkene 485 in excellent yield.
237
 The ester was crucial in 
determination of regioselectivity. 
 
 
Scheme 141. n-Bu3SnH-mediated radical cyclopropane ring rupture. 
 
 
4.9.1 Introduction of the Handle – Allylic Halogenation  
 One possible approach to introduce a halide (Cl, Br or I) in the -position on alkene 401  
would be allylic halogenation with N-chlorosuccinimide (NCS),
302
 N-bromosuccinimide 
(NBS)
303
 or N-iodosuccinimide (NIS)
304
 to afford allylic halide 485 (Scheme 142). 
 
 
Scheme 142. Allylic halogenation of alkene 401. 
 
Surprisingly, several attempts to introduce bromide at C8 position involving NBS
304-309
 failed 
miserably (Scheme 143). Instead of generating desired alkene 486, NMR analysis revealed that 
cycloadduct 401 was brominated at multiple sites. This startling outcome was rather wearisome 
because it evoked that the necessary halide substituent would have to be introduced into the 
molecule from the very onset.   
 
 
Scheme 143. Failed allylic bromination of cycloadduct 401. 
 
 
Additionally, an attempt was made to brominate cyclopropanes 407 and 408 directly with NBS 
to bromides 487 and 488. However, this ambitious goal also failed as NMR analysis revealed 
unreacted esters 407 and 408, along with minor unidentified side-products (Scheme 144). 
 
 
Scheme 144. Failed allylic bromination of cyclopropanes 407 and 408. 
 
 
 
4.9.2 Introduction of the Handle – Allylic Oxidation at C8 
 Unsuccessful allylic bromination was a setback but alternative ways to introduce a halide 
at C8 position were available. One such method involved allylic oxidation of alkene 401 to 
afford allylic alcohol 489 and subsequent conversion to a radical precursor 485 (Scheme 150).
232 
This particular approach would add two synthetic steps but it would also allow options for 
introduction of several radical precursors.  
 
 
Scheme 145. Allylic oxidation at C8 of cycloadduct 401. 
 
Scientific literature is rich in examples of allylic oxidations employing oxidizing agents such as 
pyridinium dichromate (PDC)
310
 metal catalysts
311,312,313
 or selenium dioxide (SeO2).
314,315
 
However, allylic oxidation in a six-member ring possess inherent problems when methylene and 
methine sites are available with the latter being favored.
316  
We were hoping the topological 
constraints of our tricyclic system would overcome this. However, subjecting cycloadduct 401 to 
metal-mediated allylic oxidation
311 
failed to furnish desired alcohol 489 but yielded multiple 
oxidized byproducts (Scheme 146).  Correspondingly, employing SeO2 did result in allylic 
oxidation but the major product was alcohol 490 where the C5a position was oxidized; oxidation 
at the C8 position was minimal and gave a mixture of epimers 489.  
 
 
 
Scheme 146. Failed allylic oxidation at C8 of cycloadduct 401. 
 
 
Thus, as speculated before, introduction of a handle for the radical clock reaction would have to 
be introduced earlier in the synthesis. A redesign of the initial approach that afforded 
cycloadduct 485 was thus necessary. 
4.9.3 Synthesis of Chlorinated cis-Cycloadduct 
Unsuccessful introduction of either halogen and/or hydroxyl on cycloadduct 401 required 
an alternate synthesis to achieve radical precursor 485. The goal was thus to install a halide on 
initial diene backbone (Scheme 147). Hence, it was envisaged that halide cycloadduct 491 could 
arise from IMDA of triene 492, in turn generated from introduction of oxazolidinedione to 
alcohol 493. This would arise via Sonogashira coupling
317
 of alkyne 494 and alkene 495 
followed by stereoselective reduction.
 318,319 
There was a concern, however, regarding stability of 
halide triene 492 during IMDA. An initial literature review
320
 suggested that at elevated 
temperatures halides, in particular, bromides and iodides tend to decompose. Therefore, chloride 
was any chosen to reduce chances of unfavorable degradation.   
 
 
Scheme 147. Retrosynthesis of halogenated cycloadduct 491. 
 
4.9.3.1 Synthesis of Chlorinated Triene 
Synthesis of chlorinated cycloadduct 491 was achieved via modification of our approach 
to triene 405 (Section 4.8.1). Commercially available alkyne 494 was coupled to  
trans-1,2-dichloroethylene 495 via Sonogashira reaction
137 
to furnish alcohol 496 (Scheme 148). 
Careful stereoselective reduction of enyne with sodium bis(2-methoxyethoxy) aluminum hydride 
(Red-Al)
318,319 
afforded almost exclusively E,E-diene 493. The three-step protocol developed by 
Shibuya
168
 introduced oxazolidinedione 263 moiety via Mitsunobu reaction
177,178
 to furnish 
carbamate 497. Subsequent reduction/elimination yielded triene 492. 
 
 
Scheme 148. Synthesis of chlorinated triene 492. 
 
 
4.9.3.2 Intramolecular [4 + 2] Diels-Alder Cycloaddition 
 With triene 492 at hand, it was subjected to our by now standard IMDA cycloaddition. It 
was expected that cycloaddition would proceed effortlessly yielding similar results as previously 
described (Section 4.2 and Section 4.8.1). However, initial results were disappointing  
(Scheme 149). Exposing triene 492 to high temperature (~ 181 C) resulted in decomposition of 
generated cycloadducts. Numerous attempts to separate and characterize these products were 
unsuccessful.  
 
 
Scheme 149. Unsuccessful IMDA on triene 492. 
 
Therefore, a systematic study was launched to determine the cause of such severe degradation. 
Running reactions at NMR scale revealed that within first 24 h of heating (~ 181 C), triene 492 
was converted to two products, presumably cis-491 and trans-498 cycloadducts (Schema 150). 
However, after a further 24 h, degradation of previously formed products was evident. 
 
 
Scheme 150. Partial conversion of triene 492 to cycloadducts 491 and 498. 
 
 
Product degradation after 24 h at these elevated temperatures suggested a decrease in 
temperature might reduce decomposition and improve overall selectivity. Indeed, a temperature 
gradient IMDA study did reveal that lowering the temperature to ~ 155 C not only allowed for 
formation of desired cycloadducts 491 and 498 (Scheme 151) but minimized their degradation 
(Table 12). 
 
 
Scheme 151. Successful IMDA of triene 492 at reduced temperature. 
 
 
# T (°C) Time (h)    cis / trans     Yield (491 & 498) 
1 182     72 decomposition                      - 
2 175     72 decomposition                      - 
3 166     72 1.6 : 1 (partial decomposition)             71 % (by NMR) 
4 155     96        3.4 : 1             80% (by NMR) 
5 145    120   no reaction                      - 
 
Table 12. Optimization of IMDA for chlorinated cycloadduct. 
 
 
4.9.3.3 Structure Elucidation by NMR Analysis 
4.9.3.3.1 Structure Elucidation of Major Chlorinated cis-Cycloadduct 
Structure elucidation achieved by multiple NMR techniques (
1
H, 
13
C, DEPT, gDQCOSY, 
1D & 2D NOESY, zTOCSY, HOMODEC, gHSQC, gH2BC and gHMBC).  
In the case of cis-491, its formation in 
1
H NMR was manifested by disappearance of the 
characteristic methylene and methine signals in triene 492 and formation of only two methine 
signals in cis-491. Additionally, mass spectrometry data revealed conservation of mass 
(214.0648 g/mol for 492 and 214.0646 g/mol for cis-491) suggesting successful [4 + 2] 
cycloaddition. 
 Having established IMDA has proceeded satisfactorily, we moved to determine the 
stereochemistry of the ring junction. 2D gDQCOSY abreast with decoupling of the CDCl3 
solution proved very useful as the important diagnostic signals were kindly resolved. As a matter 
of fact, all signals were distinct except for H4ax and H4eq that were merged. The key diagnostic 
signals, H5a and H9a, had J = 4.2 Hz corresponding to dihedral angel of ~ 60 which is typical 
of cis-fused rings and were very similar to cis-401 shifts. The position of exo-chloride group was 
determined by small J = 1.6 Hz between H6 and H8ax suggesting dihedral angel of ~ 90. If 
chloride were endo, we would have seen ~ J = 7 Hz between H6 and H8eq which was not 
observed. Also, there is a small J = 2.1 Hz and J = 2.4 Hz between H9 and H8ax. Furthermore, 
H8ax signal is fairly deshielded suggesting an electron withdrawing group. Additional coupling 
constants are presented in Figure 51. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 51. Diagnostic coupling constants for cis-491 in CDCl3. 
 
 
Further evidence of a cis-ring junction, its conformation and position of chloride group came 
from 1D and 2D NOESY experiments (Figure 52). It was revealed that the A ring adopted a boat 
conformation based on observed weak nÖe (1.3%) between H5a and H8ax across the A-ring. 
This also proved that since there existed nÖe between H8ax and H5a, chloride must be in  
exo position. Ring B, on the other hand, adopted chair-like conformation based on observed 
weak nÖe’s between H6 and H4ax (1.4%).  
 
 
 
 
 
 
 
 
 
Figure 52. Diagnostic nÖe’s for cis-491 in CDCl3. 
 
 
 
 
 
 
4.9.3.3.2 Structure Elucidation of Minor Chlorinated trans-Cycloadduct 
Similarly, identity of trans-498 cycloadduct was confirmed. Formation of minor 
cycloadduct in 
1
H NMR was manifested by disappearance of the characteristic methylene and 
methine signals in triene 492 and formation of a single peak in trans-406 in alkene region 
integrating for two protons. Additionally, mass spectrometry data revealed conservation of mass 
(214.0648 g/mol for 492 and 214.0637 g/mol for trans-498) suggesting successful [4 + 2] 
cycloaddition.  
Having established IMDA has proceeded satisfactorily, we moved to determine the 
stereochemistry of the ring junction. 2D gDQCOSY abreast with decoupling of the CDCl3 
solution proved very useful as the important diagnostic signals were kindly resolved. As a matter 
of fact, all signals were distinct except for H5a and H4eq and H6 and H7 that were merged. The 
key diagnostic signals, H5a and H9a had J = 9.6 Hz corresponding to dihedral angel of ~ 180 
which is typical of trans-fused rings. Also, signal H5ax had a J = 12.5 Hz to H5a, suggesting 
trans-orientation. The position of exo chloride group was determined by small J = 1.7 Hz 
between H6 and H8ax suggesting dihedral angel of ~ 90. If chloride were endo, we would have 
seen ~ J = 7 Hz between H6 and H8eq which was not observed. Also, there was a small  
J = 5.0 Hz and J = 5.1 Hz between H9 and H8ax dihedral angel of ~ 60. Furthermore, H8ax 
signal is fairly deshielded suggesting an electron withdrawing group. Additional coupling 
constants are presented in Figure 53. 
 
 
 
 
 
 
 
 
 
 
Figure 53. Diagnostic coupling constants for trans-498 in CDCl3. 
 
 
Further evidence of a trans-ring junction and its conformation came from 1D and 2D NOESY 
experiments (Figure 54). It was revealed that the A ring adopted an inverted boat conformation 
based on observed weak nÖe’s between H5a and H8ax across the A-ring. Ring B, on the other 
hand, adopted chair-like conformation based on observed weak nÖe’s between H5ax and H9a.  
  
 
 
 
 
 
 
 
 
 
Figure 54. Diagnostic nÖe’s for trans-498 in CDCl3. 
 
 
4.9.4 Cyclopropanation with Ester-Stabilized Diazo Reagent  
4.9.4.1 Synthesis of Chlorinated cis-Cyclopropane 
Successful generation of the desired cycloadduct 491, as the main product, allowed 
progression to the next step  installation of a cyclopropane ring with mono ester substituent. 
Employing conditions as previously optimized (Section 4.6.1.4 and Section 4.8.3), alkene 491 
was converted to cyclopropanes endo-500 and exo-499 in ratio 1.7:1, respectively (Scheme 152). 
As predicted, due to -chloride, endo-500 was preferred over exo-499. 
 
 
Scheme 152. Cyclopropanation of alkene 491.  
 
 
4.9.4.2 Structure Elucidation by NMR Analysis 
4.9.4.2.1 Structure Elucidation of Chlorinated exo--Monoester 
S Structure elucidation achieved by multiple NMR techniques (
1
H, 
13
C, DEPT, 
gDQCOSY, 1D & 2D NOESY, zTOCSY, HOMODEC, gHSQC, gH2BC and gHMBC). 
In the case of cyclopropane exo-499, its formation in 
1
H NMR was manifested by 
conversion of the obscure and characteristic alkene signals in cycloadduct 491 and formation of 
two broad and nicely resolved doublet of doublet of doublets leaning towards each other in 
cyclopropane exo-499. Further evidence came from mass spectrometry data which revealed that 
presumed cyclopropane exo-499 (exact mass 300.1003 g/mol) gained 86.0357 mass units from 
cycloadduct 491 (214.0646 g/mol) which corresponded to the exact mass of ethyl 2-diazoacetate 
carbenoid.  
Having established cyclopropanation has proceeded satisfactorily, we moved to 
determine the stereo- and regiochemistry of attached cyclopropane. 2D gDQCOSY abreast with 
decoupling of the C6D6 solution proved very useful as the important diagnostic signals were 
kindly resolved due to lack of H3a side chain. The key diagnostic signal for the cis-ring junction 
H9a, H5a, C-O bond (H9) were very similar to 
1
H NMR of cyclopropane monoester exo-407 
(Figure 50). The -facial position of the cyclopropane ring was initially deduced from coupling 
constants for signals H8ax, H7, H6, H5a and H13. H7 and H6 had J = 9.7 Hz and J = 9.8 Hz 
suggesting a dihedral angel of ~ 0. Also, H7 had J = 7.8 Hz and J = 8.0 Hz to H8ax suggesting 
that they were trans and H6 had J = 8.1 Hz to H5a pointing as well to trans orientation. In 
addition, H13 had J = 3.9 Hz to H6 and J = 3.7 Hz to H7 suggesting that H6 and H7 are on the 
same plane and H13 is on the opposite, trans plane pointing above the A-ring and forcing ester 
group away from the ring in exo position. Additional coupling constants are presented in Figure 
55. 
 
 
 
 
 
 
 
 
 
 
Figure 55. Diagnostic coupling constants for exo-499 in C6D6. 
Further evidence of -position of cyclopropane ring and its conformation came from 1D and 2D 
NOESY experiments (Figure 56). It was presumed that the A ring retained its boat conformation 
(as in cycloadduct 351a) due to the presence of -cyclopropane. This is supported by nÖe 
between H8ax and H5a (tips of the boat). Ring B also retained its chair-like conformation based 
on observed nÖe’s between H9 and H3aax and H6 and H4ax. Exo-position of the ester was 
confirmed by nÖe's between H13 and H8ax and H5a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 56. Diagnostic nÖe’s for exo-499 in C6D6. 
 
 
 
4.9.4.2.2 Structure Elucidation of Chlorinated endo--Monoester 
Similarly, in the case of cyclopropane endo-500, its formation in 
1
H NMR was 
manifested by conversion of the obscure and characteristic alkene signals in cycloadduct 491 and 
formation of two broad and nicely resolved quartet and triplet leaning towards each other in 
cyclopropane endo-500. Further evidence came from mass spectrometry data which revealed that 
presumed cyclopropane endo-500 (exact mass 300.0992 g/mol) gained 86.0346 mass units from 
cycloadduct 491 (214.0646  g/mol) which corresponded to the exact mass of ethyl 2-diazoacetate 
carbenoid.  
Having established cyclopropanation has proceeded satisfactorily, we moved to 
determine the stereo- and regiochemistry of attached cyclopropane. 2D gDQCOSY abreast with 
decoupling of the C6D6 solution proved very useful as the important diagnostic signals were 
kindly resolved due to lack of H3a side chain. The key diagnostic signal for the cis-ring junction 
H9a, H5a, C-O bond (H9) were clearly distinct but not similar (in terms of shifts) to 
cyclopropane endo-408 (Figure 57). The -facial position of the cyclopropane ring was initially 
deduced from coupling constants for signals H6 (triplet), H7 (quartet) and H13 (m) which had 
basically the same J = 8.3 Hz suggesting a dihedral angel of ~ 0. Hence, all three signals must 
have been in the same plane otherwise, one signal would have had a smaller coupling constant as 
it was seen in exo-500. Additionally, having H13 in the same plane as H6 and H7 would place 
ester group above the A-ring, this in endo-position. Also, there is J = 8.1 Hz and J = 8.5 Hz 
between H7 and H8ax.  
 
 
 
 
 
 
 
 
 
 
Figure 57. Diagnostic coupling constants for endo-500 in C6D6. 
 
Further evidence of -position of cyclopropane ring and its conformation came from 1D and 2D 
NOESY experiments (Figure 58). It was presumed that the A ring retained its boat conformation 
(as in cycloadduct 491) due to the presence of -cyclopropane. This is supported by nÖe 
between H8ax and H5a (tips of the boat). Ring B also retained its chair-like conformation based 
on observed weak nÖe’s between H9a and H3aax and H9a and H5ax. Furthermore, endo-position 
of the ester group is supported by lack of nÖe between H13 and either H8ax or H5a and nÖe's 
between H13 and H7 and H13 and H6. 
  
 
Figure 58. Diagnostic nÖe’s for endo-500 in C6D6. 
 
 
 
 
4.9.5 Cyclopropane Rupture – Radical Clock  
4.9.5.1 Radical Clock     
Armed with novel cyclopropane systems 499 and 500, radical cyclopropane rupture was 
initiated following the procedure previously described by Shishido et al.
237
 (Scheme 153) in 
order to generate alkene 479 via intermediate 478.
 
However, several concerns arose with this 
approach. First of all, the original protocol called for reaction of n-tributyltin hydride  
(n-Bu3SnH) with iodide.
237 
In our case, chloride would be utilized as its precursors was easily 
available to generate esters 499 and 500.
 
Additionally, n-Bu3SnH is not usually a preferred 
choice for removal of secondary chloride under radical conditions; more appropriate partner 
would be tris(trimethylsilyl)silane [(TMS)3SiH]
322
, for instance. However, in order to 
successfully rupture the adjacent cyclopropane ring, any radical should ideally undergo 
intramolecular rearrangement rather than intermolecular reduction.
237
 
 
 
Scheme 153. Radical clock approach to rupture cyclopropane ring. 
 
 
 
 
In addition, analysis of this reaction pathway suggested formation of a trans-cycloheptene ring 
501 a highly unlikely event. As previously stated (Section 4.7.3), larger rings undergo rupture at 
much slower rate unless radical formation can be stabilized by adjacent substituents
234
 of which 
there are none in esters 499 and 500 (Scheme 154).  
 
 
Scheme 154. Kinetics of cyclopropane ring rupture. 
 
 
Taking into account all possible variables described above, esters 499 and 500 were subjected to 
excess of n-Bu3SnH (4 equiv) and azobisisobutyronitrile (AIBN) (20%) in benzene (10 mM) 
confined to a sealed tube and refluxed at 110 C for 72 h (Scheme 155). Benzene was chosen 
instead of toluene to prevent any possible radical cleavage of it that may have led to side 
products. Additionally, since benzene boils 21 C lower than toluene, thus sealed tube conditions 
were chosen to add extra thermal energy and pressure to the system.   
Gratifyingly, the only product generated was the desired alkene 479 as suggested by 
initial NMR analysis of the crude. Subsequently, column chromatography revealed pure  
,-unsaturated 479 in 90% yield. 
 
 
Scheme 155. Successful rupture of cyclopropane via radical clock to alkene 479. 
 
 
4.9.5.2 Structure Elucidation by NMR Analysis 
4.9.5.2.1 Structure Elucidation of Ruptured Alkene 
Structure elucidation achieved by multiple NMR techniques (
1
H, 
13
C, DEPT, gDQCOSY, 
1D & 2D NOESY, zTOCSY, HOMODEC, gHSQC, gH2BC and gHMBC). 
In the case of alkene 479, its formation in 
1
H NMR was manifested by appearance of two 
alkenes peaks suggesting a double bond. Further evidence came from mass spectrometry data 
which revealed that cyclopropanes 499 and 500 (exact mass 300.1003 g/mol and 300.0992 
g/mol, respectively) both lost 11.9789 and 11.9778 mass units, respectively (lost mass 
corresponds to loss of Cl
-
 and gain of Na
+
) to yield alkene 479 (exact mass 288.1214 g/mol).  
Having established cyclopropane rupture has proceeded satisfactorily, we moved to 
determine the stereo- and regiochemistry of alkene structure. 2D gDQCOSY abreast with 
decoupling of the CDCl3 solution proved very useful as the important diagnostic signals were 
kindly resolved. As a matter of fact, all peaks were distinct which allowed for thorough analysis  
The key diagnostic signals for the cis-ring junction (H9a and H5a) were located 
effortlessly, as they were very similar to previous cis-structures, and allowed for further 
assignment of all signals. The key signal was H6 which had J = 10.1 Hz to H5a suggesting a 
dihedral angel of ~ 180, and thus trans-alignment and J = 1.3 Hz to H7 signifying a dihedral 
angel of ~ 90. This information was crucial because it shed light on the conformation of the  
A-ring and suggested an inverted boat where H6 was in the axial downward (with respect to H9 
which was upward) position and thus placing C6 group in the equatorial up position. This was 
further substantiated by interaction between H8 and H9 which had J = 3.3 Hz and J = 3.6 Hz 
suggesting a dihedral angel of ~ 60. If H6 had been in equatorial down position, it would have 
had a dihedral angel of ~ 90 to H5a (0 – 2 Hz), a dihedral angel of ~ 0 to H7 (7 – 11 Hz) and 
H9 would have had a dihedral angel of ~ 90 to H8 (0 – 2 Hz) which was not observed. 
Additional coupling constants are presented in Figure 59. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 59. Diagnostic coupling constants for alkene 479 in CDCl3. 
 
 
There was a predicament, however, whether the A-ring was a six- or a seven-member ring. 
Analysis using C-H analysis exposed the clear winner. Firstly, gHSQC and DEPT revealed that 
two H13 signals were on the same carbon indicating methylene and H6 was on one carbon 
signifying methine carbon. This was further substantiated by gH2BC (correlate protons with 
carbons through 
1
H – 1H vicinal and 1H – 13C one-bond coupling connectivity) which showed 
that H5a and H7 protons were correlating with carbon bearing H6. Finally, gHMBC (correlates 
protons with carbons, usually over 2-3 bonds with the 3-bond being stronger) definitively proved 
that C13 was interacting with C7 and C5a signals and C6 with C9a.   
 Further evidence of alkene 479 ring’s conformation came from 1D and 2D NOESY 
experiments (Figure 55). It was presumed that the A-ring adopted inverted boat conformation 
(H6ax downwards and H9 upwards) placing H6 on the axial position facing downward. This 
conformation would results in ring B being in its preferred chair-like conformation which was 
deduced based on nÖe’s between H6ax and H4ax and H13 and H5eq. Additional coupling 
constants are presented in Figure 60. 
 
 
 
 
 
 
 
 
 
 
 
Figure 60. Diagnostic nÖe’s for alkene 479 in CDCl3. 
 
 
 
 
 
4.10 Conclusion 
The purpose of this dissertation research was to design and execute the total synthesis of 
()-Gephyrotoxin 287C. However, due to unforeseen hurdles, firstly with the over-ambitious 
tandem cascade to form pyrrolidine C-ring that failed and secondly with futile cyclopropane ring 
rupture that occurred only after significant redesign, the attainment of the final goal has not been 
completed. Nevertheless, significant progress has been made towards the total synthesis of  
()-Gephyrotoxin 287C. Through completed model studies, the synthesis of all five stereocenters 
(C1, C3a, C5a, C6, and C9a) has been established and the compound contains much of the 
functionality needed for final embellishments. Studies are ongoing to complete the total 
synthesis of ()-Gephyrotoxin 287C 1. The aim is to complete the target in 18 linear steps.  
The final few steps are known literature procedures and utilize reagents that are easy to run on 
large scales. The only necessary improvements are slightly higher yields for selected steps, for 
example, cyclopropanation.  
 
 
 
 
 
 
 
 
 
 
Chapter 5 
5. Recommendations for Future Studies 
Obviously our prime objective is the complete total synthesis of ()-GTX 1. The 
successful cyclopropane rupture with complete regioselectivity allows for progression to the 
final target. Therefore, the last obstacle envisaged would be selective excision of carbamate 
moiety to release free amine. The concept envisaged subjecting alkene 502 to a metal (Pd), 
which would eliminate the oxazolone moiety by formation of a -allyl complex to generate 
secondary amine 503 (Scheme 156). This in turn, would undergo Michael addition proceeded by 
removal of the acetal group to form ABC scaffold 504. The overall concept behind this particular 
approach was to revisit our failed C-ring formation via tandem elimination/ring closure  
(Section 4.5). 
 
 
Scheme 156. Carbamate excision by formation of a -allyl complex. 
 
The underlying methodology was developed by Tsuji et al.
323
 Addition of palladium (0) 
to an allylic system 505 with a good leaving group (X) would lead to -allyl insertion of the 
metal and transfer of X to metal’s vacant site to form -allyl complex 506 (Scheme 157).323 
Addition of ammonium formate (HCO2H  NH3) as a hydride source would replace ligand(s) on 
palladium to afford complex 507 which would subsequently undergo decarboxylation to yield 
complex 508 which would transfer a hydride to form either alkene 509 or 510.
323
 
 
 
Scheme 157. Mechanism for allylic transposition. 
 
 
Allylic transposition has been applied successfully to excise simple carbamates. Suzuki et 
al.
324 
demonstrated this concept by exposing carbamate 511 to palladium (0) which upon 
insertion into double bond and subsequent delocalization cleaved the C-O bond, releasing 
carbamate anion and -allylpalladium complex 512 (Scheme 158). Introduction of a nucleophile 
(primary amine) led to an attack at the least hindered side, excision of carbon dioxide, 
dissociation of palladium (0) and formation of desired amine 513.   
 
 
Scheme 158. Pd-mediated excision of carbamate. 
 
 
Similarly, Guibe et al.
325
 exposed carbamate 514 to palladium (0) to form  
-allylpalladium complex that was quenched by tinhydride acting as a nucleophile to furnish 
amine 515 and alkene 516 (Scheme 159). 
 
 
Scheme 159. Carbamate excision with Pd and tin hydride. 
 
 
With the last obstacles tackled, the total synthesis of ()-GTX 1 would proceed as shown 
(Scheme 160). Commercially available alkyne 494 would be extended to alkene 436 via 
Sonogashira coupling. Stereoselective reduction would afford alcohol 493 which in turn would 
be oxidized to aldehyde 517 followed by Grignard addition to generate alcohol 518. A three-step 
protocol developed by Shibuya would be employed
168 
to install oxazolidinedione 263 to furnish 
carbamate 519 which would undergo chemoselective reduction then elimination to generate 
desired alkene 520. Intramolecular Diels-Alder cycloaddition would furnish desired  
cis-cycloadduct 521, which in turn would undergo face-selective cyclopropanation to ester 522 
and regiospecific ring rupture to yield alkene 523. Hydrolysis of cyclic acetal and standard 
Wittig extension would afford alkene 502, which in turn would undergo -allylic reduction, 
employing palladium chemistry, to furnish amine 503. Hydrolysis of cyclic acetal would release 
the required ,-unsaturated Michael acceptor, which would undergo spontaneous 1,4-addition 
followed by aldehyde reduction to generate alcohol 524. Hydrogenation of alkene 524 would 
afford ester 525, which would undergo partial reduction to aldehyde 526 and subsequent enyne 
extension would yield desired ()-GTX 1. We are currently on step 523, investigating the  
-allylic reduction of the cyclic carbamate 523. The final steps, closure of the C-ring in Michael 
fashion, homologation of the C6 side chain, are either known or closely analogous to prior 
studies. Therefore, we are highly confident in the future success of our approach.  
 
Scheme 160. Proposed synthetic route to ()-GTX 1. 
Experimental 
 
 
General Experimental Procedures: All non-aqueous reactions were carried out under argon 
using standard techniques for the exclusion of air and moisture. All solvents used were obtained 
anhydrous, either by appropriate distillation or by direct purchase. Where necessary, reagents 
were dried and purified according to the recommended methods. Thin layer chromatography was 
carried out on EM Science pre-coated 5 cm glass plates (250 mm w/fluorescent indicator). Flash 
chromatography was performed over ICN Flash Silica Gel (230-400 mesh, 32-63 μM). Infra-red 
absorption spectra were recorded as thin films or NaCl discs. 
1
H and 
13
C NMR spectra were 
recorded at 400/500 and 100/125 MHz, respectively, as referenced to the appropriate deuterium 
lock. Standard splitting patterns are abbreviated: s (singlet), d (doublet), t (triplet), q (quartet), p 
(pentet), m (multiplet), br (broad), v (very), app (apparent). J values are given in Hz. 
 
oxazolidine-2,4-dione (263): to a stirred solution of glycolamide (5.0 g; 66.61 mmol; 1.0 eqiuv) 
and 1.0 M potassium tert-butoxide in tert-butyl alcohol (8.221 g; 73.27 mmol; 1.1 equiv) was 
added diethyl carbonate (9.443 g; 79.93 mmol; 1.2 equiv) and reaction was brought to reflux.  
After 24 h, heat was removed and excess solvent removed in vacuo.  Brine (50 mL) was added 
and the mixture was acidified to pH = 2 with 6 N aqueous hydrochloric acid (10 mL).  
Ethyl acetate (25 mL) was added and the resulting mixture partitioned, and the aqueous layer 
further extracted with ethyl acetate (3 x 25 mL). The combined organic phases were washed with 
brine (25 mL), dried (magnesium sulfate), filtered and reduced in vacuo to yield white solid: 
4.4956 g; 44.48 mmol; 67%; 
1
H NMR: (400 MHz; DMSO-d6)  11.847 (s, 1H)  4.755 (s, 2H); 
 
13
C NMR: (100 MHz; DMSO-d6)  173.523, 156.799, 69.293. 
 
(E)-hepta-4,6-dienal (261): To a stirred solution of 1,4-pentadien-3-ol 259 (10.0 g;  
0.1189 moles; 1.0 equiv) in vinyl isobutyl ether 260 (50.07 ml; 0.4875 mol; 4.1 equiv) was 
added sodium acetate (0.4388 g; 5.351 mmol; 0.045 equiv) and mercury (II) acetate (1.5154 g; 
4.756 mmol; 0.04 equiv) and brought to reflux. After 24 h, heat was removed and excess vinyl 
isobutyl ether removed in vacuo to yield 15.5841 g of cloudy oil. In vacuo distillation at 55 C 
and 7 mmHg yielded colorless oil: 9.8915 g; 89.8 mmol; 75%. 
1
H NMR: (400 MHz; CDCl3)  
 9.775 (s, 1H),  6.283 (dt, J = 17.1, 2 x 10.3 Hz, 1H),  6.082 (ddm, J = 15.2, 10.5 Hz, 1H),  
 5.685 (dt, J = 14.7, 2 x 7.0 Hz, 1H),  5.119 (ddd, J = 16.5, 1.3, 0.7 Hz, 1H),  5.000  
(ddd, J = 10.0, 1.2, 0.6 Hz, 1H),  2.551 (tm, J = 2 x 7.2 Hz, 2H),  2.420 (dd, J = 14.0, 7.2 Hz, 
2H); 
13
C NMR: (100 MHz; CDCl3)  201.764, 136.665, 132.287, 115.950, 47.740, 43.089, 
24.983. 
 
tert-butyl(3-iodopropoxy)dimethylsuilane (281): To a stirred suspension of 3-bromo-1-
propanol 280 (2.17 g; 15.64 mmol; 1.0 equiv) and 4-dimethylaminopyridine (0.2102 g;  
1.72 mmol; 0.11 equiv) in CH2Cl2 (50 mL) cooled to 0 C, was added dropwise triethyl amine 
(2.39 mL; 17.2 mmol; 1.1 eqiuv) followed by tert-butyldimethylsilyl chloride (2.59 g;  
17.2 mmol; 1.1 equiv) and stirring continued, allowing to warm up to rt. After 24 h, sat. aq. 
ammonium chloride (50 mL) was added, the mixture partitioned, and the aqueous layer extracted 
with dichloromethane (5 x 25 mL). The combined organic phases were washed with brine  
(20 mL), dried (magnesium sulfate), filtered and reduced in vacuo to yield 3.9856 g of crude 
cloudy oil. In vacuo distillation at 85 C and 5 mmHg yielded colorless oil: 3.7635 g;  
14.86 mmol; 95% which was used directly in the next step.  
To a stirred solution of tert-butyl(3-bromopropoxy)dimethylsilane (3.7626 g;  
14.86 mmol; 1.0 equiv) in acetone (100 mL), was added sodium iodide (11.14 g; 74.29 mmol; 
5.0 equiv) and the solution was brought to reflux. After 48 h, acetone was removed in vacuo.  
Water (25 mL) and diethyl ether (25 mL) were added, the resulting mixture partitioned, and the 
aqueous layer further extracted with diethyl ether (3 x 25 mL). The combined organic phases 
were washed with brine (25 mL), dried (magnesium sulfate), filtered and reduced in vacuo to 
yield colorless oil: 4.1932 g; 13.97 mmol; 94% 
1
H NMR: (400 MHz; CDCl3)  3.652  
(t, J = 2 x 5.6 Hz, 2H),  3.262 (t, J = 2 x 6.6 Hz, 2H),  1.971 (p, J = 4 x 6.2 Hz, 2H ),  
 0.883 (s, 9H),  0.057 (s, 6H); 13C NMR: (100 MHz; CDCl3)  62.226, 36.062, 25.879, 
18.215, 3.661, -5.331.  
 
(E)-1-((tert-butyldimethylsilyl)oxy)deca-7,9-dien-4-ol (283): To a stirred solution of  
tert-butyl(3-iodopropoxy)dimethylsilane 281 (0.5537 g; 1.844 mmol; 1 eqiuv) in diethyl ether 
(10 mL), cooled to -78 C, was added dropwise a solution of tert-butyl lithium (Aldrich, 1.7 M in 
pentane; 2.4 mL; 4.057 mmol; 2.2 equiv) and cooling-stirring continued. After 30 min, the 
solution was allowed to warm to rt. After 90 min, solution was cooled to 0 C, was added 
dropwise (E)-hepta-4,6-dienal 261 (0.2235 g; 2.0285 mmol; 1.1 equiv) in diethyl ether (5 mL) 
and cooling-stirring continued. After 3 h, the orange mixture was quenched with sat. aq. 
ammonium chloride (25 mL) and water added (25 mL). The resulting mixture was partitioned, 
and the aqueous layer further extracted with diethyl ether (4 x 25 mL). The combined organic 
phases were washed with brine (25 mL), dried (magnesium sulfate), filtered and reduced  
in vacuo to yield 0.5251 g of crude alcohol. Further purification by flash chromatography  
(silica ratio 30:1; 5% to 30% ethyl acetate/hexane) yielded yellowish oil: 0.4734 g; 1.664 mmol; 
82%. Rf 0.36 (20% ethyl acetate/hexane); 
1
H NMR: (400 MHz; CDCl3)  6.300 (dt, J = 16.8,  
2 x 10.3 Hz, 1H),  6.073 (ddd, J = 15.3, 10.0, 1.0 Hz, 1H),  5.716 (dtd, J = 15.2, 2 x 7.2,  
4.4 Hz, 1H),  5.081 (dm, J = 17.0 Hz, 1H),  4.952 (ddm, J = 10.0, 4.0 Hz, 1H),  
 3.602–3.675  (m, 3H),  2.725 (d, J = 4.4 Hz 1H),  2.113–2.288 (m, 2H),  1.435–1.1.714  
(m, 6H),  0.894 (s, 9H),  0.061 (s, 6H); 13C NMR: (100 MHz ; CDCl3)  137.174, 134.950, 
131.141, 114.842, 70.770, 63.508, 36.692, 34.802, 29.073, 28.853, 25.879, 18.268, -5.430;  
IR: (thin film) max 3373, 3086, 2933, 2859, 1651, 1603, 1466, 1388, 1254, 1096, 1004, 950, 
897, 886, 777, 714, 659 cm
-1
; HRMS: m/z [M + H
+
] Calcd for C16H33O2Si: 285.2250.  
Found: 285.2241.    
 
(E)-3-(1-((tert-butyldimethylsilyl)oxy)deca-7,9-dien-4-yl)oxazolidine-2,4-dione (284): To a 
stirred solution of triphenylphosphine (0.8569 g; 3.2669 mmol; 1.4 equiv),  
1-(tertbutyldimethylsilyloxy)deca-7,9-dien-4-ol 283 (0.6639 g; 2.334 mmol; 1.0 equiv) and  
2,4-oxazolidinedione 263 (0.3677 g; 36.40 mmol; 1.3 equiv) in dichloromethane (10 mL), cooled 
to 0 C, was added dropwise via syringe pump over 1 h neat diisopropyl azodicarboxylate  
(0.58 mL; 3.0335 mmol; 1.3 equiv), and stirring continued, allowing to warm up to rt. After 24h, 
the orange solution was reduced in vacuo to yield 5.0324 g of orange oil. Further purification by 
flash chromatography (silica 20:1; 5% to 10% ethyl acetate/hexane) yielded colorless oil:  
0.4598 g; 1.251 mmol; 63%. Rf 0.47 (20% ethyl acetate/hexane); 
1
H NMR: (400 MHz; CDCl3) 
 6.277 (dt, J = 16.6, 2 x 10.1 Hz, 1H),  6.030 (dd, J = 15.0, 10.4 Hz, 1H),  
 5.624 (dtd, J = 14.5, 2 x 7.1, 1.2 Hz, 1H),  5.110 (ddd, J = 16.4, 5.2, 2.2 Hz, 1H),  
 4.982 (dd, J  = 9.9, 4.4 Hz, 1H),  4.585 (s, 2H),  3.988–4.062 (m, 1H),  
 3.586 (td, J = 2 x 6.2, 1.2 Hz, 2H),  1.952–2.214 (m, 4H),  1.711–1.799 (m, 2H),  
 1.406–1.491 (m, 2H),  0.880 (s, 9H),  0.033 (s, 6H); 13C NMR: (100 MHz; CDCl3)  
 170.959, 155.476, 136.711, 133.190, 131.733, 115.775, 66.953, 62.127, 53.871, 30.348, 
29.741, 29.407, 27.837, 25.879, 18.260, -5.399; IR: (thin film) max 3541, 3086, 2951, 2860, 
1815, 1739, 1652, 1603, 1409, 1384, 1334, 1253, 1166, 1099, 1059, 1007, 959, 901, 839, 775, 
731, 662 cm
-1
; HRMS: m/z [M + H
+
] Calcd for C19H34NO4Si: 368.2257. Found: 368.2254. 
 
(E)-3-(1-(tert-butyldimethylsilyloxy)deca-7,9-dien-4-yl)oxazol-2(3H)-one (285): To a stirred 
solution of 3-(1-(tert-butyldimethylsilyloxy)deca-7,9-dien-4-yl)oxazolidine-2,4-dione 284 
(3.4687 g; 9.437 mmol; 1.0 equiv) in methanol (10 mL), cooled to 0 C, was added portion-wise 
sodium borohydride (0.3571 g; 9.44 mmol; 1.0 equiv) and stirring, cooling continued.  
After 2 h, further 1.0 equiv of sodium borohydride was added and stirring, cooling continued. 
After 4 h, further 1.0 equiv of sodium borohydride was added and stirring, cooling continued. 
After 6 h, the reaction was quenched with acetone (10 mL) and sat.aq. ammonium chloride  
(30 mL). Water (20 mL) and ethyl acetate (25 mL) were added, the resulting mixture partitioned, 
and the aqueous layer further extracted with ethyl acetate (3 x 25mL). The combined organic 
phases were washed with brine (25 mL), dried (magnesium sulfate), filtered and reduced  
in vacuo to yield 3.7518 g of crude aminol. Rf 0.52 (50% ethyl acetate/hexane); 
To a stirred solution of the above crude aminol in dichloromethane (50 mL), cooled to  
0 C, was added triethyl amine (1.2115 g; 11.97 mmol; 2.0 equiv) and cooling-stirring continued.  
After 10 min, was added dropwise methanesulfonyl chloride (1.029 g; 8.979 mmol; 1.5 equiv) 
and stirring continued, allowing to warm to rt. After 24 h, sat. aq. sodium bicarbonate  (50 mL) 
was added, the resulting mixture partitioned, and the aqueous layer further extracted with 
dichloromethane (4 x 25 mL). The combined organic phases were washed with brine (25 mL), 
dried (magnesium sulfate), filtered and reduced in vacuo to yield 1.955 g of crude triene as 
yellow oil. Further purification by flash chromatography (silica 20:1; 10% to 20%  
ethyl acetate/hexane) yielded colorless oil: 1.5049 g; 4.281 mmol; 72%. Rf  0.36  
(20% ethyl acetate/hexane); 
1
H NMR: (400 MHz; CDCl3)  6.808 (d, J = 1.9 Hz, 1H),  
 6.472 (dd, J = 2.1, 0.4 Hz, 1H),  6.271 (dt, J = 16.8, 2 x 10.1 Hz, 1H),  6.039 (ddq, J = 15.0, 
10.4, 3 x 0.7 Hz, 1H),  5.634 (dt, J = 14.7, 2 x 7.2 Hz, 1H),  5.099 (dd, J = 16.4, 1.3 Hz, 1H),  
 4.977 (dd, J = 9.2, 1.3 Hz, 1H),  3.966 (m, 1H),  3.588 (td, J = 2 x 6.2, 1.8 Hz, 2H),  
 2.007–2.112 (m, 2H),  1.678–1.792 (m, 3H),  1.567–1.664 (m, 1H),  1.389–1.515 (m, 2H), 
 0.872 (s, 9H),  0.024 (s, 6H); 13C NMR: (100 MHz ; CDCl3)  155.689, 136.726, 132.811, 
131.839, 127.810, 115.479, 112.452, 62.021, 53.864, 33.877, 30.470, 28.914, 28.846, 25.811, 
18.162, -5.480; IR: (thin film) max 3125, 2934, 2859, 1748, 1652, 1602, 1466, 1388, 1251, 
1098, 1004, 960, 900, 839, 776, 679cm
-1
; HRMS: m/z [M + H
+
] Calcd for C19H34NO4Si: 
352.2257. Found: 352.2309. 
 
Diels–Alder cycloaddition of 285: To a stirred solution of  
4-(3-(tert-butyldimethylsilyloxy)propyl)octahydrooxazolo[5,4,3-ij]quinolin-2(3
1
H)-one 285 
(0.5694 g; 1.619 mmole; 1.0 equiv), in o-dichlorobenzene (32 mL; 0.0506 M), was added a trace 
of 1,4-hydroquinone (0.012 g; 2% by wt.). The colorless solution was de-gased with argon for  
30 min, placed under an atmosphere of argon and brought rapidly to reflux. After 72 h, heat was 
removed and the brown solution partially reduced in vacuo (hi-vac; 85 C) to yield 0.5491 g of 
the crude cycloadducts as dark brown solid. Further purification by flash chromatography  
(silica 100:1; ethyl acetate to hexane 10% to 50%) yielded each cycloadduct as a brown liquid: 
First, the minor trans-cycloadduct, (3
1
S,4S,6aR,9aR)-4-(3-(tert-
butyldimethylsilyloxy)propyl)-4,5,6,6a,9,9a-hexahydrooxazolo[5,4,3-ij]quinolin-2(3
1
H)-one 
(289): 0.0797 g; 0.2267 mmol; 14%. Rf 0.69 (50% ethyl acetate/hexane); 
1
H NMR: (400 MHz; 
CDCl3)  5.767 (dm, J = 3.5 Hz, 2H),  4.565 (td, J = 2 x 7.7, 5.6 Hz, 1H),  3.924 (dt, J = 10.4, 
2 x 5.2 Hz, 1H),  3.609 (t, J = 2 x 6.0 Hz, 2H),  2.981 (dd, J = 10.0, 8.1 Hz, 1H),  
 2.884 (m, 1H),  2.189 (ddd, J = 14.3, 5.5, 2.0 Hz, 1H),  1.938 (ddd, J = 12.9, 6.4, 3.2 Hz, 
1H),  1.843–1.443 (m, 8H),  0.859 (s, 9H), 0.018 (s, 6H); 13C NMR: (100 MHz ; CDCl3)  
 157.609, 131.915, 125.427, 71.605, 62.340, 57.112, 49.895, 36.920, 29.521, 28.641, 28.550, 
27.328, 25.864, 23.322, 18.222, 5.367; IR: (thin film) max 2934, 2860, 1753, 1464, 1408, 1371, 
1329, 1248, 1097, 1044, 966, 847, 776, 754, 685 cm
-1
; HRMS: m/z [M + H
+
] Calcd for 
C19H34NO3Si: 352.2257. Found: 352.2307. 
Next, the major cis-cycloadduct, (3
1
S,4S,6aS,9aR)-4-(3-(tert-
butyldimethylsilyloxy)propyl)-4,5,6,6a,9,9a-hexahydrooxazolo[5,4,3-ij]quinolin-2(3
1
H)-one 
(287): 0.3026 g; 0.8608 mmol; 53%. Rf 0.54 (40% ethyl acetate/hexane); 
1
H NMR: (400 MHz; 
CDCl3)  5.910 (dm; J = 8.8 Hz, 1H),  5.660 (dm; J = 9.5 Hz, 1H),  4.871 (dddd; J = 9.0, 4.1, 
1.2, 0.8 Hz, 1H),  4.030 (ddd, J = 9.1, 4.5, 1.2 Hz, 1H),  3.870 (dt J = 9.8, 2 x 4.6 Hz, 1H),  
 3.607 (m, 2H),  2.585 (ddd, J = 16.6, 6.9, 1.2 Hz, 1H),  2.127 (m, 1H),  
 2.010 (ddd, J = 16.5, 4.2, 3.2 Hz, 1H),  1.901 (tt, J = 2 x 14.0, 2 x 3.5 Hz, 1H),  1.675–1.791 
(m, 3H),  1.424–1.531 (m, 4H),  0.863 (s, 9H),  0.018 (s, 6H); 13C NMR: (100 MHz; CDCl3)  
 157.244, 131.437, 126.770, 72.371, 62.492, 51.967, 48.689, 31.069, 29.498, 27.738, 26.205, 
25.917, 23.542, 22.753, 18.253, -5.324; IR: (thin film) max 2932, 2858, 1745, 1425, 1380, 1249, 
1093, 1048, 1015, 945, 839, 805, 789, 764, 726, 693, 674 cm
-1
; HRMS: m/z [M + H
+
] Calcd for 
C19H34NO3Si: 352.2257. Found: 352.2303. 
 
(3
1
S,4S,6aS,9aR)-4-(3-hydroxypropyl)-4,5,6,6a,9,9a-hexahydrooxazolo[5,4,3-ij]quinolin-
2(3
1
H)-one (298): To a stirred solution of (3
1
S,4S,6aS,9aR)-4-(3-(tert-
butyldimethylsilyloxy)propyl)-4,5,6,6a,9,9a-hexahydrooxazolo[5,4,3-ij]quinolin-2(3
1
H)-one 287 
(0.869 g; 2.4719 mmol; 1.0 equiv) in methanol (10 mL), cooled to 0 C, was added dropwise 
concentrated hydrochloric acid (0.28 mL), and stirring continued allowing to warm up to rt. 
After 24 h, the reaction was quenched with sat. aq. sodium bicarbonate (50 mL) and ethyl acetate 
(10 mL) was added, the resulting mixture partitioned, and the aqueous layer further extracted 
with ethyl acetate (3 x 10mL). The combined organic phases were washed with brine (25 mL), 
dried (magnesium sulfate), filtered and reduced in vacuo to yield 0.657 g of crude alcohol. 
Further purification by flash chromatography (silica 10:1; 5% isopropanol/ethyl acetate) yielded 
white powder: 0.563 g; 2.373 mmol; 96%. Rf 0.37 (10% isopropanol/ethyl acetate); 
1
H NMR: 
(400 MHz; CDCl3)  5.937 (dm, J = 8.0 Hz, 1H),  5.681 (dm, J = 9.5 Hz, 1H),  
 4.909 (dddd, J = 8.8, 4.4, 2.6, 0.8 Hz, 1H),  4.066 (dd, J = 9.0, 4.4 Hz, 1H),  
 3.948 (dt, J = 10.0, 2 x 4.9 Hz, 1H), 3.631–3.707 (m, 2H),  2.607 (ddd, J = 16.1, 6.9, 1.8 Hz, 
1H),  2.154 (m, 1H),  2.033 (dq, J = 16.1, 3 x 2.7 Hz, 2H),  1.930–1.711 (m, 4H),  
 1.605–1.443 (m, 4H); 13C NMR: (100 MHz; CDCl3)  157.593, 131.339, 126.801, 72.629, 
62.431, 51.952, 48.605, 30.940, 29.073, 27.700, 26.433, 23.564, 22.601. IR: (thin film)  
max 3422, 3032, 2938, 2866, 1728, 1431, 1379, 1248, 1047, 746, 696 cm
-1
;  
HRMS: m/z [M + H
+
] Cacld for C13H20NO3: 238.1443. Found: 238.1441;  
 
(3
1
S,4R,6aS,9aR)-4-(3-hydroxypropyl)-4,5,6,6a,9,9a-hexahydrooxazolo[5,4,3-ij]quinolin-
2(3
1
H)-one (304): White powder: 0.017 g; 0.0791 mmol; 3%. Rf 0.38 (10% isopropanol/ethyl 
acetate); 
1
H NMR: (500 MHz; CDCl3)  5.947 (td, J = 2 x 6.6, 3.5 Hz, 1H),  5.693 (dd, J = 9.5, 
1.0 Hz, 1H),  4.834 (ddd, J = 8.6, 3.9, 2.3 Hz, 1H),  3.930 (ddd, J = 9.0, 4.4, 1.0 Hz, 1H),  
 3.658 (td, J = 2 x 6.1, 3.4 Hz, 2H),  3.084 (tdd, J = 2 x 10.8, 5.4, 2.5 Hz, 1H),  
 2.574 (ddd, J = 16.4, 6.6, 2.2 Hz, 1H),  2.234–2.397 (m, 1H),  2.192 (m, 1H),  
 2.138 (bs, 1H),  2.003–2.080 (m, 2H),  1.611–1.823 (m, 4H),  1.567 (ddd, J = 13.4, 6.1, 3.2 
Hz, 1H),  1.458 (qd, J = 3 x 13.3, 3.4 Hz, 1H); 13C NMR: (125 MHz ; CDCl3)  155.733, 
131.300, 127.105, 71.287, 62.421, 58.942, 57.424, 31.356, 29.916, 28.304, 27.892, 27.650, 
27.557; IR: (thin film) max 3407, 2931, 2864, 1727, 1436, 1355, 1254, 1121, 1052, 960, 750, 
698 cm
-1
; HRMS: m/z [M + H
+
] Cacld for C13H20NO3: 238.1443. Found: 238.1442; 
 
3-((3
1
S,4S,6aS,9aR)-2-oxo-2,3
1
,4,5,6,6a,9,9a-octahydrooxazolo[5,4,3-ij]quinolin-4-
yl)propanal (324): To a stirred solution of 2-iodoxybenzoic acid (0.8054 g; 2.876 mmol;  
2.5 equiv) in dimethyl sulfoxide (4 mL) was added  (3
1
S,4S,6aS,9aR)-4-(3-hydroxypropyl)-
4,5,6,6a,9,9a-hexahydrooxazolo[5,4,3-ij]quinolin-2(31H)-one 298 (0.237 g; 1.151 mmole;  
1.0 equiv) and stirring continued. After 24 h, the reaction was quenched with sat. aq. sodium 
thiosulfate (30 mL) sat. aq. sodium bicarbonate (30 mL). Water (10 mL) and dichloromethane 
(25 mL) were added, the resulting mixture partitioned, and the aqueous layer further extracted 
with dichloromethane (3 x 25mL). The combined organic phases were washed with brine  
(25 mL), dried (magnesium sulfate), filtered and reduced in vacuo to yield 1.8584 g of crude 
aldehyde. Further purification by flash chromatography (silica 30:1; ethyl acetate) yielded white 
powder: 0.23 g; 0.9784 mmol; 85%. Rf 0.71 (20% methanol/ethyl acetate); 
1
H NMR: (400 MHz; 
CDCl3)  9.799 (t, J = 2 x 0.8 Hz, 1H),  5.929 (tdm, J = 2 x 6.4, 3.5 Hz, 1H),  
 5.677 (dtm, J = 9.3, 2 x 2.8 Hz, 1H),  4.882 (dddd, J = 9.0, 3.8, 2.1, 1.3 Hz, 1H),  
 4.052 (ddd, J = 9.2, 4.5, 1.4 Hz, 1H),  3.868 (dm, J = 10.9 Hz, 1H),  2.602 (ddd, J = 15.5, 
6.4, 1.6 Hz, 1H),  2.553 (t, J = 2 x 6.6 Hz, 2H),  2.117–2.216 (m, 2H),  
 2.026 (ddm, J = 15.6, 2.8 Hz, 1H),  1.907 (dt, J = 14.4, 2 x 3.7 Hz, 1H),  
 1.722–1.842 (m, 2H),  1.574–1.659 (m, 1H),  1.468 (dm, J = 14.0 Hz, 1H); 13C NMR:  
(100 MHz; CDCl3)  201.248, 157.556, 131.164, 126.801, 72.637, 51.800, 48.894, 40.903, 
30.849, 27.662, 23.716, 22.684, 22.548; IR: (thin film) max 2926, 1725, 1430, 1375, 1261, 
1045, 750cm
-1
; HRMS: m/z [M + H
+
] Calcd for C13H18NO3: 236.1287. Found: 236.1278. 
 
(E)-tert-butyl-5-((3
1
S,4R,6aS,9aR)-2-oxo-2,3
1
,4,5,6,6a,9,9a-octahydrooxazolo[5,4,3-
ij]quinolin-4-yl)pent-2-enoate (319): To a stirred solution of 3-((3
1
S,4S,6aS,9aR)-2-oxo-
2,31,4,5,6,6a,9,9a-octahydrooxazolo[5,4,3-ij]quinolin-4-yl)propanal 324 (0.2022 g;  
0.8594 mmol; 1.0 equiv) in benzene (15 mL) was added  
tert-butyl-2-tri(phenyl)phosphoranylideneacetate (0.6470 g; 1.719 mmol; 2.0 equiv) and the 
solution was brought to reflux. After 5 h, heat was removed and the yellow solution reduced  
in vacuo to yield 0.8472 g of the crude ester. Further purification by flash chromatography (silica 
52:1; ethyl acetate/hexane 30% to 50%) yielded white powder: 0.2293 g; 0.6878 mmol; 80%.  
Rf 0.4 (50% ethyl acetate/hexane); 
1
H NMR: (400 MHz; CDCl3)  6.835 (dt, J = 15.7, 2 x 7.0 
Hz, 1H),  5.928 (td, J = 6.4, 2 x 3.6, 2.8 Hz, 1H),  5.758 (dt, J = 15.6, 2 x 1.6 Hz, 1H),  
 5.669 (dt, J = 9.3, 3.6, 3.0 Hz, 1H),  4.887 (ddm, J = 9.2, 2 x 1.2 Hz, 1H),  4.024 (ddd,  
J = 9.3, 4.6, 4.4 Hz, 1H),  3.904 (dt, J = 10.1, 2 x 5.0 Hz, 1H),  2.602 (ddd, J = 16.6, 2 x 7.0,  
2 x 2.0, 2 x 1.6 Hz, 1H),  2.120–2.233 (m, 3H),  2.020 (dp, J = 16.4, 2 x 3.1 Hz, 1H),  
 1.706–1.935 (m, 4H),  1.397–1.555 (m, 11H); 13C NMR: (100 MHz ; CDCl3)  165.933, 
157.335, 146.651, 131.232, 126.869, 123.341, 80.104, 72.531, 51.959, 48.742, 30.887, 28.899, 
28.633, 28.079, 27.662, 23.564, 22.639; IR: (thin film) max 2971, 2945, 2860, 1731, 1649, 
1429, 1366, 1349, 1322, 1289, 1248, 1157, 1092, 1046, 756, 742, 697cm
-1
; HRMS:  
m/z [M + H
+
] Calcd for C19H28NO4: 334.2018. Found: 334.2016. 
 
(E)-5-((3
1
S,4R,6aS,9aR)-2-oxo-2,3
1
,4,5,6,6a,9,9a-octahydrooxazolo[5,4,3-ij]quinolin-4-
yl)pent-2-enal (326):  To a stirred solution of (E)-tert-butyl-5-((3
1
S,4R,6aS,9aR)-2-oxo-
2,3
1
,4,5,6,6a,9,9a-octahydrooxazolo[5,4,3-ij]quinolin-4-yl)pent-2-enoate 319 (0.2293 g;  
0.6878 mmol; 1.0 equiv) in dichloromethane (10 mL), cooled to -78 C, was added 1 M solution 
of diisobutylaluminium hydride in hexane (2.75 mL; 2.751 mmol; 4.0 equiv) and cooling, 
stirring continued. After 4 h, the reaction was quenched with methanol (5 mL) followed by 2 M 
sodium hydroxide (10 mL) and the reaction slowly warmed up to rt. After 30 min, diethyl ether 
(15 mL) was added and the resulting mixture partitioned, and the aqueous layer further extracted 
with diethyl ether (4 x 15 mL) and washed with 1 M hydrochloric acid (5 mL). Combined 
organic phases were dried (magnesium sulfate), filtered and reduced in vacuo to yield 0.1791 g 
of crude alcohol. Rf 0.34 (ethyl acetate); 
 To a stirred solution of the above crude alcohol 325 (0.1791 g; 1.36 mmol; 1.0 equiv) in 
dimethyl sulfoxide (1 mL), was added 2-iodoxybenzoic acid (0.38 g; 1.36 mmol; 2.0 equiv) 
dissolved in dimethyl sulfoxide (2 mL) and stirring continued. After 24 h, reduced  
2-iodoxybenzoic acid was filtered off and organic phase loaded directly onto the column. Further 
purification by flash chromatography (silica 20:1; ethyl acetate) yielded white solid: 0.1222 g; 
0.4677 mmol; 68%. Rf 0.49 (ethyl acetate); 
1
H NMR: (500 MHz; CDCl3)  9.511 (d, J = 7.8 Hz, 
1H),  6.902 (dt, J = 13.8, 2 x 6.6 Hz, 1H),  6.144 (dd, J = 15.7, 7.8 Hz, 1H),  5.955 (m, 1H),  
 5.691 (dm, J = 9.3 Hz, 1H),  4.919 (dm, J = 8.4 Hz, 1H),  4.046 (dd, J = 9.0, 4.5 Hz, 1H),  
 3.970 (dt, J = 10.0, 2 x 4.9 Hz, 1H),  2.631 (dd, J=16.4, 6.9 Hz, 1H),  2.316–2.437 (m, 2H), 
 2.181 (m, 1H),  2.049 (dm, J = 16.4 Hz, 1H),  1.933–2.011 (m, 1H),  
 1.893 (dm, J = 14.0Hz, 1H),  1.767–1.857 (m, 2H),  1.546–1.615 (m, 1H),  1.475 (dm,  
J = 13.5 Hz, 1H); 
13
C NMR: (500MHz ; CDCl3)  193.889, 157.228, 133.145, 131.090, 
126.964, 72.641, 51.983, 48.472, 30.873, 29.457, 28.515, 27.682, 23.556, 22.661; IR: (thin film) 
max 2929, 1733, 1683, 1424, 1378, 1243, 1129, 1089, 1044, 1019, 881, 802, 755, 748, 692 cm
-1
; 
HRMS: m/z [M + H
+
] Calcd for C15H20NO3: 262.1443. Found: 262.1421. 
2-((1S,3aS,5aS,9aR)-1,2,3,3a,4,5,5a,9a-octahydropyrrolo[1,2-a]quinolin-1-yl)acetaldehyde 
(329 & 330): To a stirred solution of (E)-5-((3
1
S,4R,6aS,9aR)-2-oxo-2,3
1
,4,5,6,6a,9,9a-
octahydrooxazolo[5,4,3-ij]quinolin-4-yl)pent-2-enal 326 (0.1222 g; 0.4677 mmol; 1.0 equiv) in 
methanol (40 mL) was added pyridinium p-toluenesulfonate (0.03 g; 0.117 mmol, 0.25 equiv) 
and stirring continued at rt. After 24 h, potassium carbonate wad added (0.2 g; 1.447 mmol;  
10.0 equiv) and solids filtered off. Excess solvent was reduced in vacuo to yield 0.0814 g of 
crude acetal. Rf 0.44 (ethyl acetate); 
To a stirred solution of the above crude acetal 327 (0.0814 g, 0.2648 mmol; 1.0 equiv) in 
tetrahydrofuran (5 mL), cooled to -78 C, was added 1 M potassium tert-butoxide solution in 
tetrahydrofuran (0.8 mL; 0.7944 mmol; 3.0 equiv) and stirring continued allowing to warm up to 
0 C. After 6 h, water (10 mL) and diethyl ether (15 mL) were added and the resulting mixture 
partitioned, and the aqueous layer further extracted with diethyl ether (4 x 15 mL). Combined 
organic phases were washed with brine (20 mL), dried (magnesium sulfate), filtered and reduced 
in vacuo to yield 0.056 g of crude amine. Rf 0.2 (20% methanol/ethyl acetate); 
To a stirred solution of the above crude amine 328 (0.056 g; 0.2126mmol; 1.0 equiv) was 
added tetrahydrofuran (5 mL), 1 M hydrochloric acid (2 mL) and stirring continued. After 2 h, 
freshly prepared and degassed 1% sodium methoxide in methanol (50 mL) was added and 
stirring continued. After 2 h, solvent was reduced in vacuo to yield 0.0962 g of crude amine. 
Further purification by flash chromatography (silica 20:1; 20% to 50% ethyl acetate/hexane,  
1% triethyl amine) yielded colorless oil: 0.018 g; 0.08283 mmol; 34%. Rf 0.29  
(50% ethyl acetate/hexane); 
1
H NMR: (500 MHz; CDCl3) (major isomer 329)  9.798 (t,  
J = 2 x 2.2 Hz, 1H),  5.910–5.967 (m, 2H),  5.844–5.888 (m, 2H),  3.876 (dm, J = 7.3 Hz, 
1H),  3.361 (ddd, J = 15.5, 7.8, 3.8 Hz, 1H),  2.651 (dd, J = 3.7, 2.0 Hz, 1H),  2.618 (dd,  
J = 3.7, 2.0 Hz, 1H),  2.470–2.530 (m, 1H),  2.425 (ddd, J = 16.5, 7.7, 2.3 Hz, 1H),  
 2.081–2.142 (m, 1H),  2.004–2.081 (m, 1H),  1.790–1.853 (m, 1H),  1.728 (ddd, J = 12.4, 
6.3, 3.0 Hz, 1H),  1.502 (dddd, J = 12.8, 10.8, 7.1, 3.5 Hz, 1H),  1.432 (dtd, J = 13.2, 2 x 4.1, 
2.8 Hz, 1H),  1.285–1.138 (m, 2H),  1.019 (tdd, J = 2 x 12.8, 10.8, 4.1 Hz, 1H); 
 dimethyl 2-diazomalonate (338): To a stirred solution of tosyl chloride 335 (10.0 g;  
0.0525 mmol; 1.0 equiv) in acetone (100 mL) heated to 45 C, was added sodium azide (3.819 g; 
0.0588 mmol; 1.12 equiv) dissolved in 1:2 water/acetone mixture (60 mL), and stirring continued 
allowing the reaction mixture to cool down to rt. After 24 h, sodium chloride was filtered off, 
excess solvent reduced in vacuo and diethyl ether (20 mL) was added and the resulting mixture 
partitioned, and the aqueous layer further extracted with diethyl ether (3 x 25 mL). The 
combined organic phases were washed with brine (50 mL), dried (magnesium sulfate), filtered 
and reduced in vacuo to yield 10.338 g of crude azide as colorless oil. 
 To a stirred solution of crude azide 336 in acetonitrile (30 mL), cooled to 0 C, was 
added dropwise triethyl amine (16.4 mL; 0.1179 mmol; 2.25 equiv) and dimethyl malonate 337 
(9.0 mL; 0.0786 mmol; 1.5 equiv) and stirring continued allowing to warm up to rt. After 24 h, 
excess solvent was reduced in vacuo. Diethyl ether (100 mL) and 2 M potassium hydroxide  
(50 mL) were added and the resulting mixture partitioned, and the aqueous layer further 
extracted with diethyl ether (3 x 25 mL). The combined organic phases were washed with brine 
(50 mL), dried (magnesium sulfate), filtered and reduced in vacuo to yield 2.265 g of crude diazo 
as yellow oil. Further purification by vacuum distillation (0.65 mmHg at 60 C) yielded yellow 
oil: 1.9956 g; 0.0126 mmol; 24%;
 1
H NMR: (500 MHz; CDCl3)  3.830 (s, 6H); 
13
C NMR:  
(125 MHz; CDCl3)  161.424, 52.496, 41.070. [CAUTION! This experiment should be 
conducted behind an auxiliary safety shield in a closed fume hood because of the explosive 
nature of diazo and azide compounds].
 
 
(3S,4
1
S,6aR,7aR,8aR,8bS)-dimethyl 3-(3-((tert-butyldimethylsilyl)oxy)propyl)-5-
oxooctahydro-1H-cyclopropa[f]oxazolo[5,4,3-ij]quinoline-8,8(4
1
H)-dicarboxylate (331):  
To a stirred solution of (3
1
S,4S,6aS,9aR)-4-(3-((tert-butyldimethylsilyl)oxy)propyl)-
4,5,6,6a,9,9a-hexahydrooxazolo[5,4,3-ij]quinolin-2(3
1
H)-one 287 (0.6208 g; 1.766 mmol;  
1.0 equiv) in dichloromethane (10 mL) and Rh2(esp)2 (0.0139 g, 0.01766 mmol, 1.0 mol% ) was 
added neat dimethyl diazomalonate 338 (0.698 g; 4.415 mmol; 2.5 equiv) and stirring continued.  
After 24 h, a further 1.0 mol% of bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic 
acid)] and 2.5 equiv of dimethyl diazomalonate 338 were added and stirring continued.  
After 48 h, the mixture was reduced in vacuo to yield 2.0448 g of crude cyclopropane. Further 
purification by flash chromatography (silica 300:1; 20% acetone/hexane) yielded white powder: 
0.57 g; 1.183 mmol; 67%. Rf 0.43 (40% acetone / hexane); 
1
H NMR: (400 MHz; C6D6)  
 4.068 (dtm, J = 8.8, 2 x 2.6 Hz, 1H),  4.001 (dt, J = 9.9, 2 x 4.9 Hz, 1H),  3.528–3.620  
(m, 2H),  3.389 (s, 3H),  3.224 (s, 3H),  2.838 (dd, J = 8.8, 3.8 Hz, 1H),  2.144 (ddd,  
J = 15.3, 7.6, 2.6 Hz, 1H),  1.969 (ddd, J = 9.2, 8.3, 7.9 Hz, 1H),  1.872 (dd, J = 9.4, 7.6 Hz, 
1H),  1.335–1.545 (m, 6H),  1.182–1.244 (m, 1H),  1.045–1.122 (m, 2H),  0.997 (s, 9H),  
 0.839 (dqm, J = 12.6, 3 x 1.2 Hz, 1H),  0.099 (s, 6H); 13C NMR: (100 MHz ; C6D6)  
 170.757, 167.798, 156.544, 72.460, 63.241, 52.890, 52.511, 51.138, 48.869, 38.086, 30.346, 
27.250, 27.189, 26.787, 24.154, 22.811, 22.766, 22.637, 22.288, 19.116, -4.521; IR: (thin film) 
max 2951, 2857, 1741, 1424, 1326, 1251, 1202, 1132, 1092, 1045, 836, 777, 757cm
-1
; HRMS: 
m/z [M + H
+
] Calcd for C24H40NO7Si: 482.2574. Found: 482.2572. 
 
(3S,4
1
S,6aR,7aR,8S,8aR,8bS)-ethyl 3-(3-((tert-butyldimethylsilyl)oxy)propyl)-5-
oxodecahydro-1H-cyclopropa[f]oxazolo[5,4,3-ij]quinoline-8-carboxylate (333): to a stirred 
solution of (3
1
S,4S,6aS,9aR)-4-(3-((tert-butyldimethylsilyl)oxy)propyl)-4,5,6,6a,9,9a-
hexahydrooxazolo[5,4,3-ij]quinolin-2(3
1
H)-one 287 (0.6208 g; 1.766 mmol; 1.0 equiv)  
in dichloromethane (10 mL) and bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic 
acid)] (0.0139 g; 0.01766 mmol; 1.0 mol%) was added neat ethyl 2-diazoacetate 347 (0.698 g;  
4.415 mmol; 2.5 equiv) and stirring continued. After 24 h, a further 1.0 mol% of 
bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] and 2.5 equiv of  
ethyl 2-diazoacetate 347 were added and stirring continued. After 48 h, the mixture was reduced 
in vacuo to yield 2.0448 g of crude cyclopropane. Further purification by flash chromatography 
(silica 300:1; 20% acetone/hexane) yielded white powder: 0.57 g; 1.183 mmol; 67%. Rf 0.43 
(40% acetone/hexane); 
1
H NMR: (500 MHz; CDCl3)  4.740 (dt, J = 9.3, 2 x 2.4 Hz, 1H),  
 4.106 (qd, J = 3 x 7.1, 1.1 Hz, 2H),  3.980–4.011 (m, 1H),  3.763 (dd, J = 9.3, 3.8 Hz, 1H),  
 3.633 (t, J = 2 x 5.8 Hz, 2H),  2.600 (ddd, J = 15.6, 7.4, 2.7 Hz, 1H),  1.940–2.028 (m, 1H), 
 1.874–1.908 (m, 2H),  1.778 (ddm, J = 11.4, 7.0 Hz, 1H),  1.645 (ddd, J = 9.1, 7.7, 3.5 Hz, 
1H),  1.443–1.548 (m, 5H),  1.232–1.260 (m, 5H),  0.965 (ddd, J = 15.7, 8.2, 2.2 Hz, 1H),  
 0.878 (s, 9H),  0.037 (s, 6H); 13C NMR: (500 MHz ; CDCl3) ; 172.967, 156.301, 72.376, 
62.413, 60.670, 51.088, 48.511, 31.107, 30.671, 29.480, 26.351, 26.281, 25.915, 22.319, 22.218, 
18.746, 18.287, 16.247, 14.208, -5.329; IR: (thin film) max 2931, 2857, 1737, 1729, 1425, 1250, 
1169, 1090, 1059, 836, 757, 672 cm
-1
; HRMS: m/z [M + H
+
] Calcd for C23H39NO5Si: 438.2676. 
Found: 438.2672. 
 
(E)-hepta-4,6-dien-1-yl 4-methylbenzenesulfonate (403): To a stirred solution of (E)-hepta-
4,6-dienal 261 (9.86 g; 89.51 mmol; 1.0 equiv) in methanol (20 mL) at 0 C, was added sodium 
borohydride (6.772 g; 179.2 mmol; 2.0 equiv) and cooling-stirring continued. After 6 h, the 
reaction was quenched with acetone (10 mL) and sat. aq. ammonium chloride (30 mL). Water 
(20 mL) and ethyl acetate (25 mL) were added, the resulting mixture partitioned, and the 
aqueous layer further extracted with ethyl acetate (4 x 25mL). The combined organic phases 
were washed with brine (25 mL), dried (magnesium sulfate), filtered and reduced in vacuo to 
yield 10.039 g of crude alcohol. Rf 0.51 (50% ethyl acetate/hexane); 
To a stirred solution of crude (E)-hepta-4,6-dien-1-ol 402 (10.039 g; 89.5 mmol;  
1.0 equiv), 4-(dimethylamino)pyridine (1.1 g; 8.95 mmol; 0.1 equiv) and triethyl amine (18.11 g; 
179 mmol; 2.0 equiv) in dichloromethane (40 mL), cooled to 0 C, was added neat tosyl chloride 
(18.77 g; 98.45 mmol; 1.1 equiv) and cooling, stirring continued. After 6 h, sat. aq. sodium 
bicarbonate (100 mL) was added and the resulting mixture partitioned, and the aqueous layer 
further extracted with dichloromethane (5 x 20 mL). The combined organic phases were washed 
with brine (50 mL), dried (magnesium sulfate), filtered and reduced in vacuo to yield 19.249 g of 
crude tosyl as brown oil. Further purification by flash chromatography (silica 20:1; 1% to 5% 
diethyl ether/hexane) yielded yellow oil: 16.93 g; 63.55 mmol; 71%. Rf 0.57  
(50% diethyl ether/hexane); 
1
H NMR: (500 MHz; CDCl3)  7.790 (d, J = 8.2 Hz, 2H),  7.345 
(d, J = 8.1 Hz, 2H),  6.239 (dt, J = 17.0, 2 x 10.3 Hz, 1H),  5.959 (dd, J = 15.1, 10.4 Hz, 1H),  
 5.545 (dt, J = 15.0, 2 x 7.3 Hz, 1H),  5.071 (d, J = 17.1 Hz, 1H),  4.978 (d, J = 10.1 Hz, 1H), 
 4.026 (t, J = 2 x 6.3 Hz, 2H),  2.450 (s, 3H),  2.117 (q, J = 3 x 7.2 Hz, 2H),  
 1.746 (p, J = 4 x 6.8 Hz, 2H); 13C NMR: (500MHz ; CDCl3)  144.704, 136.749, 132.553, 
132.257, 129.829, 127.898, 115.655, 69.699, 28.273, 28.164, 21.641; IR: (thin film)   
max  2925, 1598, 1360, 1188, 1176, 1097, 1006, 942, 918, 815, 663 cm
-1
; HRMS:  
m/z [M + Na
+
] Calcd for C14H18O3SNa: 289.0874. Found: 289.0848. 
 
(E)-3-(hepta-4,6-dien-1-yl)oxazol-2(3H)-one (405): To a stirred solution of sodium hydride  
(1.13 g; 47.03 mmol; 1.2 equiv) in anhydrous dimethyl sulfoxide (60 mL) cooled to 10 C was 
added dropwise oxazol-2(3H)-one 404 (3.3335 g; 39.19 mmol; 1.0 equiv) dissolved in anhydrous 
dimethyl sulfoxide (10 mL) and stirring and cooling continued. After 30 min, was added 
dropwise (E)-hepta-4,6-dien-1-yl 4-methylbenzenesulfonate 403 (10.9 g; 40.92 mmol;  
1.05 equiv) dissolved in anhydrous dimethyl sulfoxide (5 mL) and stirring continued allowing to 
warm up to rt. After 24 h, water (900 mL) was added and the resulting mixture partitioned, and 
the aqueous layer further extracted with diethyl ether (6 x 50 mL). The combined organic phases 
were washed with brine (50 mL), dried (magnesium sulfate), filtered and reduced in vacuo to 
yield 4.0256 g of crude triene as brown oil. Further purification by flash chromatography  
(silica 30:1; 10% to 50% ethyl acetate/hexane) yielded yellow oil: 2.318 g; 12.93 mmol; 33%.  
Rf 0.43 (50% ethyl acetate/hexane); 
1
H NMR: (500 MHz; CDCl3)  6.762 (dd, J = 2.0, 0.8 Hz, 
1H),  6.500 (dd, J = 2.0, 0.8 Hz, 1H),  6.251 (dtd, J = 16.9, 2 x 10.3, 0.8 Hz, 1H),  
 6.036 (dddd, J = 15.1, 10.3, 1.4, 0.7 Hz, 1H),  5.618 (dtd, J = 15.3, 2 x 7.2, 0.6 Hz, 1H),  
 5.073 (dd, J = 16.8, 2.2 Hz, 1H),  4.954 (dd, J = 9.9, 2.0 Hz, 1H),  3.542–3.513 (m, 2H),  
 2.099 (ddm, J = 14.5, 7.2 Hz, 2H),  1.718–1.777 (m, 2H); 13C NMR: (125 MHz ; CDCl3) 
155.554, 136.609, 132.592, 132.047, 127.424, 115.592, 115.530, 43.304, 29.114, 28.071;  
IR: (thin film) 3476, 3136, 2938, 1743, 1652, 1602, 1449, 1409, 1378, 1253, 1127, 1090, 1007, 
954, 903, 761, 681 max cm
-1
; HRMS: m/z [M + H
+
] Calcd for C10H14NO2: 180.1025.  
Found: 180.1034. 
 
Diels–Alder cycloaddition of 405: To a stirred solution of (E)-3-(hepta-4,6-dien-1-yl)oxazol-
2(3H)-one 405 (1.747 g; 9.748 mmol; 1.0 equiv) in o-dichlorobenzene (195 mL; 0.0499 M), was 
added a trace of 1,4-hydroquinone (0.035 g; 2% by wt.). The colorless solution was de-gased 
with argon for 30 min, placed under an atmosphere of argon and brought rapidly to reflux. After 
72 h, heat was removed and the brown solution partially reduced in vacuo (hi-vac; 85 C) to 
yield 1.958 g of the crude cycloadducts as dark brown solid. Further purification by flash 
chromatography (silica 100:1; ethyl acetate/hexane 40% to 100%) yielded each cycloadduct as a 
brown liquid: 
First, the minor trans-cycloadduct, (3
1
S,6aR,9aR)-4,5,6,6a,9,9a 
hexahydrooxazolo[5,4,3-ij]quinolin-2(3
1
H)-one (406): 0.3321 g; 1.853 mmol; 19%; Rf 0.51 
(80% ethyl acetate/hexane); 
1
H NMR: (500 MHz; CDCl3)  5.788 (dm, J = 3.9 Hz, 2H),  
 4.616 (td, J = 2 x 8.1, 5.4 Hz, 1H),  3.901 (ddd, J = 13.7, 5.0, 1.1 Hz, 1H),  2.989 (ddd,  
J = 13.6, 12.7, 4.1 Hz, 1H),  2.875–2.295 (m, 2H),  2.219 (ddd, J = 14.4, 5.5, 1.3 Hz, 1H),  
 2.142 (ddd, J = 12.6, 6.5, 2.9 Hz, 1H),  1.839 (ddd, J = 12.2, 9.9, 2.3 Hz, 1H),  1.719 (ddm,  
J = 13.5, 3.5Hz, 1H),  1.549–1.646 (m, 1H),  1.461 (qd, J = 3 x 13.2, 3.1 Hz, 1H); 13C NMR:  
(125 MHz; CDCl3) 157.493, 131.938, 125.509, 71.450, 61.043, 41.584, 36.828, 28.631, 27.113, 
24.677; IR: (thin film) max 2917, 2853, 1732, 1439, 1423, 1356, 1306, 1244, 1218, 1176, 1151, 
1112, 1089, 1061, 1032, 996, 970, 922, 905, 873, 861, 835, 799, 757, 703, 678cm
-1
;  
HRMS: m/z [M + H
+
] Calcd for C10H14NO2: 180.1025. Found: 180.1043. 
Next, the major cis-cycloadduct, (3
1
S,6aS,9aR)-4,5,6,6a,9,9a-hexahydrooxazolo[5,4,3-
ij]quinolin-2(3
1
H)-one (401): 0.8037 g; 4.485 mmol; 46%; Rf 0.29 (80% ethyl acetate/hexane); 
1
H NMR: (500 MHz; CDCl3)  5.922  (td, J = 2 x 6.9, 3.7 Hz, 1H),  5.663 (ddm, J = 9.5,  
1.5 Hz, 1H),  4.887 (ddd, J = 9.2, 4.0, 1.9 Hz, 1H),  3.959 (ddd, J = 9.1, 4.3, 1.5 Hz, 1H),  
 3.809 (dm, J = 12.9 Hz, 1H),  2.760–2.818 (m, 1H),  2.581 (ddd, J = 15.8, 6.8, 1.9 Hz, 1H), 
 2.176 (m, 1H),  1.990–2.057 (m, 2H),  1.664–1.734 (m, 1H),  1.479–1.534 (m, 2H);  
13
C NMR: (125 MHz; CDCl3) 156.504, 130.903, 126.233, 71.870, 55.065, 40.159, 30.344, 
27.160, 26.600, 19.540; IR: (thin film) max 3032, 2933, 2859, 1743, 1432, 1371, 1349, 1335, 
1287, 1265, 1247, 1209, 1196, 1168, 1152, 1117, 1081, 1043, 1010, 985, 947, 916, 883, 864, 
841, 754, 717, 696 cm
-1
; HRMS: m/z [M + H
+
] Calcd for C10H14NO2: 180.1025.  
Found: 180.1036. 
 Cyclopropanation of cycloadduct 401: To a stirred solution of (3
1
S,6aS,9aR)-4,5,6,6a,9,9a-
hexahydrooxazolo[5,4,3-ij]quinolin-2(3
1
H)-one 401 (0.5216 g; 2.911 mmol; 1.0 equiv) in 
dichloromethane (5 mL) and bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)]  
(0.022 g, 0.02911 mmol, 1.0 mol% ) was added neat ethyl 2-diazoacetate  347 (0.8302 g;  
7.276 mmol; 2.5 equiv) and stirring continued. After 24 h, a further 1.0 mol% of 
bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] and 2.5 equiv of  
ethyl 2-diazoacetate 347 were added and stirring continued. After 48 h, the mixture was reduced 
in vacuo to yield 2.2261 g of crude cyclopropanes. Further purification by flash chromatography 
(silica 100:1; 20% to 100% hexane/ethyl acetate) yielded each cyclopropane as a white solid: 
First, exo--cyclopropane, (41S,6aR,7aR,8S,8aR,8bS)-ethyl-5-oxodecahydro-1H-
cyclopropa[f]oxazolo[5,4,3-ij]quinoline-8-carboxylate (407): 0.2549 g; 0.9608 mmol; 33%; Rf 
0.4 (ethyl acetate); 
1
H NMR: (500 MHz; C6D6)  3.961 (qd, J = 3 x 7.1, 2.2 Hz,2H),  
 3.888 (dt, J = 9.2, 2 x 2.6 Hz, 1H),  3.811 (ddd, J = 12.8, 5.1, 0.9 Hz, 1H),  2.528 (dd,  
J = 9.1, 3.8 Hz, 1H),  2.200 (td, J = 2 x 12.8, 3.5 Hz, 1H),  2.001 (ddd, J = 15.4, 7.4, 2.6 Hz, 
1H),  1.657 (dtd, J = 8.8, 2 x 7.7, 3.7 Hz, 1H),  1.419 (ddd, J = 9.3, 7.4, 3.6 Hz, 1H),  1.332  
(ddd, J = 13.6, 6.3, 3.0 Hz, 1H),  1.136 (qd, J = 3 x 13.6, 3.6 Hz, 1H),  0.922–0.970 (m, 4H),  
 0.855 (tt, J = 2 x 13.7, 2 x 4.0 Hz, 1H),  0.704 (ddd, J = 13.7, 6.7, 3.4 Hz, 1H),  0.261 (td,  
J = 2 x 7.3, 3.6 Hz, 1H),  0.050 (ddd, J = 15.3, 7.9, 2.2 Hz, 1H); 13C NMR: (125 MHz; C6D6) 
173.128, 156.035, 72.117, 61.080, 55.008, 40.943, 31.579, 31.415, 27.181, 26.730, 19.592, 
19.234, 17.031, 14.906; IR: (thin film) max 2935, 1736, 1431, 1382, 1360, 1319, 1263, 1195, 
1170, 1119, 1054, 1035, 993, 921, 891, 874, 833, 756cm
-1
; HRMS: m/z [M + H
+
] Calcd for 
C14H20NO4: 266.1392. Found: 266.1370. 
First, endo--cyclopropane, (41S,6aR,7aR,8R,8aR,8bS)-ethyl-5-oxodecahydro-1H-
cyclopropa[f]oxazolo[5,4,3-ij]quinoline-8-carboxylate (408): 0.2085 g; 0.7859 mmol; 27%;  
Rf 0.51 (ethyl acetate); 
1
H NMR: (500 MHz; C6D6)  4.179 (dt, J = 9.0, 2 x 2.6 Hz, 1H),  
 3.816–3.897 (m, 3H),  2.811 (dd, J = 9.0, 4.0 Hz, 1H),  2.247 (td, J = 2 x 12.9, 3.7 Hz, 1H), 
 1.934 (td, J = 2 x 7.4, 3.8 Hz, 1H),  1.855 (dt, J = 8.2, 2 x 2.7 Hz, 1H),  
 1.314–1.360 (m, 2H),  1.191–1.282 (m, 1H),  1.149 (p, J = 4 x 8.3Hz, 1H),  1.058 (tt,  
J = 2 x 13.7, 2 x 4.1 Hz, 1H),  0.920 (t, J = 2 x 7.1 Hz, 3H),  0.823 (ddd, J = 13.2, 6.5, 3.4 Hz, 
1H),  0.765 (q, J = 3 x 8.3 Hz, 1H); 13C NMR: (125 MHz ; C6D6) ; 172.287, 156.385, 73.199, 
60.613, 55.522, 40.927, 27.142, 23.165, 19.856, 19.234, 19.171, 17.942, 15.560, 14.812;  
IR: (thin film) max 2927, 2857, 1742, 1712, 1435, 1383, 1350, 1260, 1222, 1155, 1088, 1057, 
1040, 1003, 970, 917, 876, 858, 809, 748, 731, 678cm
-1
; HRMS: m/z [M + H
+
] Calcd for 
C14H20NO4: 266.1392. Found: 266.1378. 
 
5-diazo-2,2-dimethyl-1,3-dioxane-4,6-dione (431): To a stirred solution of tosyl chloride 335 
(10 g; 0.0525 mmol; 1.0 equiv) in acetone (100 mL) heated to 45 C, was added sodium azide 
(3.819 g; 0.0588 mmol; 1.12 equiv) dissolved in 1:2 water/acetone mixture (60 mL), and stirring 
continued allowing the reaction mixture to cool down to rt. After 24 h, sodium chloride was 
filtered off, excess solvent reduced in vacuo and diethyl ether (20 mL) was added and the 
resulting mixture partitioned, and the aqueous layer further extracted with diethyl ether (3 x 25 
mL). The combined organic phases were washed with brine (50 mL), dried (magnesium sulfate), 
filtered and reduced in vacuo to yield 10.338 g of crude azide as colorless oil. 
 To a stirred solution of crude azide 336 in acetonitrile (30 mL), cooled to 0 C, was 
added dropwise triethyl amine (13.2 mL; 0.0943 mmol; 1.5 equiv) and  
2,2-Dimethyl-1,3-dioxane-4,6-dione (9.063 g; 0.0629 mmol; 1.2 equiv) and stirring continued 
allowing to warm up to rt. After 24 h, excess solvent was reduced in vacuo and further 
purification by flash chromatography (silica 20:1; dichloromethane) yielded pink powder:  
2.4599 g; 14.56 mmol; 28%. Rf 0.37 (dichloromethane);
 1
H NMR: (500 MHz; CDCl3)  1.749 
(s, 6H); 
13
C NMR: (125 MHz; CDCl3)  158.209, 106.968, 26.646. [CAUTION! This 
experiment should be conducted behind an auxiliary safety shield in a closed fume hood because 
of the explosive nature of diazo and azide compounds].   
 
(4
1
S,6aR,7aR,8S,8aR,8bS)-8-(hydroxymethyl)octahydro-1H-cyclopropa[f]oxazolo[5,4,3-
ij]quinolin-5(4
1
H)-one (434): To a stirred solution of (4
1
S,6aR,7aR,8S,8aR,8bS)-ethyl 5-
oxodecahydro-1H-cyclopropa[f]oxazolo[5,4,3-ij]quinoline-8-carboxylate 407 (0.279 g;  
1.052 mmol; 1.0 equiv) in tetrahydrofuran (2 mL), cooled to 0 C, was added a solution of 
lithium borohydride (2 M in THF, 1.1 mL; 2.103 mmol; 2.2 equiv) and stirring continued 
allowing to warm up to rt. After 2 h, a further 2.0 equiv of lithium borohydride was added and 
again at 4 h and 6 h. After 24 h, the reaction was quenched with acetone (5 mL) and sat. aq. 
ammonium chloride (20 mL). Ethyl acetate (10 mL) was added and the resulting mixture 
partitioned, and the aqueous layer further extracted with ethyl acetate (3 x 10 mL). The 
combined organic phases were washed with brine (50 mL), dried (magnesium sulfate), filtered 
and reduced in vacuo to yield 0.202 g of crude alcohol as yellow oil. Further purification by flash 
chromatography (silica 25:1; 0% to 10% methanol/ethyl acetate) yielded white powder: 0.082 g; 
0.3675 mmol; 35%. Rf 0.43 (17% methanol/ethyl acetate); 
1
H NMR: (500 MHz; CDCl3)  
 4.748 (ddd, J = 9.2, 2.8, 1.9 Hz, 1H),  3.909 (ddd, J = 13.5, 4.1, 1.7 Hz, 1H),  3.654 (dd,  
J = 9.2, 3.7 Hz, 1H),  6.975 (dd, J = 11.3, 7.0 Hz, 1H),  6.909 (dd, J = 11.3, 7.0 Hz, 1H),  
 2.864 (td, J = 2 x 12.4, 3.9 Hz, 1H),  2.548 (qd, J = 3 x 10.4, 6.2 Hz, 1H),  2.078 (dm,  
J = 10.6 Hz, 1H),  1.647–1.812 (m, 3H),  1.534 (dm, J = 14.0 Hz, 1H),  1.240 (dt, J = 7.2,  
2 x 3.4 Hz, 1H),  0.887–0.996 (m, 2H),  0.799 (tt, J = 2 x 7.1, 2 x 3.7 Hz, 1H),  0.677 (td,  
J = 2 x 8.5, 3.9 Hz, 1H); 
13
C NMR: (125 MHz ; CDCl3)  156.271, 72.703, 65.939, 55.229, 
40.541, 32.041, 31.441, 26.872, 26.670, 18.707, 12.643, 10.121; IR: (thin film) max 3414, 2934, 
2860, 1729, 1436, 1258, 1042, 1000, 757, 688 cm
-1
; HRMS: m/z [M + H
+
] Calcd for 
C12H18NO3: 224.1287. Found: 224.1281. 
 
 
 (4
1
S,6aR,7aR,8R,8aR,8bS)-8-(hydroxymethyl)octahydro-1H-cyclopropa[f]oxazolo[5,4,3-
ij]quinolin-5(4
1
H)-one (436): To a stirred solution of (4
1
S,6aR,7aR,8R,8aR,8bS)-ethyl 5-
oxodecahydro-1H-cyclopropa[f]oxazolo[5,4,3-ij]quinoline-8-carboxylate 408 (0.279 g;  
1.052 mmol, 1.0 equiv) in tetrahudrofuran (2 mL), cooled to 0 C, was added a solution of 
lithium borohydride (2 M in THF, 1.1 mL; 2.103 mmol; 2.2 equiv) and stirring continued 
allowing to warm up to rt. After 2 h, a further 2.0 equiv of lithium borohydride was added and 
again at 4 h and 6 h. After 24 h, the reaction was quenched with acetone (5 mL) and sat. aq. 
ammonium chloride (20 mL). ethyl acetate (10 mL) was added and the resulting mixture 
partitioned, and the aqueous layer further extracted with ethyl acetate (3 x 10 mL). The 
combined organic phases were washed with brine (50 mL), dried (magnesium sulfate), filtered 
and reduced in vacuo to yield 0.2242 g of crude alcohol as yellow oil. Further purification by 
flash chromatography (silica 25:1; 0% to 10% methanol/ethyl acetate) yielded white powder: 
0.05 g; 0.224 mmol; 21%. Rf 0.34 (17% methanol/ethyl acetate); 
1
H NMR: (500 MHz; CDCl3)  
 4.792 (dt, J = 9.0, 2 x 2.3 Hz, 1H),  3.916 (ddd, J = 13.0, 3.2, 1.2 Hz, 1H),  3.656–3.780  
(m, 3H),  2.873 (td, J = 2 x 12.8, 3.9 Hz, 1H),  2.352 (ddd, J = 15.5, 6.9, 2.6 Hz, 1H),  
 1.998 (dd, J = 11.1, 3.3 Hz, 1H),  1.708–1.804 (m, 2H),  1.524 (dd, J = 10.0, 2.4 Hz, 1H),  
 1.172–1.311 (m, 4H),  0.958–1.028 (m, 2H); 13C NMR: (125 MHz ; CDCl3)  156.299, 
72.833, 58.075, 55.242, 40.562, 27.236, 25.095, 20.978, 20.012, 18.448, 10.820, 8.477;  
IR: (thin film) max 3410, 2933, 1726, 1439, 1258, 1021, 757, 681 cm
-1
; HRMS: m/z [M + H
+
] 
Calcd for C12H18NO3: 224.1287. Found: 224.1292. 
 
(3
1
R,6aR,9aR)-6a-hydroxy-4,5,6,6a,9,9a-hexahydrooxazolo[5,4,3-ij]quinolin-2(3
1
H)-one 
(490): To a stirred solution of selenium dioxide (0.0645 g; 0.5806 mmol; 1.2 equiv) in  
1,4-dioxane (5 mL) was added (3
1
S,6aS,9aR)-4,5,6,6a,9,9a-hexahydrooxazolo[5,4,3-ij]quinolin-
2(3
1
H)-one 401 (0.0867 g; 0.4834 mmol; 1.0 equiv) and brought to reflux. After 18 h, the 
yellowish solution was reduced in vacuo to yield 0.1458 g of crude alcohol. Further purification 
by flash chromatography (silica 300:1; methanol/chloroform, 0% to 20%) yielded white powder:  
0.0117 g; 0.006 mmol; 17%.  Rf 0.14 (80% ethyl acetate/hexane); 
1
H NMR: (500 MHz; CDCl3) 
 6.133 (dm, J = 9.5 Hz, 1H),  5.839 (dm, J = 9.6 Hz, 1H),  4.992 (ddd, J = 8.1, 3.8, 2.6 Hz, 
1H),  3.845ppm (dd, J = 8.8, 1.4 Hz, 1H),  3.797 (dtd, J = 13.2, 5.2, 2 x 1.5 Hz, 1H),  
 2.772 (td, J = 2 x 13.1, 3.1 Hz, 1H),  2.546–2.567 (m, 2H),  2.064 (dt, J = 14.4, 2 x 6.5 Hz, 
1H),  1.791 (s, 1H),  1.696–1.721 (m, 1H),  1.675–1.694 (m, 1H), 1.662 (d, J = 3.7 Hz, 1H),  
 1.636 (d, J = 3.6 Hz, 1H),  1.404–1.502 (m, 1H); 13C NMR: (125 MHz; CDCl3)  156.777, 
132.608, 131.744, 71.232, 65.184, 60.849, 40.058, 37.466, 27.495, 22.077; IR: (thin film)  
max 3407, 2936, 1722, 1444, 1397, 1256, 1061, 738 cm
-1
; HRMS: m/z [M + H
+
] Calcd for 
C10H14NO3: 196.0974. Found: 196.0981. 
 (E)-7-chlorohept-6-en-4-yn-1-ol (496): To a stirred solution of 
tetrakis(triphenylphosphine)palladium(0) (0.515 g; 0.4457 mmol; 2.5 mol%),  
trans-1,2-dichloroethylene 495 (3.457 g; 35.66 mmol; 2.0 equiv), 4-pentyn-1-ol 494 (1.5 g; 
17.83 mmol; 1.0 equiv) and piperidine (3.34 g; 39.25 mmol; 2.2 equiv) in tetrahydrofuran  
(20 mL), cooled to 0 C, was added neat copper (I) iodide (0.34 g; 1.749 mmol; 0.1 equiv) and 
stirring continued allowing to warm up to rt. After 24 h, the brown solution was reduced  
in vacuo to yield 8.946 g of brown oil. Further purification by flash chromatography (silica 50:1; 
20% diethyl ether/hexane) yielded colorless oil: 2.449 g; 16.94 mmol; 95%. Rf 0.54  
(diethyl ether); 
1
H NMR: (500 MHz; CDCl3)  6.419 (d, J = 13.6 Hz, 1H),  5.875 (d,  
J = 13.6 Hz, 1H),  3.684 (t, J = 2 x 6.2 Hz, 2H),  2.444 (bs, 1H),  2.388 (td, J = 2 x 6.9,  
1.4 Hz, 2H),  1.737 (p, J = 4 x 6.5 Hz, 2H); 13C NMR: (125 MHz ; CDCl3)  129.058, 113.927, 
92.280, 76.011, 61.230, 30.966, 15.788; IR: (thin film) max 3452, 2952, 2878, 1720, 1711, 
1095, 920, 671 cm
-1
; HRMS: m/z [M + H
+
] Calcd for C7H10ClO: 145.0420. Found: 145.0453. 
 
(4E,6E)-7-chlorohepta-4,6-dien-1-ol (493): To a stirred solution of (E)-7-chlorohept-6-en-4-yn-
1-ol 496 (0.7485 g; 5.176 mmol; 1.0 equiv) in tetrahydrofuran (10 mL), cooled to -78 C, was 
added drop-wise 3.5 M sodium bis(2-methoxyethoxy)aluminum in toluene (20.7 mL;  
20.71 mmol; 4.0 equiv) and cooling, stirring continued. After 30 min, cooling bath was removed 
and reaction mixture was brought to reflux. After 18 h, reaction mixture was cooled to -78 C 
and 2 M sodium hydroxide was added (10 mL) and cooling, stirring continued. After 30 min, 
reaction mixture was allowed to warm up to rt, partitioned and the aqueous layer extracted with 
diethyl ether (3 x 15 mL) and washed with 1 M hydrochloric acid (2 x 5mL). Combined organic 
phases were dried (magnesium sulfate), filtered and reduced in vacuo to yield 0.935 g of 
yellowish oil. Further purification by flash chromatography (silica 20:1; 0% to 5% 
methanol/chloroform) yielded colorless oil: 0.729 g; 4.972 mmol; 96%. Rf 0.17 (chloroform);  
1
H NMR: (500 MHz; CDCl3)  6.408 (dd, J = 12.9, 11.0 Hz, 1H),  6.09 (d, J = 13.5 Hz, 1H),  
 6.003 (dd, J = 15.1, 10.9 Hz, 1H),  5.707 (dt, J = 14.9, 2 x 7.0 Hz, 1H),  3.646 (t,  
J = 2 x 6.4 Hz, 2H),  2.171 (q, J = 3 x 7.2 Hz, 2H),  1.661 (p, J = 4 x 7.0 Hz, 2H),  1.492 (bs, 
1H); 
13
C NMR: (125 MHz; CDCl3)  135.021, 133.557, 126.662, 118.737, 62.180, 31.854, 
28.857; IR: (thin film) max 3359, 3064, 3023, 2935, 1582, 1461, 1350, 1057, 976, 923, 816, 
756, 671 cm
-1
; HRMS: m/z [M + H
+
] Calcd for C7H12ClO: 147.0577. Found: 147.0556. 
 
3-((4E,6E)-7-chlorohepta-4,6-dien-1-yl)oxazolidine-2,4-dione (497): To a stirred solution of 
triphenylphosphine (0.4093 g; 1.561 mmol; 1.3 equiv), 2,4-oxazolidinedione 263 (0.1213 g;  
1.2 mmol; 1.1 equiv), (E)-octa-5,7-dien-2-ol (0.16g; 1.091mmol; 1eq) 493 in dichloromethane 
(10 mL), cooled to 0 C, was added dropwise over 3 h, neat via a syringe pump diisopropyl 
azodicarboxylate (0.3089 g; 1.528 mmol; 1.4 equiv) and stirring continued allowing to warm up 
to rt. After 24 h, the orange solution was reduced in vacuo to yield 1.2861 g of orange oil. 
Further purification by flash chromatography (silica 100:1; 10% ethyl acetate/hexane) yielded 
colorless oil: 0.219 g; 3.323 mmol; 87%. Rf 0.49 (50% ethyl acetate/hexane); 
1
H NMR:  
(500 MHz; CDCl3)  6.402 (dd, J = 13.1, 10.9 Hz, 1H),  6.118 (d, J = 13.2 Hz, 1H),  
 6.015 (dd, J = 15.2, 10.9 Hz, 1H),  5.656 (dt, J = 15.0, 2 x 7.3 Hz, 1H),  4.670 (s, 2H),  
 3.557 (t, J = 2 x 7.3 Hz, 2H),  2.132 (q, J = 3 x 7.1 Hz, 2H),  1.771 (p, J = 4 x 7.3 Hz, 2H); 
13
C NMR: (125 MHz ; CDCl3)  170.390, 155.796, 133.332, 133.269, 127.315, 119.445, 
67.768, 39.653, 29.589, 26.576; IR: (thin film) max 2950, 1815, 1732, 1448, 1417, 1347, 1260, 
1154, 1110, 1048, 982, 815, 763, 698 cm
-1
; HRMS: m/z [M + Na
+
] Calcd for C10H1ClNO3Na: 
252.0403. Found: 252.0402. 
 
3-((4E,6E)-7-chlorohepta-4,6-dien-1-yl)oxazol-2(3H)-one (492): To a stirred solution of  
3-((4E,6E)-7-chlorohepta-4,6-dien-1-yl)oxazolidine-2,4-dione 497 (4.865 g; 21.18 mmol;  
1.0 equiv) in methanol (20 mL), cooled to 0 C, was added portion-wise sodium borohydride 
(0.801 g; 21.18 mmol; 1.0 equiv) and stirring, cooling continued. After 2 h, further 1.0 equiv of 
sodium borohydride was added and stirring, cooling continued. After 4 h, further 0.5 equiv of 
sodium borohydride was added and stirring, cooling continued. After 5 h, the reaction was 
quenched with acetone (10 mL) and sat. aq. ammonium chloride (30 mL). Water (20 mL) and 
ethyl acetate (25 mL) were added, the resulting mixture partitioned, and the aqueous layer further 
extracted with ethyl acetate (3 x 25 mL). The combined organic phases were washed with brine 
(25 mL), dried (magnesium sulfate), filtered and reduced in vacuo to yield 5.8662 g of crude 
aminol. Rf 0.49 (ethyl acetate); 
To a stirred solution of the above crude aminol in dichloromethane (10 mL), cooled to  
0 C, was added triethyl amine (11.78 mL; 84.73 mmol; 4.0 equiv) and cooling-stirring 
continued. After 10 min, was added dropwise methanesulfonyl chloride (2.63 mL; 33.89 mmol; 
1.6 equiv) and stirring continued, allowing to warm to rt. After 2 h, sat. aq. sodium bicarbonate 
(50 mL) was added, the resulting mixture partitioned, and the aqueous layer further extracted 
with dichloromethane (4 x 25 mL). The combined organic phases were washed with brine  
(25 mL), dried (magnesium sulfate), filtered and reduced in vacuo to yield 5.208 g of crude 
triene as yellow oil. Further purification by flash chromatography (silica 100:1; 20% ethyl 
acetate/hexane) yielded yellowish oil: 3.304 g; 15.46 mmol; 73%. Rf  0.29 (ethyl acetate);  
1
H NMR: (500 MHz; CDCl3)  6.782 (d, J = 1.6 Hz, 1H),  6.494 (d, J = 1.6 Hz, 1H),  6.379 
(dd, J = 12.9, 11.1 Hz, 1H),  6.246 (d, J = 13.2 Hz, 1H),  5.992 (dd, J = 15.1, 10.9 Hz, 1H),  
 5.639 (dt, J = 15.2, 2 x 7.3 Hz, 1H),  3.540 (t, J = 2 x 7.2 Hz, 2H),  2.112 (q, J = 3 x 7.2 Hz, 
2H),  1.759 (q, J = 4 x 7.3 Hz, 2H); 13C NMR: (125 MHz ; CDCl3)  155.656, 133.324, 
133.269, 127.634, 127.463, 119.461, 115.452, 43.389, 29.355, 28.149; IR: (thin film) max 2928, 
1744, 1582, 1450, 1409, 1251, 1126, 1092, 978, 815, 673 cm
-1
; HRMS: m/z [M + H
+
] Calcd for 
C10H13ClNO2: 214.0635. Found: 214.0648. 
 
Diels–Alder cycloaddition of 492: To a stirred solution of 3-((4E,6E)-7-chlorohepta-4,6-dien-1-
yl)oxazol-2(3H)-one 492 (0.8884 g; 4.158 mmol; 1.0 equiv) in o-dichlorobenzene (83.2 mL,  
0.05 M), was added a trace of 1,4-hydroquinone (0.018 g, 2% by wt). The colorless solution was 
de-gased with argon for 30 min, places under an atmosphere of argon and brought to 155 C. 
After 96 h, heat was removed and the brown solution was loaded directly onto silica gel  
(silica ratio 100 : 1) and chromatographed in (methanol/chloroform 1% to 5% to 10%) yielded 
each cycloadduct as an impure white solid that were further purified. 
First, the minor trans-cycloadduct, (3
1
S,6aR,9S,9aS)-9-chloro-4,5,6,6a,9,9a-
hexahydrooxazolo[5,4,3-ij]quinolin-2(3
1
H)-one (498): Further purification by flash 
chromatography (silica 300:1; 20% acetone/hexane) yielded white powder: 0.1599 g;  
0.7484 mmol; 18%. Rf 0.54 (40% acetone/hexane); 
1
H NMR: (500 MHz; CDCl3)  5.828 (m, 
2H),  4.696 (dd, J = 8.5, 5.0 Hz, 1H),  4.472 (dd, J = 5.1, 1.7 Hz, 1H),  3.907 (dd, J = 13.8, 
5.3 Hz, 1H),  3.110 (dd, J = 9.6, 7.3 Hz, 1H),  2.999 (tdd, J = 2 x 12.5, 3.9, 1.2 Hz, 1H),  
 2.183 (ddd, J = 12.4, 5.5, 2.7 Hz, 1H),  1.741–1.784 (m, 2H),  1.579 (qdd, J = 3 x 13.0,  
5.6, 3.6 Hz, 1H),  1.490 (qd, J = 3 x 12.5, 3.1 Hz, 1H); 13C NMR: (125 MHz ; CDCl3)  
 156.076, 131.946, 130.763, 80.090, 59.401, 56.287, 41.241, 36.820, 26.825, 24.451;  
IR: (thin film) max 2940, 2858, 1757, 1428, 1363, 1307, 1255, 1163, 1059, 1037, 1004, 923, 
899, 831, 769, 741 cm
-1
; HRMS: m/z [M + H
+
] Calcd for C10H13ClNO2: 214.0635. Found: 
214.0637. 
Next, the major cis-cycloadduct, (3
1
S,6aS,9R,9aS)-9-chloro-4,5,6,6a,9,9a-
hexahydrooxazolo[5,4,3-ij]quinolin-2(3
1
H)-one (491): Further purification by flash 
chromatography (silica 100:1; methanol/chloroform 1% to 5%) yielded white powder: 0.5508 g; 
2.578 mmol; 62%. Rf 0.57 (ethyl acetate); 
1
H NMR: (500 MHz; CDCl3)  5.862 (dd, J = 9.6,  
1.6 Hz, 1H),  5.669 (dd, J = 9.7, 1.0 Hz, 1H),  4.898 (dd, J = 9.0, 2.1 Hz, 1H),  4.362 (dm,  
J = 2.4 Hz, 1H),  4.014 (dd, J = 8.7, 4.2 Hz, 1H),  3.764 (dd, J = 13.4, 4.3 Hz, 1H),  2.80 (td, 
J = 2 x 12.9, 3.7 Hz, 1H),  2.17 (m, 1H),  1.996 (dd, J = 14.1, 1.4 Hz, 1H),  1.716 (tt,  
J = 2 x 13.8, 2 x 3.9 Hz, 1H),  1.395–1.518 (m, 2H); 13C NMR: (125 MHz ; CDCl3)  155.928, 
131.751, 131.191, 75.303, 55.439, 54.092, 41.031, 30.92, 26.685, 20.116; IR: (thin film)  
max 2942, 2859, 1757, 1495, 1445, 1428, 1364, 1308, 1227, 1163, 1059, 1037, 1004, 971, 923, 
900, 813, 769, 741 cm
-1
; HRMS: m/z [M + H
+
] Calcd for C10H12ClNO2: 214.0635. Found: 
214.0646. 
 
Cyclopropanation of cycloadduct 491: To a stirred solution of (3
1
S,6aS,9R,9aS)-9-chloro-
4,5,6,6a,9,9a-hexahydrooxazolo[5,4,3-ij]quinolin-2(3
1
H)-one 491 (0.346 g; 1.162 mmol;  
1.0 equiv) and bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] (0.012 g;  
1.0 mol%) in dichloromethane (5 mL) was added via a syringe pump (0.3  mL/h) ethyl 
diazoacetate 347 (3.73 mL; 4.049 mmol; 2.5 equiv) dissolved in dichloromethane (2.27 mL) and 
stirring continued at rt. After 24 h, further 2.5 equiv of ethyl diazoacetate 347 was added via a 
syringe pump (0.3 mL/h). After 72 h, the orange solution was reduced in vacuo to yield 1.4934 g 
of crude cyclopropane monoester. Further purification by flash column chromatography (silica 
ratio 300 : 1, acetone/hexane 0% to 20% to 30% to 40%) yielded each cyclopropane monoester 
as a white solid:   
First, exo--cyclopropane, (41S,6aS,7R,7aR,8R,8aR,8bS)-ethyl 7-chloro-5-
oxodecahydro-1H-cyclopropa[f]oxazolo[5,4,3-ij]quinoline-8-carboxylate (499): white 
powder: 0.08 g; 0.2669 mmol; 23%. Rf 0.29 (60% acetone / hexane); 
1
H NMR:  
(500 MHz; CDCl3)  4.769 (dd, J = 9.0, 1.8 Hz, 1H),  4.135 (dd, J = 3 x 7.1 Hz, 2H),  3.954 
(dd, J = 13.4, 4.3 Hz, 1H),  3.857 (dd, J = 9.0, 3.6 Hz, 1H), 3.465 (dd, J = 7.8, 1.7 Hz, 1H),  
 2.894 (td, J = 2 x 13.1, 3.4 Hz, 1H),  2.097 (dd, J = 13.1, 2.6 Hz, 1H),  1.971 (ddd, J = 9.8, 
8.0, 3.7 Hz, 1H),  1.683–1.839 (m, 2H),  1.639 (ddd, J = 9.7, 8.1, 3.9 Hz, 1H),  1.533–1.585 
(m, 2H),  1.337 (dm, J = 2.8 Hz, 1H),  1.266 (t, J = 2 x 3.8 Hz, 3H); 13C NMR: (125 MHz ; 
CDCl3)  171.651, 155.033, 75.653, 61.121, 58.070, 56.614, 40.720, 30.702, 29.449, 26.094, 
23.681, 20.349, 18.543, 14.138; IR: (thin film) max 2939, 1746, 1433, 1371, 1266, 1200, 1179, 
1064, 1000, 915, 886, 851, 777, 754, 686 cm
-1
; HRMS: m/z [M + H
+
] Calcd for C14H19ClNO4: 
300.1003 Found: 300.0991. 
First, endo--cyclopropane, (41S,6aS,7R,7aR,8S,8aR,8bS)-ethyl-7-chloro-5-
oxodecahydro-1H-cyclopropa[f]oxazolo[5,4,3-ij]quinoline-8-carboxylate (500): white 
powder: 0.132 g; 0.4404 mmol; 38%. Rf 0.43 (60% acetone/hexane); 
1
H NMR: (500 MHz; 
C6D6)  4.726 (dd, J = 8.1, 1.8 Hz, 1H),  4.248 (dd, J = 8.8, 1.7 Hz, 1H),  3.827 (q,  
J = 3 x 7.1 Hz, 2H),  3.751 (dd, J = 14.1, 4.5 Hz, 1H),  2.791 (dd, J = 8.8, 0.8Hz, 1H),  2.185 
(td, J = 2 x 12.9, 3.5 Hz, 1H),  1.7641.785 (m, 1H),  1.604 (q, J=3 x 8.5Hz, 1H),  1.388 (t, 
J=2 x 8.2Hz, 1H),  1.125–1.215 (m, 2H),  0.816–0.981 (m, 5H),  0.771 (ddm, J = 14.3,  
2.3 Hz, 1H); 
13
C NMR: (125 MHz ; C6D6)  171.813, 155.568, 76.834, 61.173, 58.643, 51.599, 
41.036, 26.395, 23.655, 23.071, 19.638, 18.938, 18.673, 14.641; IR: (thin film) max 2939, 1746, 
1433, 1371, 1266, 1200, 1178, 1146, 1131, 1091, 1064, 1000, 886, 851, 776,  754, 686 cm
-1
; 
HRMS: m/z [M + H
+
] Calcd for C14H19ClNO4: 300.1003 Found: 300.0992. 
 2-((3
1
S,6aS,7R,9aR)-2-oxo-2,3
1
,4,5,6,6a,7,9a-octahydrooxazolo[5,4,3-ij]quinolin-7-yl)acetate 
(479): To a 75 mL flame-dried heavy-walled sealed tube, fitted with septum and stir-bar, was 
added (4
1
S,6aS,7R,7aR,8R,8aR,8bS)-ethyl 7-chloro-5-oxodecahydro-1H-
cyclopropa[f]oxazolo[5,4,3-ij]quinoline-8-carboxylate 499 (0.0575 g; 0.1918 mmol; 1.0 equiv) 
or (4
1
S,6aS,7R,7aR,8S,8aR,8bS)-ethyl 7-chloro-5-oxodecahydro-1H-cyclopropa[f]oxazolo[5,4,3-
ij]quinoline-8-carboxylate 500 (0.0575 g; 0.1918 mmol; 1.0 equiv), dissolved in benzene  
(20 mL) was added and solution de-gassed with argon. After 1 h, 2,2′-azobis(2-
methylpropionitrile) was added (0.015 g; 50 mol%) followed by tributyltin hydride (0.206 mL; 
0.7672 mmol; 4.0 equiv). The tube was sealed and heated immediately to 110 C with vigorous 
stirring. After 72 h, heat was removed and the reaction allowed to cool to rt. The tube was 
opened and organic solvent was removed in vacuo to yield 0.4467 g of crude alkene. Further 
purification by flash chromatography (silica 15:1; 50% to 100% hexane/ethyl acetate) yielded 
white solid: 0.046 g; 0.1734 mmol; 90%. Rf 0.43 (ethyl acetate); 
1
H NMR: (500 MHz; CDCl3)  
 5.948 (dd, J = 10.3, 1.3 Hz, 1H),  5.760 (dt, J = 10.3, 2 x 3.3 Hz, 1H),  4.995 (ddd, J = 8.2, 
3.6, 1.6 Hz, 1H),  4.154 (q, J = 3 x 7.1 Hz, 2H),  3.849 (dd, J = 12.7, 5.3 Hz, 1H),  3.803 (dd, 
J = 8.3, 3.7 Hz, 1H),  2.723–2.817 (m, 2H),  2.519 (dd, J = 15.5, 4.5 Hz, 1H),  2.258 (dd,  
J = 15.5, 8.6 Hz, 1H),  1.987 (dd, J = 14.4, 2.6 Hz, 1H), 1.811 (ddd, J = 10.1, 6.6, 3.4 Hz, 1H), 
 1.692 (ddddd, J = 15.0, 13.8, 13.7, 5.9, 3.4 Hz, 1H),  1.578 (ddd, J = 14.0, 2.8, 1.2 Hz, 1H),  
 1.507 (tt, J = 2 x 14.0, 2 x 3.8 Hz, 1H),  1.266 (t, J = 2 x 7.1 Hz, 3H); 13C NMR: (125 MHz; 
CDCl3)  171.916, 157.228, 136.009, 122.761, 70.407, 60.724, 55.517, 41.109, 37.871, 34.998, 
28.732, 24.879, 18.450, 14.223; IR: (thin film) max 2940, 2866, 1749, 1423, 1372, 1347, 1315, 
1291, 1267, 1183, 1158, 1080, 1032, 998, 973, 932, 896, 790, 758 cm
-1
; HRMS: m/z [M + Na
+
] 
Calcd for C14H19lNO4Na: 288.1206. Found: 288.1214. 
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FidFile: std1h
P
ulse Sequence: std1h (s2pul)
Solvent: DMSO
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13C OBSERVE
 Sample Name:
 
 
 
 
A
r
chive directory:
 
 
 
 Sample directory:
 
 
 
 
FidFile: std13c
P
ulse Sequence: std13c (s2pul)
Solvent: DMSO
D
a
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ollected on: Apr  6 2010
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q
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time 1.199 sec
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STANDARD 1H OBSERVE
 Sample Name:
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 Sample directory:
 
 
 
 
FidFile: std1h
P
ulse Sequence: std1h (s2pul)
Solvent: CDCl3
D
a
t
a
 
c
ollected on: Feb 23 2010
O
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a
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o
r
:
 
m
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N
M
RS-500  "500york"
 
P
ulse 42.9 degrees
 
A
c
q
.
 
time 3.744 sec
 
Width 6000.6 Hz
 64 repetitions
O
BSERVE   H1, 399.8561338 MHz
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13C OBSERVE
 Sample Name:
 
 
 
 
A
r
chive directory:
 
 
 
 Sample directory:
 
 
 
 
FidFile: std13c
P
ulse Sequence: std13c (s2pul)
Solvent: CDCl3
D
a
t
a
 
c
ollected on: Feb 23 2010
O
p
e
r
a
t
o
r
:
 
m
ed
V
N
M
RS-500  "500york"
 
P
ulse 54.2 degrees
 
A
c
q
.
 
time 1.199 sec
 
Width 25000.0 Hz
 512 repetitions
O
BSERVE  C13, 100.5439059 MHz
D
E
C
O
U
P
L
E
 
 
H1, 399.8581477 MHz
 
P
o
w
e
r
 46 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
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C
ESSING
 
Line broadening 1.0 Hz
F
T
 
size 65536
T
o
t
al time 10 min
2 0 1 . 7 6 4
1 3 2 . 2 8 7
1 3 6 . 6 6 5
1 3 2 . 0 9 0
1 1 5 . 9 5 0
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4 3 . 0 8 9
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STANDARD 1H OBSERVE
 Sample Name:
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 Sample directory:
 
 
 
 
FidFile: std1h
P
ulse Sequence: std1h (s2pul)
Solvent: CDCl3
D
a
t
a
 
c
ollected on: Feb 19 2010
O
p
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r
a
t
o
r
:
 
m
ed
V
N
M
RS-500  "500york"
 
P
ulse 42.9 degrees
 
A
c
q
.
 
time 3.744 sec
 
Width 6000.6 Hz
 64 repetitions
O
BSERVE   H1, 399.8561331 MHz
D
A
T
A
 
P
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O
C
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F
T
 
size 65536
T
o
t
al time 4 min 0 sec
  2 . 0 0
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13C OBSERVE
 Sample Name:
 
 
 
 
A
r
chive directory:
 
 
 
 Sample directory:
 
 
 
 
FidFile: std13c
P
ulse Sequence: std13c (s2pul)
Solvent: CDCl3
D
a
t
a
 
c
ollected on: Feb 19 2010
O
p
e
r
a
t
o
r
:
 
m
ed
V
N
M
RS-500  "500york"
 
P
ulse 54.2 degrees
 
A
c
q
.
 
time 1.199 sec
 
Width 25000.0 Hz
 128 repetitions
O
BSERVE  C13, 100.5439120 MHz
D
E
C
O
U
P
L
E
 
 
H1, 399.8581477 MHz
 
P
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e
r
 46 dB
 
c
o
n
tinuously on
 
W
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T
Z
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D
A
T
A
 
P
R
O
C
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Line broadening 1.0 Hz
F
T
 
size 65536
T
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STANDARD 1H OBSERVE
 Sample Name:
 
 
 
 
A
r
chive directory:
 
 
 
 Sample directory:
 
 
 
 
FidFile: std1h
P
ulse Sequence: std1h (s2pul)
Solvent: CDCl3
D
a
t
a
 
c
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o
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:
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P
ulse 42.9 degrees
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q
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time 3.744 sec
 
Width 6000.6 Hz
 64 repetitions
O
BSERVE   H1, 399.8561334 MHz
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C
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F
T
 
size 65536
T
o
t
al time 4 min 0 sec
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13C OBSERVE
 Sample Name:
 
 
 
 
A
r
chive directory:
 
 
 
 Sample directory:
 
 
 
 
FidFile: std13c
P
ulse Sequence: std13c (s2pul)
Solvent: CDCl3
D
a
t
a
 
c
ollected on: Jan 14 2010
O
p
e
r
a
t
o
r
:
 
m
ed
V
N
M
RS-500  "500york"
 
P
ulse 54.2 degrees
 
A
c
q
.
 
time 1.199 sec
 
Width 25000.0 Hz
 512 repetitions
O
BSERVE  C13, 100.5439074 MHz
D
E
C
O
U
P
L
E
 
 
H1, 399.8581477 MHz
 
P
o
w
e
r
 46 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
O
C
ESSING
 
Line broadening 1.0 Hz
F
T
 
size 65536
T
o
t
al time 10 min
1 3 1 . 1 4 1
1 3 4 . 9 5 0
1 3 7 . 1 7 4
1 1 4 . 8 4 2
7 0 . 7 7 0
7 6 . 6 8 1
7 7 . 0 0 0
7 7 . 3 1 9
6 3 . 5 1 6
2 5 . 8 7 9
2 8 . 8 6 1
2 9 . 0 7 3
3 4 . 8 0 2
3 6 . 6 9 9
1 8 . 2 6 8
- 5 . 4 3 0
p
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STANDARD 1H OBSERVE
 Sample Name:
 
 
 
 
A
r
chive directory:
 
 
 
 Sample directory:
 
 
 
 
FidFile: std1h
P
ulse Sequence: std1h (s2pul)
Solvent: CDCl3
D
a
t
a
 
c
ollected on: Jan 19 2010
O
p
e
r
a
t
o
r
:
 
m
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V
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RS-500  "500york"
 
P
ulse 42.9 degrees
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time 3.744 sec
 
Width 6000.6 Hz
 64 repetitions
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STANDARD 1H OBSERVE
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A
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FidFile: std1h
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ulse Sequence: std1h (s2pul)
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ollected on: Feb 16 2010
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13C OBSERVE
 Sample Name:
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chive directory:
 
 
 
 Sample directory:
 
 
 
 
FidFile: std13c
P
ulse Sequence: std13c (s2pul)
Solvent: CDCl3
D
a
t
a
 
c
ollected on: Feb 16 2010
O
p
e
r
a
t
o
r
:
 
m
ed
V
N
M
RS-500  "500york"
 
P
ulse 54.2 degrees
 
A
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time 1.199 sec
 
Width 25000.0 Hz
 5000 repetitions
O
BSERVE  C13, 100.5439135 MHz
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H1, 399.8581477 MHz
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Line broadening 1.0 Hz
F
T
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T
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al time 1 hr, 39 min
1 5 5 . 6 8 9
1 2 7 . 8 1 0
1 3 1 . 8 3 9
1 3 2 . 8 1 1
1 3 6 . 7 2 6
1 1 5 . 4 7 9
1 1 2 . 4 5 2
7 7 . 0 0 0
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STANDARD 1H OBSERVE
 Sample Name:
 
 
 
 
A
r
chive directory:
 
 
 
 Sample directory:
 
 
 
 
FidFile: std1h
P
ulse Sequence: std1h (s2pul)
Solvent: CDCl3
D
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ollected on: Jan 28 2010
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:
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 64 repetitions
O
BSERVE   H1, 399.8561329 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 65536
T
o
t
al time 4 min 0 sec
  1 . 7 2
  0 . 9 3
  1 . 0 1
  2 . 2 2
  0 . 9 0
  1 . 0 3
  1 . 0 5
  1 . 1 3
  8 . 8 4
  9 . 1 6
  5 . 4 7 p
p
m
1
2
3
4
5
6
7
8
9
10
 
 
13C OBSERVE
 Sample Name:
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 Sample directory:
 
 
 
 
FidFile: std13c
P
ulse Sequence: std13c (s2pul)
Solvent: CDCl3
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ollected on: Jan 27 2010
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ulse 54.2 degrees
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time 1.199 sec
 
Width 25000.0 Hz
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STANDARD 1H OBSERVE
 Sample Name:
 
 
 
 
A
r
chive directory:
 
 
 
 Sample directory:
 
 
 
 
FidFile: std1h
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13C OBSERVE
 Sample Name:
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FidFile: std13c
P
ulse Sequence: std13c (s2pul)
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T
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al time 1 hr, 19 min
1 5 7 . 2 4 4
1 3 1 . 4 3 7
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7 7 . 0 0 0
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STANDARD 1H OBSERVE
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 Sample directory:
 
 
 
 
FidFile: std1h
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ulse Sequence: std1h (s2pul)
Solvent: CDCl3
D
a
t
a
 
c
ollected on: Mar 12 2010
O
p
e
r
a
t
o
r
:
 
m
ed
V
N
M
RS-500  "500york"
 
P
ulse 42.9 degrees
 
A
c
q
.
 
time 3.744 sec
 
Width 6000.6 Hz
 64 repetitions
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13C OBSERVE
 Sample Name:
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chive directory:
 
 
 
 Sample directory:
 
 
 
 
FidFile: std13c
P
ulse Sequence: std13c (s2pul)
Solvent: CDCl3
D
a
t
a
 
c
ollected on: Mar 12 2010
O
p
e
r
a
t
o
r
:
 
m
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V
N
M
RS-500  "500york"
 
P
ulse 54.2 degrees
 
A
c
q
.
 
time 1.199 sec
 
Width 25000.0 Hz
 4536 repetitions
O
BSERVE  C13, 100.5439074 MHz
D
E
C
O
U
P
L
E
 
 
H1, 399.8581477 MHz
 
P
o
w
e
r
 46 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
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P
R
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Line broadening 1.0 Hz
F
T
 
size 65536
T
o
t
al time 1 hr, 59 min
1 5 7 . 5 9 3
1 3 1 . 3 3 9
1 2 6 . 8 0 1
7 2 . 6 2 9
7 6 . 6 8 1
7 7 . 0 0 0
7 7 . 3 1 9
6 2 . 4 3 1
5 1 . 9 5 2
4 8 . 6 0 5
2 7 . 7 0 0
2 9 . 0 7 3
3 0 . 9 4 8
2 6 . 4 3 3
2 3 . 5 6 4
2 2 . 6 0 1
p
p
m
0
20
40
60
80
100
120
140
160
180
200
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
I
-99-spec4_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
I
-99-spec4_1_20140716_01
 
FidFile: PROTON_01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jul 16 2014
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 2.045 sec
 
Width 8012.8 Hz
 64 repetitions
O
BSERVE   H1, 499.7467159 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 32768
T
o
t
al time 4 min 19 sec
  0 . 8 1
  0 . 8 4
  0 . 8 2
  0 . 8 7
  2 . 0 0
  0 . 8 7
  0 . 9 1
  0 . 9 1
  1 . 0 1
  2 . 0 2
  4 . 6 6
  1 . 0 4
  0 . 9 9
p
p
m
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
 
 
M
E
D
-
I
-99-spec4_1
 Sample Name:
 
 
 
M
E
D
-
I
-99-spec4_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
I
-99-spec4_1_20140716_01
 
FidFile: CARBON_01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jul 16 2014
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 3.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 1.022 sec
 
Width 32051.3 Hz
 1000 repetitions
O
BSERVE  C13, 125.6614150 MHz
D
E
C
O
U
P
L
E
 
 
H1, 499.7492100 MHz
 
P
o
w
e
r
 40 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
O
C
ESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 1 hr, 7 min
1 5 5 . 7 3 3
1 3 1 . 3 0 0
1 2 7 . 1 0 5
7 7 . 2 5 7
7 7 . 0 0 0
7 6 . 7 5 1
7 1 . 2 8 7
6 2 . 4 2 1
5 8 . 9 4 2
5 7 . 4 2 4
2 8 . 3 0 4
2 9 . 9 1 6
3 1 . 3 5 6
2 7 . 8 9 2
2 7 . 6 5 0
2 7 . 5 5 7
p
p
m
0
20
40
60
80
100
120
140
160
180
200
220
Plotname: --Not assigned--
 
 
STANDARD 1H OBSERVE
 Sample Name:
 
 
 
 
A
r
chive directory:
 
 
 
 Sample directory:
 
 
 
 
FidFile: std1h
P
ulse Sequence: std1h (s2pul)
Solvent: CDCl3
D
a
t
a
 
c
ollected on: May 24 2011
O
p
e
r
a
t
o
r
:
 
m
ed
V
N
M
RS-500  "500york"
 
P
ulse 42.9 degrees
 
A
c
q
.
 
time 3.744 sec
 
Width 6000.6 Hz
 36 repetitions
O
BSERVE   H1, 399.8561371 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 65536
T
o
t
al time 4 min 0 sec
  0 . 8 5
  0 . 9 2
  1 . 0 5
  1 . 0 2
  0 . 9 7
  1 . 1 4
  2 . 8 9
  1 . 9 1
  1 . 0 7
  0 . 9 7
  2 . 6 6
  1 . 2 2
  1 . 1 5
p
p
m
1
2
3
4
5
6
7
8
9
10
 
 
13C OBSERVE
 Sample Name:
 
 
 
 
A
r
chive directory:
 
 
 
 Sample directory:
 
 
 
 
FidFile: std13c
P
ulse Sequence: std13c (s2pul)
Solvent: CDCl3
D
a
t
a
 
c
ollected on: May 24 2011
O
p
e
r
a
t
o
r
:
 
m
ed
V
N
M
RS-500  "500york"
 
P
ulse 54.2 degrees
 
A
c
q
.
 
time 1.199 sec
 
Width 25000.0 Hz
 1564 repetitions
O
BSERVE  C13, 100.5439059 MHz
D
E
C
O
U
P
L
E
 
 
H1, 399.8581477 MHz
 
P
o
w
e
r
 46 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
O
C
ESSING
 
Line broadening 1.0 Hz
F
T
 
size 65536
T
o
t
al time 40 min
2 0 1 . 2 4 8
1 5 7 . 5 4 8
1 3 1 . 1 6 4
1 2 6 . 8 0 1
7 2 . 6 3 7
7 6 . 6 8 1
7 7 . 0 0 0
7 7 . 3 1 9
5 1 . 8 0 0
4 8 . 8 9 4
4 7 . 7 4 0
4 0 . 9 0 3
2 7 . 6 6 2
3 0 . 8 4 9
2 3 . 7 1 6
2 2 . 6 8 4
2 2 . 5 4 8
p
p
m
0
20
40
60
80
100
120
140
160
180
200
 
 
STANDARD 1H OBSERVE
 Sample Name:
 
 
 
 
A
r
chive directory:
 
 
 
 Sample directory:
 
 
 
 
FidFile: std1h
P
ulse Sequence: std1h (s2pul)
Solvent: CDCl3
D
a
t
a
 
c
ollected on: Mar 31 2010
O
p
e
r
a
t
o
r
:
 
m
ed
V
N
M
RS-500  "500york"
 
P
ulse 42.9 degrees
 
A
c
q
.
 
time 3.744 sec
 
Width 6000.6 Hz
 64 repetitions
O
BSERVE   H1, 399.8561338 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 65536
T
o
t
al time 4 min 0 sec
  1 . 0 6
  1 . 1 6
  1 . 0 4
  1 . 2 0
  1 . 1 7
  1 . 1 2
  1 . 1 5
  1 . 2 9
  3 . 3 4
  1 . 3 4
  5 . 0 6
 1 1 . 9 6
p
p
m
1
2
3
4
5
6
7
8
9
10
 
 

G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
I
-165-spec1_0
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
I
-165-spec1_0_20130204_01
 
FidFile: PROTON_01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Feb  4 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 2.975 sec
 
Width 5506.6 Hz
 128 repetitions
O
BSERVE   H1, 499.7485587 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 32768
T
o
t
al time 8 min 29 sec
  0 . 9 3
  1 . 0 0
  0 . 9 1
  1 . 0 9
  1 . 1 1
  1 . 1 0
  1 . 1 3
  1 . 0 3
  1 . 1 5
  1 . 9 3
  1 . 0 9
  1 . 2 0
  1 . 2 9
  1 . 0 5
  2 . 3 2
  1 . 1 3
  1 . 1 5
p
p
m
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
 
 
M
E
D
-
I
-165-spec1_0
 Sample Name:
 
 
 
M
E
D
-
I
-165-spec1_0
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
I
-165-spec1_0_20130204_01
 
FidFile: CARBON_01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Feb  4 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 5.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 1.022 sec
 
Width 32051.3 Hz
 1000 repetitions
O
BSERVE  C13, 125.6618772 MHz
D
E
C
O
U
P
L
E
 
 
H1, 499.7510562 MHz
 
P
o
w
e
r
 40 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
O
C
ESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 1 hr, 40 min
1 9 3 . 8 8 9
1 5 7 . 2 2 8
1 2 6 . 9 6 4
1 3 1 . 0 9 0
1 3 3 . 1 4 5
7 7 . 2 5 7
7 7 . 0 0 0
7 6 . 7 5 1
7 2 . 6 4 1
5 1 . 9 8 3
4 8 . 4 7 2
2 9 . 4 5 7
3 0 . 8 7 3
2 8 . 5 1 5
2 7 . 6 8 2
2 3 . 5 5 6
2 2 . 6 6 1
p
p
m
0
20
40
60
80
100
120
140
160
180
200
220
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
I
-127-spec5_2
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
I
-127-spec5_2_20111103_01
 
FidFile: PROTON_01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Nov  3 2011
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 2.975 sec
 
Width 5506.6 Hz
 64 repetitions
O
BSERVE   H1, 499.7585665 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 32768
T
o
t
al time 4 min 14 sec
  0 . 8 5
  2 . 1 2
  2 . 4 3
  1 . 0 0
  1 . 1 0
  1 . 1 5
  1 . 2 5
  1 . 1 5
  1 . 2 5
  1 . 1 8
  1 . 4 2
  1 . 5 7
  1 . 5 2
  1 . 5 3
  2 . 7 3
  1 . 3 4
p
p
m
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
 
 


G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
I
-117-2D-beta
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
I
-117-2D-beta_20121008_01
 
FidFile: PROTON_01
P
ulse Sequence: PROTON (s2pul)
Solvent: c6d6
D
a
t
a
 
c
ollected on: Oct  8 2012
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 2.975 sec
 
Width 5506.6 Hz
 512 repetitions
O
BSERVE   H1, 499.7485394 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 32768
T
o
t
al time 33 min
  1 . 0 0
  1 . 0 2
  2 . 0 8
  2 . 9 5
  3 . 0 0
  1 . 0 0
  1 . 1 0
  1 . 0 3
  1 . 0 8
  6 . 8 0
  1 . 3 0
  2 . 2 5
  9 . 3 0
  1 . 2 1
  5 . 8 2
p
p
m
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
 
 
M
E
D
-
I
-117-2D-beta
 Sample Name:
 
 
 
M
E
D
-
I
-117-2D-beta
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
I
-117-2D-beta_20121008_01
 
FidFile: CARBON_01
P
ulse Sequence: CARBON (s2pul)
Solvent: c6d6
D
a
t
a
 
c
ollected on: Oct  8 2012
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 3.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 1.022 sec
 
Width 32051.3 Hz
 2000 repetitions
O
BSERVE  C13, 125.6617675 MHz
D
E
C
O
U
P
L
E
 
 
H1, 499.7511012 MHz
 
P
o
w
e
r
 40 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
O
C
ESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 2 hr, 14 min
1 6 7 . 7 5 7
1 7 0 . 8 0 8
1 5 6 . 5 4 1
1 2 8 . 4 2 5
1 2 8 . 5 2 7
1 2 8 . 6 2 0
1 2 8 . 7 2 1
1 2 8 . 8 0 7
1 2 8 . 9 0 8
2 6 . 7 7 7
2 7 . 0 3 3
2 7 . 2 2 8
3 0 . 2 5 6
3 8 . 0 5 5
4 8 . 7 3 5
5 0 . 9 6 9
5 2 . 5 8 0
5 2 . 9 3 8
6 3 . 1 5 8
7 2 . 4 1 3
2 4 . 0 7 6
2 2 . 7 6 8
2 2 . 6 2 8
2 2 . 5 6 6
2 2 . 2 6 2
1 9 . 1 1 7
- 4 . 5 3 0
- 4 . 5 6 1p
p
m
0
20
40
60
80
100
120
140
160
180
200
220
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
I
-125-2Dbetta
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
I
-125-2Dbetta_20121015_01
 
FidFile: PROTON_01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Oct 15 2012
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 2.975 sec
 
Width 5506.6 Hz
 128 repetitions
O
BSERVE   H1, 499.7485607 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 32768
T
o
t
al time 8 min 29 sec
  0 . 9 0
  1 . 9 1
  0 . 8 6
  0 . 9 6
  1 . 8 2
  0 . 9 4
  0 . 9 6
  1 . 9 1
  1 . 0 6
  1 . 7 1
  4 . 7 2
  5 . 6 2
  1 . 1 5
  9 . 0 3
  5 . 4 9 p
p
m
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
I
-125-2Dbetta
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
I
-125-2Dbetta_20121016_01
 
FidFile: CARBON_01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Oct 16 2012
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 3.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 1.022 sec
 
Width 32051.3 Hz
 2000 repetitions
O
BSERVE  C13, 125.6618792 MHz
D
E
C
O
U
P
L
E
 
 
H1, 499.7510562 MHz
 
P
o
w
e
r
 40 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
O
C
ESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 2 hr, 14 min
1 7 2 . 9 6 7
1 5 6 . 3 0 1
7 7 . 0 0 0
7 7 . 2 5 7
7 6 . 7 4 3
7 2 . 3 7 6
6 2 . 4 1 3
6 0 . 6 7 0
5 1 . 0 8 8
4 8 . 5 1 1
3 1 . 1 0 7
3 0 . 6 7 1
2 9 . 4 8 0
2 6 . 3 5 1
2 6 . 2 8 1
2 5 . 9 1 5
2 2 . 3 1 9
2 2 . 2 1 8
1 8 . 7 4 6
1 8 . 2 8 7
1 6 . 2 4 7
1 4 . 2 0 8
- 5 . 3 2 9
- 5 . 3 0 6
p
p
m
0
20
40
60
80
100
120
140
160
180
200
220
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
-3-spec4_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-3-spec4_1_20140630_01
 
FidFile: PROTON_01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jun 30 2014
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 5.000 sec
 
P
ulse 90.0 degrees
 
A
c
q
.
 
time 2.045 sec
 
Width 8012.8 Hz
 128 repetitions
O
BSERVE   H1, 499.7467159 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 32768
T
o
t
al time 15 min
  1 . 8 4
  1 . 9 6
  0 . 8 0
  0 . 8 4
  0 . 8 2
  0 . 9 3
  0 . 8 3
  1 . 9 2
  3 . 1 8
  1 . 8 0
  2 . 0 0
p
p
m
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
 
 
M
E
D
-
V
-3-spec4_1
 Sample Name:
 
 
 
M
E
D
-
V
-3-spec4_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-3-spec4_1_20140630_01
 
FidFile: CARBON_01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jun 30 2014
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 3.000 sec
 
P
ulse 90.0 degrees
 
A
c
q
.
 
time 1.022 sec
 
Width 32051.3 Hz
 2000 repetitions
O
BSERVE  C13, 125.6614130 MHz
D
E
C
O
U
P
L
E
 
 
H1, 499.7492100 MHz
 
P
o
w
e
r
 40 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
O
C
ESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 2 hr, 14 min
1 2 9 . 8 2 9
1 3 2 . 2 5 7
1 3 2 . 5 5 3
1 3 6 . 7 4 9
1 4 4 . 7 0 4
1 2 7 . 8 9 8
1 1 5 . 6 5 5
7 7 . 0 0 0
7 7 . 2 5 7
7 6 . 7 4 3
6 9 . 6 9 9
2 8 . 1 6 4
2 8 . 2 7 3
2 1 . 6 4 1
p
p
m
0
20
40
60
80
100
120
140
160
180
200
220
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
-47-spec1_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-47-spec1_1_20130719_01
 
FidFile: PROTON_01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jul 19 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 2.045 sec
 
Width 8012.8 Hz
 64 repetitions
O
BSERVE   H1, 499.7467154 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 32768
T
o
t
al time 4 min 19 sec
  0 . 9 0
  0 . 9 9
  0 . 9 4
  1 . 0 0
  0 . 9 6
  1 . 0 5
  0 . 9 7
  2 . 1 6
  2 . 0 6
  2 . 1 7
p
p
m
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
-47-spec1_2
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-47-spec1_2_20130722_01
 
FidFile: CARBON_01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jul 22 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 5.000 sec
 
P
ulse 90.0 degrees
 
A
c
q
.
 
time 1.022 sec
 
Width 32051.3 Hz
 1500 repetitions
O
BSERVE  C13, 125.6614287 MHz
D
E
C
O
U
P
L
E
 
 
H1, 499.7492100 MHz
 
P
o
w
e
r
 40 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
O
C
ESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 2 hr, 30 min
1 5 5 . 5 5 4
1 2 7 . 4 2 4
1 3 2 . 0 4 7
1 3 2 . 5 9 2
1 3 6 . 6 0 9
1 1 5 . 5 9 2
1 1 5 . 5 3 0
7 6 . 7 4 3
7 7 . 0 0 0
7 7 . 2 4 9
4 3 . 3 0 4
2 9 . 1 1 4
2 8 . 4 2 9
2 8 . 0 7 1
2 4 . 3 3 5
p
p
m
0
20
40
60
80
100
120
140
160
180
200
220
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
-9-spec3_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-9-spec3_1_20130326_01
 
FidFile: PROTON_01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Mar 26 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 2.975 sec
 
Width 5506.6 Hz
 64 repetitions
O
BSERVE   H1, 499.7467152 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 32768
T
o
t
al time 4 min 14 sec
  1 . 9 9
  1 . 0 0
  1 . 1 1
  1 . 1 5
  2 . 0 8
  1 . 1 2
  1 . 1 3
  1 . 0 4
  1 . 1 6
  1 . 3 3
  1 . 1 6
p
p
m
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
-9-spec3_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-9-spec3_1_20130326_01
 
FidFile: CARBON_01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Mar 27 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 3.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 1.022 sec
 
Width 32051.3 Hz
 2000 repetitions
O
BSERVE  C13, 125.6614150 MHz
D
E
C
O
U
P
L
E
 
 
H1, 499.7492100 MHz
 
P
o
w
e
r
 40 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
O
C
ESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 2 hr, 14 min
1 5 7 . 4 9 3
1 3 1 . 9 3 8
1 2 5 . 5 0 9
7 6 . 7 4 3
7 7 . 0 0 0
7 7 . 2 0 2
7 7 . 2 4 9
7 1 . 4 5 0
6 1 . 0 4 3
4 1 . 5 8 4
3 6 . 8 2 8
2 4 . 6 7 7
2 7 . 1 1 3
2 8 . 6 3 1
p
p
m
0
20
40
60
80
100
120
140
160
180
200
220
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
-9-spec2_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-9-spec2_1_20130319_01
 
FidFile: PROTON_01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Mar 19 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 2.000 sec
 
P
ulse 90.0 degrees
 
A
c
q
.
 
time 2.975 sec
 
Width 5506.6 Hz
 64 repetitions
O
BSERVE   H1, 499.7467148 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 32768
T
o
t
al time 5 min 18 sec
  0 . 8 8
  0 . 9 4
  0 . 9 4
  1 . 0 0
  1 . 2 0
  1 . 2 3
  1 . 2 3
  1 . 0 4
  2 . 5 1
  1 . 2 5
  2 . 5 2
p
p
m
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
-9-spec2_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-9-spec2_1_20130319_01
 
FidFile: CARBON_01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Mar 19 2013
 
T
e
m
p
.
 25.0 C / 298.1 K
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 3.000 sec
 
P
ulse 90.0 degrees
 
A
c
q
.
 
time 1.022 sec
 
Width 32051.3 Hz
 512 repetitions
O
BSERVE  C13, 125.6614199 MHz
D
E
C
O
U
P
L
E
 
 
H1, 499.7492100 MHz
 
P
o
w
e
r
 40 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
O
C
ESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 34 min
1 5 6 . 9 7 9
1 3 1 . 2 2 2
1 2 6 . 8 1 7
7 2 . 2 4 4
7 6 . 7 5 1
7 7 . 0 0 0
7 7 . 2 5 7
5 5 . 6 2 6
4 0 . 6 8 8
2 7 . 1 6 8
2 7 . 6 2 7
3 0 . 8 8 1
1 9 . 9 6 0
p
p
m
0
20
40
60
80
100
120
140
160
180
200
220
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
-11-spec2_3
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-11-spec2_3_20130404_01
 
FidFile: PROTON_01
P
ulse Sequence: PROTON (s2pul)
Solvent: c6d6
D
a
t
a
 
c
ollected on: Apr  4 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 5.000 sec
 
P
ulse 90.0 degrees
 
A
c
q
.
 
time 2.975 sec
 
Width 5506.6 Hz
 128 repetitions
O
BSERVE   H1, 499.7467435 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 32768
T
o
t
al time 17 min
  1 . 9 8
  0 . 9 8
  1 . 0 3
  0 . 9 6
  0 . 9 9
  1 . 0 0
  0 . 9 6
  1 . 0 1
  1 . 1 1
  1 . 1 5
  4 . 0 0
  1 . 1 6
  0 . 9 9
  1 . 0 3
  0 . 9 7 p
p
m
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
 
 
M
E
D
-
V
-11-spec2_3
 Sample Name:
 
 
 
M
E
D
-
V
-11-spec2_3
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-11-spec2_3_20130404_01
 
FidFile: CARBON_01
P
ulse Sequence: CARBON (s2pul)
Solvent: c6d6
D
a
t
a
 
c
ollected on: Apr  4 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 3.000 sec
 
P
ulse 90.0 degrees
 
A
c
q
.
 
time 1.022 sec
 
Width 32051.3 Hz
 1000 repetitions
O
BSERVE  C13, 125.6612789 MHz
D
E
C
O
U
P
L
E
 
 
H1, 499.7492550 MHz
 
P
o
w
e
r
 40 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
O
C
ESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 1 hr, 7 min
1 7 3 . 3 2 3
1 5 6 . 2 2 9
1 2 8 . 6 2 0
1 2 8 . 7 2 1
1 2 8 . 8 1 5
1 2 8 . 9 1 6
1 2 9 . 0 0 9
1 2 9 . 1 0 3
7 2 . 3 1 2
6 1 . 2 7 4
5 5 . 2 0 3
1 9 . 7 8 6
2 6 . 9 2 4
2 7 . 3 7 6
3 1 . 6 1 0
3 1 . 7 7 3
4 1 . 1 3 7
1 9 . 4 2 8
1 7 . 2 2 5
1 5 . 1 0 0
p
p
m
0
20
40
60
80
100
120
140
160
180
200
220
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
-11-spec3_3
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-11-spec3_3_20130404_01
 
FidFile: PROTON_01
P
ulse Sequence: PROTON (s2pul)
Solvent: c6d6
D
a
t
a
 
c
ollected on: Apr  4 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 5.000 sec
 
P
ulse 90.0 degrees
 
A
c
q
.
 
time 2.975 sec
 
Width 5506.6 Hz
 64 repetitions
O
BSERVE   H1, 499.7468818 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 32768
T
o
t
al time 8 min 30 sec
  1 . 0 0
  3 . 0 0
  1 . 0 0
  1 . 0 3
  1 . 0 2
  1 . 9 2
  2 . 2 8
  1 . 2 2
  1 . 1 7
  1 . 0 6
  3 . 1 3
  1 . 1 7
  1 . 0 3
p
p
m
0
1
2
3
4
5
6
7
8
9
10Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
-11-spec3_3
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-11-spec3_3_20130404_01
 
FidFile: CARBON_01
P
ulse Sequence: CARBON (s2pul)
Solvent: c6d6
D
a
t
a
 
c
ollected on: Apr  4 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 3.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 1.022 sec
 
Width 32051.3 Hz
 512 repetitions
O
BSERVE  C13, 125.6613034 MHz
D
E
C
O
U
P
L
E
 
 
H1, 499.7492550 MHz
 
P
o
w
e
r
 40 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
O
C
ESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 34 min
1 7 2 . 2 8 7
1 5 6 . 3 8 5
1 2 8 . 6 2 0
1 2 8 . 7 2 1
1 2 8 . 8 1 5
1 2 8 . 9 0 8
1 2 8 . 5 2 7
1 2 8 . 4 2 5
7 3 . 1 9 9
6 0 . 6 1 3
5 5 . 5 2 2
4 0 . 9 2 7
2 3 . 1 6 5
2 7 . 1 4 2
1 9 . 8 5 6
1 9 . 2 3 4
1 9 . 1 7 1
1 7 . 9 4 2
1 5 . 5 6 0
1 4 . 8 1 2
p
p
m
0
20
40
60
80
100
120
140
160
180
200
220
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
-51-spec1_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-51-spec1_1_20130729_01
 
FidFile: PROTON_01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jul 29 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 2.045 sec
 
Width 8012.8 Hz
 16 repetitions
O
BSERVE   H1, 499.7467149 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 32768
T
o
t
al time 0 min 49 sec
  6 . 0 0
p
p
m
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
 
 
M
E
D
-
V
-51-spec1_1
 Sample Name:
 
 
 
M
E
D
-
V
-51-spec1_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-51-spec1_1_20130729_01
 
FidFile: CARBON_01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jul 29 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 3.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 1.022 sec
 
Width 32051.3 Hz
 256 repetitions
O
BSERVE  C13, 125.6614238 MHz
D
E
C
O
U
P
L
E
 
 
H1, 499.7492100 MHz
 
P
o
w
e
r
 40 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
O
C
ESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 17 min
1 5 8 . 2 0 9
1 0 6 . 9 6 0
7 6 . 7 4 3
7 7 . 0 0 0
7 7 . 2 4 9
2 6 . 6 4 6
p
p
m
0
20
40
60
80
100
120
140
160
180
200
220
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
-57-spec3_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-57-spec3_1_20130920_01
 
FidFile: PROTON_01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Sep 20 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 2.045 sec
 
Width 8012.8 Hz
 64 repetitions
O
BSERVE   H1, 499.7467159 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 32768
T
o
t
al time 4 min 19 sec
  0 . 9 6
  1 . 0 0
  0 . 9 8
  2 . 0 0
  1 . 0 0
  1 . 0 1
  1 . 0 7
  4 . 2 3
  1 . 0 8
  1 . 1 3
  2 . 1 4
  0 . 9 9
  0 . 9 8
p
p
m
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
-57-spec3_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-57-spec3_1_20130920_01
 
FidFile: CARBON_01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Sep 20 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 3.000 sec
 
P
ulse 90.0 degrees
 
A
c
q
.
 
time 1.022 sec
 
Width 32051.3 Hz
 1000 repetitions
O
BSERVE  C13, 125.6614150 MHz
D
E
C
O
U
P
L
E
 
 
H1, 499.7492100 MHz
 
P
o
w
e
r
 40 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
O
C
ESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 1 hr, 7 min
1 5 6 . 2 7 1
7 7 . 0 0 0
7 7 . 2 5 7
7 6 . 7 4 3
7 2 . 7 0 3
6 5 . 9 3 9
5 5 . 2 2 9
4 0 . 5 4 1
1 2 . 6 4 3
1 8 . 7 0 7
2 6 . 6 7 0
2 6 . 8 7 2
3 1 . 4 4 1
3 2 . 0 4 1
1 0 . 1 2 1
p
p
m
0
20
40
60
80
100
120
140
160
180
200
220
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
-57-spec3_3
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-57-spec3_3_20130927_01
 
FidFile: PROTON_01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Sep 27 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 2.045 sec
 
Width 8012.8 Hz
 64 repetitions
O
BSERVE   H1, 499.7467159 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 32768
T
o
t
al time 3 min 15 sec
  1 . 0 0
  1 . 1 4
  1 . 1 4
  2 . 2 3
  1 . 1 4
  1 . 0 9
  1 . 1 4
  2 . 4 7
  1 . 7 0
  4 . 2 2
  2 . 2 2
p
p
m
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
 
 
M
E
D
-
V
-57-spec3_3
 Sample Name:
 
 
 
M
E
D
-
V
-57-spec3_3
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-57-spec3_3_20130927_01
 
FidFile: CARBON_01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Sep 27 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 3.000 sec
 
P
ulse 90.0 degrees
 
A
c
q
.
 
time 1.022 sec
 
Width 32051.3 Hz
 2000 repetitions
O
BSERVE  C13, 125.6614140 MHz
D
E
C
O
U
P
L
E
 
 
H1, 499.7492100 MHz
 
P
o
w
e
r
 40 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
O
C
ESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 2 hr, 14 min
1 5 6 . 2 9 4
7 7 . 0 0 0
7 7 . 2 5 7
7 6 . 7 4 3
7 2 . 8 2 8
5 8 . 0 7 0
5 5 . 2 3 6
4 0 . 5 5 6
2 7 . 2 3 0
2 5 . 0 9 0
2 0 . 9 7 2
2 0 . 0 0 7
1 8 . 4 4 2
1 0 . 8 1 4
8 . 4 7 1
p
p
m
0
20
40
60
80
100
120
140
160
180
200
220
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
-55-spec3_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-55-spec3_1_20130829_01
 
FidFile: PROTON_01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Aug 29 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 2.045 sec
 
Width 8012.8 Hz
 64 repetitions
O
BSERVE   H1, 499.7467163 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 32768
T
o
t
al time 4 min 19 sec
  1 . 0 0
  1 . 0 1
  1 . 0 3
  1 . 0 2
  1 . 1 4
  1 . 1 6
  2 . 1 7
  1 . 1 5
  1 . 3 4
  2 . 6 9
  1 . 2 2
p
p
m
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
-55-spec3_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
-55-spec3_1_20130829_01
 
FidFile: CARBON_01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Aug 29 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 3.000 sec
 
P
ulse 90.0 degrees
 
A
c
q
.
 
time 1.022 sec
 
Width 32051.3 Hz
 1000 repetitions
O
BSERVE  C13, 125.6614160 MHz
D
E
C
O
U
P
L
E
 
 
H1, 499.7492100 MHz
 
P
o
w
e
r
 40 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
O
C
ESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 1 hr, 7 min
1 5 6 . 7 6 1
1 3 2 . 6 0 8
1 3 1 . 7 9 0
7 6 . 7 4 3
7 7 . 0 0 0
7 7 . 2 4 9
7 1 . 2 0 1
6 5 . 2 0 0
6 0 . 8 4 1
3 7 . 4 8 1
4 0 . 0 5 8
2 7 . 4 9 5
2 2 . 0 8 5
p
p
m
0
20
40
60
80
100
120
140
160
180
200
220
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
I
-9-spec6_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
I
-9-spec6_1_20131204_01
 
FidFile: PROTON_01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Dec  4 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 2.045 sec
 
Width 8012.8 Hz
 64 repetitions
O
BSERVE   H1, 499.7467154 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
T
 
size 32768
T
o
t
al time 3 min 15 sec
  0 . 9 9
  0 . 9 9
  2 . 4 9
  1 . 3 3
  2 . 4 8
  2 . 4 9
p
p
m
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
 
 
M
E
D
-
V
I
-9-spec6_1
 Sample Name:
 
 
 
M
E
D
-
V
I
-9-spec6_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
I
-9-spec6_1_20131204_01
 
FidFile: CARBON_01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Dec  4 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 3.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 1.022 sec
 
Width 32051.3 Hz
 512 repetitions
O
BSERVE  C13, 125.6614228 MHz
D
E
C
O
U
P
L
E
 
 
H1, 499.7492100 MHz
 
P
o
w
e
r
 40 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
R
O
C
ESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 34 min
1 2 9 . 0 5 8
1 1 3 . 9 2 7
9 2 . 2 8 0
7 6 . 0 1 1
7 6 . 7 5 1
7 7 . 0 0 0
7 7 . 2 5 7
6 1 . 2 3 0
3 0 . 9 6 6
1 5 . 7 8 8
p
p
m
0
20
40
60
80
100
120
140
160
180
200
220
Plotname: --Not assigned--
 
 
G
r
adient Shimming
 Sample Name:
 
 
 
M
E
D
-
V
I
-13-spec1_1
 
D
a
t
a
 
C
ollected on:
 
 
 500york-vnmrs500
 
A
r
chive directory:
 
 
 /home/med/vnmrsys/data
 Sample directory:
 
 
 
M
E
D
-
V
I
-13-spec1_1_20131119_01
 
FidFile: PROTON_01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Nov 19 2013
O
p
e
r
a
t
o
r
:
 
m
ed
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
c
q
.
 
time 2.045 sec
 
Width 8012.8 Hz
 64 repetitions
O
BSERVE   H1, 499.7467159 MHz
D
A
T
A
 
P
R
O
C
ESSING
F
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Appendix A 
 
Optimized geometries and energies for 285, 287, 289, 301, 303, 305, 307, 306, 308 cycloadducts 
are presented as Z-matrices.  
The following method was used to optimize geometries of each cycloadduct at STP: 
 #p opt=calcall freq=savenormalmodes rb3lyp/6-31+g(d) scf=qc geom=connectivity 
All energies are reported in Hartrees. (1 Hartree = 627.503 kcal/mol) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tag  Atom        X                           Y                             Z 
1 C -0.278209  -1.28667  -1.316077 
2 O  2.454666  -0.727203  -0.257517 
3 C  0.630583  -2.277889  -0.575899 
4 Si  4.020425  -0.105788  -0.161945 
5 C -3.114853  -1.968521   0.999422 
6 C -1.778333  -1.491039  -1.050802 
7 C  3.801184   1.636545   0.600349 
8 C -2.696893  -0.696911  -2.00845 
9 C  4.782996  -0.039592  -1.893082 
10 C -2.625005   0.852259  -1.976454 
11 C  5.082246  -1.230992   0.928138 
12 C -3.484525   1.503205  -0.924062 
13 C -4.506184   2.335275  -1.191905 
14 C  5.17806   2.319354   0.761497 
15 C -5.388364   2.964442  -0.198002 
16 C  3.130685   1.521987   1.987447 
17 C -5.760545   2.436217   0.979037 
18 C  2.912536   2.506518  -0.316133 
19 C -2.175424  -0.5428   2.449923 
20 C -1.525431  -0.384177   1.285633 
21 C  2.117118  -2.004003  -0.792464 
22 N -2.106025  -1.268297   0.369457 
23 O -3.157596  -1.504882   2.304331 
24 O -3.845688  -2.829052   0.553962 
25 H -0.124797  -1.397061  -2.398227 
26 H  0.0287  -0.262983  -1.073553 
27 H  0.415227  -3.301364  -0.915042 
28 H  0.429629  -2.252841   0.502101 
29 H -2.014913  -2.549191  -1.215485 
30 H -3.731527  -1.015193  -1.835027 
31 H -2.438119  -1.034843  -3.021398 
32 H  5.792162   0.390968  -1.870247 
33 H  4.179333   0.561126  -2.584002 
34 H  4.874731  -1.04558  -2.322969 
35 H -1.578549   1.170406  -1.85613 
36 H -2.940353   1.225741  -2.95905 
37 H  6.096321  -0.828906   1.048064 
38 H  5.184466  -2.229994   0.485076 
39 H  4.651376  -1.355589   1.928783 
40 H -3.249417   1.285293   0.117092 
41 H -4.701485   2.600439  -2.233365 
42 H  5.055135   3.321797   1.197698 
43 H  5.692512   2.446429  -0.199649 
44 H  5.84363   1.756449   1.428143 
45 H -5.784325   3.942882  -0.474662 
46 H  2.981994   2.521987   2.421975 
47 H  3.74297   0.948391   2.694602 
48 H  2.150108   1.036071   1.923964 
49 H -6.404306   2.982821   1.662909 
50 H -5.451437   1.440265   1.28796 
51 H  2.769579   3.50327   0.127731 
52 H  1.92102   2.061567  -0.460209 
53 H  3.36154   2.653752  -1.306515 
54 H -2.076243  -0.08617   3.421004 
55 H -0.701027   0.263488   1.032824 
56 H  2.70706  -2.791496  -0.30028 
57 H  2.354312  -2.032991  -1.867996 
 
Sum of electronic and zero-point Energies   -1313.385377 hartree 
Sum of electronic and thermal Energies   -1313.355531 hartree 
Sum of electronic and thermal Enthalpies   -1313.354586 hartree 
Sum of electronic and thermal Free-Energies  -1313.451145 hartree 
E (thermal)        328.014 kcal/mol    
 
 
 
 
 
 
 
 
 
 
Tag  Atom        X                           Y                             Z 
1 C  0.35154  -1.608194   0.9585 
2 O -2.328127  -0.802782  -0.115517 
3 C -0.331869  -2.157142  -0.299242 
4 Si -3.945594  -0.336258  -0.109219 
5 C  3.073876  -1.143177  -1.29077 
6 C  1.889767  -1.572941   0.859182 
7 C -3.888177   1.576338  -0.041443 
8 C  2.576763  -1.128159   2.167998 
9 C -4.815758  -1.072108   1.4027 
10 C  2.456649   0.386171   2.408493 
11 C -4.80061  -0.971166  -1.67347 
12 C  3.018232   1.211652   1.231102 
13 C  4.526447   1.159963   1.12275 
14 C -5.32212   2.152243  -0.019099 
15 C  5.141308   1.566782   0.006206 
16 C -3.144081   2.123853  -1.279774 
17 C  4.32535   2.053691  -1.165413 
18 C -3.141988   2.032722   1.231713 
19 C  3.089924   1.174268  -1.397181 
20 C  2.34543   0.753858  -0.094129 
21 C -1.855937  -2.144862  -0.216314 
22 N  2.343089  -0.69677  -0.223838 
23 O  3.505684  -0.064358  -2.016498 
24 O  3.320314  -2.290427  -1.60216 
25 H  0.087629  -2.237059   1.821427 
26 H -0.043033  -0.60804   1.173138 
27 H -0.006213  -3.191683  -0.478946 
28 H -0.02543  -1.575387  -1.177273 
29 H  2.244562  -2.57267   0.58772 
30 H  3.637418  -1.406008   2.112237 
31 H  2.146886  -1.678771   3.014081 
32 H -5.86953  -0.768808   1.449075 
33 H -4.3368  -0.762489   2.33943 
34 H -4.798299  -2.169216   1.369713 
35 H  1.4046   0.657669   2.568333 
36 H  2.988193   0.660964   3.32902 
37 H -5.844671  -0.636605  -1.72335 
38 H -4.814492  -2.068476  -1.698022 
39 H -4.294851  -0.626871  -2.583481 
40 H  2.721623   2.262185   1.386722 
41 H  5.099209   0.802921   1.977792 
42 H -5.288246   3.251355   0.018793 
43 H -5.890216   1.815731   0.85766 
44 H -5.893286   1.8774  -0.915193 
45 H  6.225373   1.546228  -0.078478 
46 H -3.083843   3.221948  -1.232112 
47 H -3.657407   1.868003  -2.215301 
48 H -2.121086   1.734911  -1.341302 
49 H  4.913353   2.07521  -2.088862 
50 H  3.980725   3.085555  -0.989039 
51 H -3.089292   3.131526   1.268792 
52 H -2.115816   1.647974   1.257123 
53 H -3.648306   1.700785   2.146908 
54 H  2.4059   1.662264  -2.098904 
55 H  1.314362   1.13271  -0.104384 
56 H -2.273521  -2.625199  -1.113707 
57 H -2.190253  -2.725269   0.658862 
 
Sum of electronic and zero-point Energies   -1313.434514 hartree 
Sum of electronic and thermal Energies   -1313.407730 hartree 
Sum of electronic and thermal Enthalpies   -1313.406786 hartree 
Sum of electronic and thermal Free-Energies  -1313.493736 hartree 
E (thermal)        330.418 kcal/mol    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tag  Atom        X                           Y                             Z 
1 C  3.193638   1.183486   0.936847 
2 C  4.501171   2.819389  -0.316137 
3 C  5.176948   1.648154  -1.004658 
4 O  4.807056  -0.794096  -1.115511 
5 C  4.191118   0.501442  -1.326838 
6 C  2.95921   0.472446  -0.411071 
7 N  2.757412  -0.953702  -0.227203 
8 C  1.739202  -1.427112   0.722883 
9 C  1.835687  -0.615604   2.043758 
10 C  1.984955   0.908617   1.839201 
11 C  3.917306  -1.643382  -0.494151 
12 O  4.17278  -2.804111  -0.254596 
13 C  0.344253  -1.390696   0.063809 
14 C -2.091221  -2.16619   0.151471 
15 O -2.607706  -0.839136   0.172287 
16 Si -4.11678  -0.372908  -0.413419 
17 C -4.246312   1.488716   0.015202 
18 C -5.469915  -1.393191   0.430271 
19 C  3.57021   2.610156   0.627261 
20 C -0.718242  -2.19967   0.819787 
21 C -4.203103  -0.68015  -2.279686 
22 C -5.588337   2.055575  -0.499612 
23 C -3.084856   2.263687  -0.645754 
24 C -4.168971   1.682317   1.545845 
25 H  4.066632   0.695453   1.404638 
26 H  4.814336   3.825995  -0.584947 
27 H  5.952249   1.231895  -0.34489 
28 H  5.691197   1.97082  -1.915308 
29 H  3.886055   0.541328  -2.378386 
30 H  2.094079   0.932262  -0.903124 
31 H  1.99939  -2.470718   0.928977 
32 H  0.958515  -0.827657   2.665275 
33 H  2.70921  -0.975871   2.603933 
34 H  2.109556   1.39688   2.814526 
35 H  1.076653   1.333924   1.388084 
36 H  0.447149  -1.798953  -0.950658 
37 H -0.00285  -0.356213  -0.04596 
38 H -2.773165  -2.844692   0.685711 
39 H -2.010941  -2.523131  -0.887758 
40 H -6.469598  -1.066412   0.117006 
41 H -5.420129  -1.315453   1.522916 
42 H -5.384436  -2.455892   0.169321 
43 H  3.087057   3.435268   1.148452 
44 H -0.833912  -1.832076   1.847468 
45 H -0.400104  -3.250398   0.890263 
46 H -5.167343  -0.357887  -2.693135 
47 H -4.096016  -1.748388  -2.50864 
48 H -3.412111  -0.146011  -2.819683 
49 H -5.668852   3.124398  -0.251489 
50 H -6.451695   1.55244  -0.04562 
51 H -5.682887   1.968765  -1.589605 
52 H -3.1507   3.333336  -0.394917 
53 H -3.106789   2.185336  -1.740196 
54 H -2.10989   1.899804  -0.301505 
55 H -4.218939   2.752896   1.7967 
56 H -3.232517   1.287263   1.956354 
57 H -4.999636   1.189117   2.066469 
 
Sum of electronic and zero-point Energies   -1313.430535 hartree 
Sum of electronic and thermal Energies   -1313.40381 hartree 
Sum of electronic and thermal Enthalpies   -1313.402866 hartree 
Sum of electronic and thermal Free-Energies  -1313.488918 hartree  
E (thermal)        330.496 kcal/mol    
 
 
 
 
 
 
 
 
 
 
 
 
 
Tag  Atom        X                           Y                             Z 
1 C -0.253232   1.575215  -0.050936 
2 C -1.58109   1.736387  -0.791417 
3 O -2.662165   1.180741  -0.047876 
4 C  2.089469  -0.459979  -1.498399 
5 C  2.32255   1.849592  -0.39042 
6 C  2.571224   2.087764   1.112213 
7 C  3.993635   1.700987   1.540082 
8 C  4.332632   0.245166   1.166224 
9 Si -3.458628  -0.255043  -0.421679 
10 C  3.57215  -0.788831   1.967334 
11 C -4.812124  -0.407773   0.925727 
12 C  3.497944  -2.056095   1.544347 
13 C -2.251491  -1.710027  -0.383377 
14 C  4.191633  -2.476633   0.271763 
15 C -4.204549  -0.134795  -2.15856 
16 C  4.106669  -1.419064  -0.842482 
17 C  4.071223   0.050184  -0.344814 
18 C -5.607558  -1.71672   0.725938 
19 C -5.781833   0.791794   0.841385 
20 C -4.159905  -0.420745   2.325973 
21 C  0.898765   2.237764  -0.825094 
22 N  2.716419   0.462563  -0.703787 
23 O  2.878452  -1.580104  -1.583643 
24 O  1.015415  -0.397715  -2.062022 
25 H -0.358888   2.015767   0.948529 
26 H -0.059009   0.506341   0.080844 
27 H -1.499147   1.271842  -1.7845 
28 H -1.801967   2.802507  -0.944967 
29 H  3.017636   2.500281  -0.951135 
30 H  1.840304   1.509761   1.689716 
31 H  2.390023   3.147786   1.332325 
32 H  4.71753   2.370643   1.053265 
33 H  4.115405   1.843695   2.621625 
34 H  5.412707   0.093987   1.329173 
35 H  3.089397  -0.480248   2.893607 
36 H  2.958556  -2.807125   2.117351 
37 H -2.745538  -2.64574  -0.676376 
38 H -1.822535  -1.857892   0.615416 
39 H -1.418139  -1.548317  -1.079049 
40 H  3.7877  -3.416256  -0.119783 
41 H  5.258035  -2.661481   0.479003 
42 H -4.764145  -1.042929  -2.417164 
43 H -3.417916  -0.01724  -2.91485 
44 H -4.886456   0.71885  -2.252856 
45 H  4.920194  -1.574584  -1.5572 
46 H  4.79704   0.664773  -0.902508 
47 H -6.389698  -1.808311   1.494939 
48 H -4.967558  -2.604676   0.806531 
49 H -6.108373  -1.751627  -0.250256 
50 H -6.545697   0.719338   1.630933 
51 H -6.310913   0.827279  -0.119536 
52 H -5.256297   1.744974   0.971758 
53 H -4.934101  -0.493507   3.105498 
54 H -3.584708   0.493941   2.509867 
55 H -3.484733  -1.275958   2.457657 
56 H  0.79075   2.029078  -1.893733 
57 H  0.836128   3.329189  -0.708696 
 
Sum of electronic and zero-point Energies   -1313.427621 hartree 
Sum of electronic and thermal Energies   -1313.401032 hartree 
Sum of electronic and thermal Enthalpies   -1313.400088 hartree 
Sum of electronic and thermal Free-Energies  -1313.485514 hartree 
E (thermal)        330.558 kcal/mol    
 
 
 
 
 
 
 
 
 
 
 
Tag  Atom        X                           Y                             Z 
1 Si  4.310484   0.54642   0.53668 
2 C -0.915507   0.203974  -0.236516 
3 C  7.049506  -0.124417   0.164371 
4 C  0.513353  -0.206492  -0.620399 
5 C  5.405566  -2.028285   0.067938 
6 C  4.332246   0.367448   2.422493 
7 C  1.558982   0.445782   0.281152 
8 C  4.511084   2.379063   0.107156 
9 C -3.5924   1.632005  -0.759316 
10 C  5.638596  -0.546502  -0.302898 
11 C -1.977148  -0.219751  -1.274482 
12 C  5.548772  -0.39694  -1.837965 
13 C -2.135878  -1.744951  -1.42305 
14 C -2.766857  -2.405003  -0.180612 
15 C -4.07141  -1.694278   0.310263 
16 C -3.976152  -1.153376   1.721601 
17 C -4.845882  -0.241911   2.172894 
18 C -5.958763   0.257013   1.285939 
19 C -5.510634   0.461594  -0.168871 
20 C -4.449366  -0.559265  -0.674225 
21 O  2.851961  -0.027836  -0.076326 
22 N -3.308057   0.308496  -0.930943 
23 O -4.884669   1.75719  -0.312107 
24 O -2.869418   2.588302  -0.954201 
25 H -0.968829   1.294128  -0.145095 
26 H -1.176992  -0.207949   0.747217 
27 H  7.812345  -0.757483  -0.313198 
28 H  7.175403  -0.229835   1.249677 
29 H  7.27954   0.915253  -0.101741 
30 H  0.725004   0.082401  -1.659399 
31 H  0.647206  -1.294216  -0.560447 
32 H  6.148369  -2.666622  -0.434368 
33 H  4.410022  -2.369042  -0.238984 
34 H  5.504442  -2.203721   1.146839 
35 H  4.153753  -0.667193   2.73928 
36 H  3.559543   0.993944   2.886756 
37 H  5.296305   0.683364   2.841554 
38 H  1.50571   1.540222   0.175993 
39 H  1.349656   0.203628   1.335214 
40 H  4.46963   2.553887  -0.974579 
41 H  5.467759   2.772311   0.474289 
42 H  3.718285   2.981663   0.569003 
43 H -1.68265   0.205014  -2.244803 
44 H  6.296478  -1.040732  -2.325942 
45 H  5.745139   0.632393  -2.164074 
46 H  4.561223  -0.68663  -2.214885 
47 H -2.751996  -1.951821  -2.30761 
48 H -1.157862  -2.19299  -1.625215 
49 H -2.975972  -3.456307  -0.40923 
50 H -2.034598  -2.413646   0.635598 
51 H -4.896468  -2.423429   0.278007 
52 H -3.180835  -1.527441   2.364809 
53 H -4.773554   0.142413   3.187931 
54 H -6.786485  -0.47055   1.284846 
55 H -6.378168   1.200551   1.650785 
56 H -6.385723   0.469189  -0.825397 
57 H -4.797704  -1.01562  -1.611515 
 
Sum of electronic and zero-point Energies   -1313.424519 hartree 
Sum of electronic and thermal Energies   -1313.397433 hartree 
Sum of electronic and thermal Enthalpies   -1313.396489 hartree 
Sum of electronic and thermal Free-Energies  -1313.484544 hartree 
E (thermal)        330.613 kcal/mol    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tag  Atom        X                           Y                             Z 
1 C -2.011743   0.234922   0.150433 
2 C -0.744996  -0.178357  -0.596367 
3 O -3.15306  -0.220523  -0.562569 
4 C  3.615847   1.64913  -0.316896 
5 C  1.823172  -0.039645  -0.635397 
6 C  2.069451  -1.530537  -0.949658 
7 C  3.54978  -1.767711  -1.272494 
8 C  4.439827  -1.561567  -0.021343 
9 Si -4.729158   0.367632  -0.509293 
10 C  5.89724  -1.437541  -0.39687 
11 C -5.43825  -0.042101  -2.207587 
12 C  6.77187  -0.646658   0.232038 
13 C -4.709309   2.243242   -0.250854 
14 C  6.375016   0.226316   1.394457 
15 C -5.718057  -0.513421   0.88493 
16 C  4.924914   0.687507   1.312986 
17 C  3.896054  -0.370518   0.840507 
18 C -5.730879  -2.036045   0.62533 
19 C -7.173207   0.005967   0.915049 
20 C -5.067519  -0.24921   2.260911 
21 C  0.530184   0.232725   0.152708 
22 N  2.994993   0.488233   0.076126 
23 O  4.811211   1.756513   0.343598 
24 O  3.214921   2.474981  -1.110294 
25 H -2.035135   1.3292   0.264893 
26 H -2.006174  -0.201145   1.161506 
27 H -0.777159  -1.264565  -0.748974 
28 H -0.76147   0.283619  -1.593181 
29 H  1.777399   0.518144  -1.578764 
30 H  1.770064  -2.154189  -0.093145 
31 H  1.435885  -1.832275  -1.790436 
32 H  3.706827  -2.780927  -1.662183 
33 H  3.862151  -1.072917  -2.064225 
34 H  4.333122  -2.468193   0.596888 
35 H  6.232309  -2.060552  -1.226519 
36 H -4.89871   0.513491  -2.984474 
37 H -6.500675   0.219668  -2.286272 
38 H -5.335512  -1.109448  -2.435883 
39 H  7.81171  -0.622904  -0.087703 
40 H -4.33584   2.540488   0.736441 
41 H -5.719331   2.658956  -0.356892 
42 H -4.077523   2.729079  -1.005508 
43 H  6.514074  -0.316304   2.342935 
44 H  7.01387   1.114855   1.457245 
45 H  4.604735   1.10257   2.276523 
46 H  3.37171  -0.775882   1.713104 
47 H -6.268699  -2.557411   1.431911 
48 H -4.715776  -2.449095   0.580977 
49 H -6.234357  -2.286931  -0.316624 
50 H -7.743745  -0.506037   1.704827 
51 H -7.698268  -0.176104  -0.031297 
52 H -7.223768   1.081976   1.12536 
53 H -5.644872  -0.743868   3.057047 
54 H -5.030651   0.820194   2.504781 
55 H -4.044613  -0.641852   2.311782 
56 H  0.582706  -0.290221   1.119856 
57 H  0.498017   1.307346   0.376047 
 
Sum of electronic and zero-point Energies   -1313.43001 hartree 
Sum of electronic and thermal Energies   -1313.402977 hartree 
Sum of electronic and thermal Enthalpies   -1313.402033 hartree 
Sum of electronic and thermal Free-Energies  -1313.489425 hartree 
E (thermal)        330.583 kcal/mol    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tag  Atom        X                           Y                             Z 
1 C  0.09989  -1.12781  -0.46586 
2 C -1.32999  -1.591598  -0.194566 
3 O -2.20091  -0.467275  -0.222944 
4 C  2.877616  -1.009405   1.663894 
5 C  2.59033  -1.994972  -0.651209 
6 C  2.984757  -1.5051  -2.071749 
7 Si -3.851441  -0.488375   0.104975 
8 C  2.752854  -0.001038  -2.400694 
9 C -5.896042   1.486102   0.220604 
10 C  2.887908   0.899055  -1.152381 
11 C -4.011143   1.917441  -1.390693 
12 C  3.401481   2.305246  -1.3383 
13 C -4.3727   1.350029  -0.00001 
14 C  3.687394   3.017606  -0.237135 
15 C -4.159401  -1.222352   1.822094 
16 C  3.463501   2.405843   1.131618 
17 C -4.747323  -1.553262  -1.179851 
18 C  4.007601   0.96307   1.185599 
19 C -3.63127   2.167003   1.08151 
20 C  3.790035   0.185732  -0.131344 
21 C  1.087026  -2.301073  -0.447949 
22 N  3.159235  -1.041908   0.3247 
23 O  3.33598   0.177481   2.19537 
24 O  2.316443  -1.849428   2.336722 
25 H  0.110521  -0.606799  -1.431141 
26 H  0.364352  -0.394958   0.305396 
27 H -1.376212  -2.088099   0.786335 
28 H -1.637062  -2.326512  -0.9561 
29 H  3.099824  -2.957929  -0.504169 
30 H  2.462768  -2.132882  -2.80272 
31 H  4.052182  -1.722838  -2.200563 
32 H  3.492094   0.297456  -3.156115 
33 H  1.768946   0.150497  -2.857992 
34 H -6.193779   2.544107   0.167355 
35 H -6.207286   1.112106   1.204543 
36 H -6.474601   0.948769  -0.541731 
37 H  1.897576   0.969166  -0.67949 
38 H -4.290865   2.980409  -1.451249 
39 H -4.540581   1.396328  -2.198693 
40 H -2.936102   1.842035  -1.589781 
41 H  3.536852   2.714891  -2.338135 
42 H  4.061597   4.036681  -0.304018 
43 H -3.571002  -0.7123   2.593985 
44 H -3.892543  -2.286507   1.852296 
45 H -5.217695  -1.147872   2.103995 
46 H  2.385565   2.360664   1.347907 
47 H  3.916151   3.008962   1.924481 
48 H -5.828239  -1.583485  -0.991412 
49 H -4.386797  -2.58983  -1.15134 
50 H -4.595644  -1.178672  -2.19935 
51 H  5.069703   0.97827   1.449529 
52 H -3.902763   3.231019   1.00633 
53 H -2.543461   2.091681   0.97015 
54 H -3.88989   1.837136   2.095692 
55 H  4.759028  -0.020772  -0.604225 
56 H  0.988149  -2.827567   0.507133 
57 H  0.817493  -3.021861  -1.234094 
 
Sum of electronic and zero-point Energies   -1313.418361 hartree 
Sum of electronic and thermal Energies   -1313.391520 hartree 
Sum of electronic and thermal Enthalpies   -1313.390576 hartree 
Sum of electronic and thermal Free-Energies  -1313.476356 hartree 
E (thermal)        330.754 kcal/mol    
 
 
 
 
 
 
 
 
 
 
 
 
Tag  Atom        X                           Y                             Z 
1 Si  4.705734  -0.499638   0.37414 
2 C -0.585016  -0.416654   0.541053 
3 C  0.73573   0.200029   0.059486 
4 C  5.81452   0.742876  -0.568694 
5 C  1.948928  -0.57557   0.567115 
6 C  4.890577  -2.263267  -0.289401 
7 C -3.3317  -1.694553  -0.488928 
8 C  5.067611  -0.509137   2.232948 
9 C -1.83691   0.238986  -0.068857 
10 C  7.299133   0.333385  -0.443739 
11 C -2.0723   1.674747   0.438308 
12 C  5.6307   2.160846   0.016495 
13 C -3.359009   2.348462  -0.104196 
14 C  5.420179   0.764846  -2.062409 
15 C -4.511105   1.336139  -0.304616 
16 C -5.914354   1.837718  -0.071859 
17 C -6.914103   0.947027   0.002387 
18 C -6.650314  -0.530319  -0.202129 
19 C -5.327958  -0.995621   0.449134 
20 C -4.278518   0.120216   0.613544 
21 O  3.138812   0.052795   0.105263 
22 N -3.042881  -0.563938   0.246599 
23 O -4.670337  -1.981567  -0.381672 
24 O -2.567771  -2.363711  -1.151492 
25 H -0.607231  -1.478868   0.273045 
26 H -0.657835  -0.359548   1.63715 
27 H  0.767637   0.209909  -1.03863 
28 H  0.835969   1.241309   0.391102 
29 H  1.900308  -1.614598   0.206645 
30 H  1.939661  -0.605215   1.668471 
31 H  5.913227  -2.636871  -0.150524 
32 H  4.655195  -2.323503  -1.358737 
33 H  4.221414  -2.957113   0.235616 
34 H  4.420289  -1.224415   2.756716 
35 H  4.904452  0.477136   2.683656 
36 H  6.104819  -0.803587   2.438307 
37 H -1.716516  0.252766  -1.163322 
38 H  7.937167  1.053952  -0.977147 
39 H  7.493813  -0.654925  -0.879601 
40 H  7.637644   0.313324   0.600341 
41 H -1.202822   2.286596   0.178976 
42 H -2.10605   1.64335   1.536158 
43 H  6.243265   2.884544  -0.542586 
44 H  5.942066   2.216336   1.06751 
45 H  4.587128   2.490633  -0.044044 
46 H -3.667112   3.132142   0.600382 
47 H -3.148697   2.852273  -1.055535 
48 H  6.044387   1.488195  -2.60892 
49 H  4.372608   1.05658  -2.198107 
50 H  5.561605  -0.212479  -2.541402 
51 H -4.451518   0.951977  -1.336431 
52 H -6.095099   2.904763   0.049275 
53 H -7.938552   1.268588   0.177412 
54 H -6.5713  -0.742775  -1.278287 
55 H -7.484384  -1.134834   0.168054 
56 H -5.525976  -1.473305   1.414474 
57 H -4.25187   0.459094   1.655172 
 
Sum of electronic and zero-point Energies   -1313.426696 hartree 
Sum of electronic and thermal Energies   -1313.399441 hartree 
Sum of electronic and thermal Enthalpies   -1313.398497 hartree 
Sum of electronic and thermal Free-Energies  -1313.487079 hartree 
E (thermal)        330.490 kcal/mol    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tag  Atom        X                           Y                             Z 
1 C  4.078718  -1.27728  -0.611926 
2 C  6.168428  -1.78584   0.552494 
3 C  6.293329  -0.307434   0.866296 
4 O  4.83251   1.646519   0.473169 
5 C  4.931063   0.368628   1.148294 
6 C  3.722376  -0.398675   0.606253 
7 N  2.822888   0.684107   0.2311 
8 C  1.550795   0.269312  -0.40121 
9 C  1.839196  -0.671605  -1.593322 
10 C  2.785098  -1.831596  -1.219099 
11 C  3.559873   1.821886  -0.032333 
12 O  3.228128   2.845771  -0.58775 
13 C -1.62076   0.572745   0.137663 
14 C -0.820304   1.068362  -1.066326 
15 O -2.965686   0.339451  -0.262848 
16 C  5.13711  -2.254175  -0.165647 
17 C  0.636114   1.456821  -0.7508 
18 Si -4.203964  -0.21093   0.736274 
19 C -5.751578  -0.229807  -0.388563 
20 C -4.404764   0.957357   2.213285 
21 C -6.978913  -0.730447   0.405063 
22 C -5.511479  -1.166677  -1.593592 
23 C -3.779647  -1.937662   1.390203 
24 C -6.034633   1.195365  -0.913056 
25 H  4.529029  -0.603786  -1.361591 
26 H  6.957864  -2.449701   0.898808 
27 H  6.742305   0.213212   0.008136 
28 H  6.973691  -0.146248   1.708659 
29 H  4.812028   0.562526   2.220538 
30 H  3.26472  -1.028503   1.379383 
31 H  1.05357  -0.330159   0.376042 
32 H  0.892922  -1.075772  -1.971235 
33 H  2.283298  -0.081325  -2.407675 
34 H  3.005135  -2.437492  -2.107675 
35 H  2.29152  -2.499219  -0.495943 
36 H -1.587747   1.329593   0.937451 
37 H -1.188605  -0.354887   0.543758 
38 H -1.334333   1.953694  -1.460623 
39 H -0.8697   0.31083  -1.858745 
40 H  5.049521  -3.310479  -0.415799 
41 H  1.058519   1.998138  -1.602024 
42 H  0.649187   2.165584   0.086305 
43 H -5.229745   0.639675   2.86379 
44 H -4.607092   1.987742   1.896801 
45 H -3.497478   0.973713   2.831079 
46 H -7.868862  -0.743488  -0.241703 
47 H -7.210691  -0.083076   1.26062 
48 H -6.838845  -1.751179   0.78339 
49 H -6.390153  -1.164678  -2.256508 
50 H -5.34375  -2.205689  -1.282098 
51 H -4.646071  -0.848576  -2.186175 
52 H -4.588847  -2.338886   2.013786 
53 H -2.87659  -1.913048   2.014026 
54 H -3.600409  -2.650429   0.576317 
55 H -6.908436   1.186631  -1.582152 
56 H -5.18445   1.593372  -1.478639 
57 H -6.255977   1.896586  -0.098481 
  
Sum of electronic and zero-point Energies   -1313.426011 hartree 
Sum of electronic and thermal Energies   -1313.399014 hartree 
Sum of electronic and thermal Enthalpies   -1313.398069 hartree 
Sum of electronic and thermal Free-Energies  -1313.485449 hartree 
E (thermal)        330.330 kcal/mol    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix B 
 
Transition state energies for 310 – 317 cycloadducts are presented as Z-matrices.  
The following method was used to locate transition state of each cycloadduct at STP: 
 #p opt=(calcall, qst3) freq=savenormalmodes rb3lyp/6-31+g(d) scf=qc geom=connectivity 
All energies are reported in Hartrees. (1 Hartree = 627.503 kcal/mol) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Tag  Atom        X                           Y                             Z 
1 C  0.340769  -1.580315    0.984191 
2 O -2.338423  -0.830444  -0.088293 
3 C -0.357942  -2.2086  -0.227675 
4 Si -3.948385  -0.34194  -0.176729 
5 C  3.253055  -1.232192  -1.198991 
6 C  1.877255  -1.550779   0.873077 
7 C -3.876583   1.560756   0.021009 
8 C  2.571516  -1.040451   2.157127 
9 C -4.941517  -1.169782   1.205936 
10 C  2.442793   0.47318   2.44765 
11 C -4.68231  -0.853315  -1.844197 
12 C  3.132579   1.341965   1.410894 
13 C  4.468832   1.170188   1.0815 
14 C -5.297705   2.161032  -0.069452 
15 C  5.065591   1.739834  -0.061802 
16 C -2.999444   2.170142  -1.09516 
17 C  4.341939   2.468129  -0.993098 
18 C -3.263898   1.92267  1.392251 
19 C  2.828589   0.949075  -1.621948 
20 C  2.083035   0.58514  -0.497409 
21 C -1.881314  -2.17992  -0.127686 
22 N  2.297844  -0.789972  -0.312349 
23 O  3.530912  -0.174165  -2.050532 
24 O  3.779429  -2.322143  -1.280719 
25 H  0.088078  -2.15208   1.888269 
26 H -0.054511  -0.570051   1.142126 
27 H -0.040282  -3.255305  -0.340201 
28 H -0.060131  -1.687661  -1.14577 
29 H  2.232831  -2.569103   0.683173 
30 H  3.633008  -1.309314   2.1046 
31 H  2.154325  -1.60268   3.002499 
32 H -5.984383  -0.827986   1.212073 
33 H -4.516427  -0.962873   2.195434 
34 H -4.961767  -2.259698   1.076248 
35 H  1.383924   0.75323   2.515691 
36 H  2.864666   0.667751   3.445585 
37 H -5.730307  -0.539474  -1.932204 
38 H -4.663754  -1.943889  -1.966766 
39 H -4.130377  -0.417383  -2.685514 
40 H  2.654234   2.288444   1.172862 
41 H  5.036908   0.394511   1.594701 
42 H -5.255353   3.253816   0.050746 
43 H -5.960991   1.775057   0.715268 
44 H -5.771196   1.960493  -1.039018 
45 H  6.059306   1.391418  -0.336199 
46 H -2.934904   3.262206  -0.974102 
47 H -3.411526   1.977991  -2.093813 
48 H -1.979559   1.769054  -1.071546 
49 H  4.817242   2.774483  -1.922489 
50 H  3.500215   3.085271  -0.691809 
51 H -3.19062   3.015554   1.500202 
52 H -2.255517   1.507848   1.506797 
53 H -3.874838   1.554934   2.226366 
54 H  2.517132   1.616263  -2.412686 
55 H  1.143043   1.034056  -0.205805 
56 H -2.311184  -2.703849  -0.994624 
57 H -2.211602  -2.710588   0.779593 
 
1 imaginary frequency    -527.66 hartree 
Sum of electronic and zero-point Energies   -1313.345406 hartree 
Sum of electronic and thermal Energies   -1313.317871 hartree 
Sum of electronic and thermal Enthalpies   -1313.316926 hartree 
Sum of electronic and thermal Free-Energies  -1313.404654 hartree 
E (thermal)        327.363 kcal/mol    
 
 
 
  
 
Tag  Atom        X                           Y                             Z 
1 C  3.346615   1.088241   1.313856 
2 C  2.597953   0.35642   2.40576 
3 C  3.365579   2.460445   1.110561 
4 H  4.192989   0.525735   0.923744 
5 C  2.609084  -1.171533   2.180255 
6 H  1.570984   0.737736   2.492861 
7 H  3.07381   0.554578   3.378547 
8 C  4.00033   3.009182  -0.024415 
9 H  2.706994   3.101049   1.697879 
10 C  1.905338  -1.685397   0.901857 
11 H  3.65455  -1.506816   2.152732 
12 H  2.145782  -1.67136   3.040324 
13 C  4.65559   2.226375  -0.965118 
14 H  2.20616  -2.727251  0.748646 
15 C  3.053491   0.709491  -1.613295 
16 N  2.391074  -0.981513  -0.294697 
17 H  3.7953   4.051363  -0.266071 
18 H  5.177795   1.316421  -0.688404 
19 H  5.011293   2.679967  -1.887614 
20 C -0.34475  -2.25293  -0.215222 
21 H  0.073046  -2.15658   1.904079 
22 H  0.028234  -0.590903   1.111965 
23 C  3.34942  -1.490173  -1.142867 
24 C  2.26924   0.406145  -0.495041 
25 C  0.368972  -1.625684   0.988234 
26 H -0.039251  -1.749036  -1.140365 
27 H -0.047271  -3.306868  -0.315771 
28 O  3.72021  -0.45938  -1.992851 
29 O  3.826155  -2.604916  -1.182891 
30 C -1.866898  -2.197501  -0.111506 
31 H  1.349717   0.908235  -0.232377 
32 O -2.304724  -0.841564  -0.100946 
33 H -2.199388  -2.707473   0.807232 
34 H -2.309247  -2.730501  -0.966235 
35 H  2.80135   1.366151  -2.430517 
36 Si -3.914839  -0.344743  -0.054424 
37 C -3.831327   1.560935  -0.210837 
38 C -4.702001  -0.891334   1.577827 
39 C -4.865389  -1.13762  -1.486359 
40 C -3.192365   1.947745  -1.563166 
41 C -5.252068   2.164008  -0.132821 
42 C -2.97274   2.14465   0.93301 
43 H -5.75818  -0.598115   1.632293 
44 H -4.189326  -0.458605   2.445375 
45 H -4.666237  -1.983366   1.684412 
46 H -5.900623  -0.775683  -1.528088 
47 H -4.911918  -2.228692  -1.375954 
48 H -4.397621  -0.922919  -2.454679 
49 H -3.113904   3.042308  -1.6474 
50 H -3.790012   1.599027  -2.414793 
51 H -2.183621   1.531711  -1.668387 
52 H -5.204249   3.258796  -0.230409 
53 H -5.742864   1.945574   0.824256 
54 H -5.902918   1.796293  -0.936473 
55 H -2.905805   3.239039   0.837538 
56 H -1.952226   1.744905   0.915101 
57 H -3.400692   1.93036   1.920601 
 
1 imaginary frequency    -538.62 hartree 
Sum of electronic and zero-point Energies   -1313.345634 hartree 
Sum of electronic and thermal Energies   -1313.318103 hartree 
Sum of electronic and thermal Enthalpies   -1313.317159 hartree 
Sum of electronic and thermal Free-Energies  -1313.405199 hartree 
E (thermal)        327.397 kcal/mol    
 
 
 
  
 
Tag  Atom        X                           Y                             Z 
1 C  0.778596   1.89335  -1.278992 
2 O -2.816298   1.044824  -0.425163 
3 C -0.406714   1.432205  -0.413695 
4 Si -3.594682  -0.446211  -0.336345 
5 C  2.198921  -0.817528  -1.189106 
6 C  2.194633   1.719149  -0.685619 
7 C -5.003041  -0.160992   0.930367 
8 C  2.276707   2.075926   0.812653 
9 C -2.394503  -1.792112   0.230472 
10 C  3.699727   2.064077   1.41237 
11 C -4.265251  -0.911159  -2.045522 
12 C  4.341789   0.690249   1.418622 
13 C  3.722774  -0.415956   1.981414 
14 C -5.973334   0.923106   0.411007 
15 C  4.155525  -1.738059   1.749214 
16 C -4.408826   0.308717   2.276691 
17 C  5.205651  -2.038434   0.897355 
18 C -5.784808  -1.474562   1.154547 
19 C  4.433713  -1.146442  -1.02584 
20 C  4.189448   0.209914  -0.806875 
21 C -1.690751   1.35097  -1.240673 
22 N  2.805297   0.401562  -0.978292 
23 O  3.213143  -1.760202  -1.274109 
24 O  1.027377  -1.108942  -1.313755 
25 H  0.661925   2.965434  -1.489665 
26 H  0.751506   1.385732  -2.250498 
27 H -0.209052   0.446238   0.014327 
28 H -0.573787   2.132322   0.414566 
29 H  2.846179   2.424119  -1.223339 
30 H  1.625999   1.405552   1.383933 
31 H  1.857061   3.084434   0.925453 
32 H -2.870257  -2.781462   0.212654 
33 H -1.513801  -1.840149  -0.422137 
34 H -2.034978  -1.614046   1.251384 
35 H  3.651748   2.467273   2.435265 
36 H  4.335908   2.761757   0.849096 
37 H -4.824993  -1.854727  -2.012041 
38 H -3.446609  -1.05028  -2.763258 
39 H -4.931814  -0.138418  -2.447016 
40 H  5.417965   0.660007   1.266626 
41 H  2.74162  -0.292265   2.438977 
42 H -6.464213   0.622998  -0.523557 
43 H -5.457358   1.873363   0.230565 
44 H -6.76747   1.108108   1.150693 
45 H  3.497872  -2.545369   2.065466 
46 H -3.738059  -0.441561   2.714303 
47 H -3.843536   1.240756   2.163429 
48 H -5.214104   0.490337   3.005171 
49 H  5.417694  -3.075758   0.648099 
50 H  6.049795  -1.363836   0.786428 
51 H -6.600213  -1.313357   1.876073 
52 H -6.2419  -1.847857   0.228934 
53 H -5.146571  -2.270801   1.55869 
54 H  5.276483  -1.580471  -1.543781 
55 H  4.871158   1.015785  -1.048983 
56 H -1.559227   0.60517  -2.038977 
57 H -1.891811   2.317043  -1.726125 
 
1 imaginary frequency    -527.03 hartree 
Sum of electronic and zero-point Energies   -1313.337616 hartree 
Sum of electronic and thermal Energies   -1313.310299 hartree 
Sum of electronic and thermal Enthalpies   -1313.309355 hartree 
Sum of electronic and thermal Free-Energies  -1313.395678 hartree 
E (thermal)        327.497 kcal/mol   
 
 
 
 
  
 
Tag  Atom        X                           Y                             Z 
1 Si  4.281097    0.586934   0.461629 
2 C -0.941317   0.41144  -0.348162 
3 C  6.977737  -0.30225   0.301553 
4 C  0.469977  -0.071469  -0.715106 
5 C  5.209958  -2.092503   0.330441 
6 C  4.19651   0.609051   2.353283 
7 C  1.536199   0.602856   0.14597 
8 C  4.641072   2.340995  -0.151936 
9 C -3.614455   1.752951  -0.441863 
10 C  5.561447  -0.680102  -0.187086 
11 C -2.013421  -0.004269  -1.377973 
12 C  5.54729  -0.695849  -1.73175 
13 C -2.11155  -1.533717  -1.576193 
14 C -2.476099  -2.36429  -0.318492 
15 C -3.758093  -1.946315   0.381218 
16 C -3.730698  -1.283463   1.599407 
17 C -4.83249  -0.600278   2.15316 
18 C -6.052357  -0.499516   1.498438 
19 C -5.507684   0.516592  -0.376955 
20 C -4.523675  -0.252668  -0.999866 
21 O  2.811273   0.056175  -0.166365 
22 N -3.359346   0.532218  -1.033873 
23 O -4.94492   1.747916  -0.052798 
24 O -2.882458   2.704686  -0.269142 
25 H -0.947435   1.502488  -0.27906 
26 H -1.218562   0.038777   0.645297 
27 H  7.712985  -1.032817  -0.067768 
28 H  7.050453  -0.296331   1.39676 
29 H  7.291911   0.684552  -0.061782 
30 H  0.688303   0.145776  -1.770318 
31 H  0.570389  -1.156721  -0.588052 
32 H  5.932853  -2.828182  -0.053838 
33 H  4.210952  -2.405087   0.005205 
34 H  5.241107  -2.148834   1.426011 
35 H  3.937674  -0.3748   2.76314 
36 H  3.442929   1.324276   2.70759 
37 H  5.156033   0.91146   2.791845 
38 H  1.52501   1.68866  -0.035691 
39 H  1.309789   0.444308   1.212091 
40 H  4.681579   2.389206  -1.246697 
41 H  5.598052   2.712829   0.235993 
42 H  3.865179   3.042517   0.180965 
43 H -1.729918   0.437812  -2.344058 
44 H  6.268174  -1.43629  -2.110819 
45 H  5.828084   0.276838  -2.155418 
46 H  4.558593  -0.960806  -2.123708 
47 H -2.816637  -1.749663  -2.388084 
48 H -1.137765  -1.87456  -1.944359 
49 H -2.534235  -3.418078  -0.623916 
50 H -1.646177  -2.298705   0.396679 
51 H -4.675071  -2.438565   0.067286 
52 H -2.757242  -1.095068   2.053156 
53 H -4.641711   0.056875   2.999202 
54 H -6.419957  -1.318303   0.885181 
55 H -6.831363   0.136974   1.912732 
56 H -6.550136   0.562213  -0.660268 
57 H -4.725031  -0.978748  -1.773075 
 
1 imaginary frequency    -531.47 hartree 
Sum of electronic and zero-point Energies   -1313.336598 hartree 
Sum of electronic and thermal Energies   -1313.308946 hartree 
Sum of electronic and thermal Enthalpies   -1313.308001 hartree 
Sum of electronic and thermal Free-Energies  -1313.396258 hartree 
E (thermal)        327.516 kcal/mol    
 
 
 
  
 
Tag  Atom        X                           Y                             Z 
1 C -1.957226  -0.225425  -0.202675 
2 C -0.659195   0.484128   0.179927 
3 O -3.056602   0.458028   0.381763 
4 C  3.351388  -1.636024   0.198667 
5 C  1.916112   0.394952   0.012161 
6 C  2.175369   1.853694  -0.401703 
7 C  3.418938   2.515597   0.242403 
8 C  4.724236   1.768093   0.05894 
9 Si -4.59725  -0.124497   0.728406 
10 C  5.31129   1.096878   1.120964 
11 C -5.180184   0.940385   2.171108 
12 C  6.34922   0.154228   0.987643 
13 C -4.497751  -1.939369   1.258318 
14 C  6.827258  -0.24632  -0.255003 
15 C -5.7468   0.085099  -0.798049 
16 C  5.056375  -1.075766  -1.173508 
17 C  4.087791  -0.069014  -1.264043 
18 C -5.790568   1.571643  -1.216555 
19 C -7.17806  -0.38331  -0.451235 
20 C -5.225365  -0.749457  -1.989231 
21 C  0.565486  -0.154434  -0.489862 
22 N  3.010964  -0.476166  -0.466486 
23 O  4.570399  -2.053206  -0.303186 
24 O  2.737204  -2.218994   1.067189 
25 H -1.923501  -1.271509   0.136253 
26 H -2.065547  -0.2372  -1.298283 
27 H -0.760498   1.540915  -0.096302 
28 H -0.551932   0.448758   1.272765 
29 H  1.925508   0.326503   1.109699 
30 H  2.225964   1.919374  -1.497427 
31 H  1.298261   2.440936  -0.109102 
32 H  3.501141   3.536031  -0.157059 
33 H  3.223095   2.616126   1.319045 
34 H  5.323862   2.017733  -0.81284 
35 H  4.812145   1.149454   2.089693 
36 H -4.532216   0.779119   3.041444 
37 H -6.208524   0.704801   2.471912 
38 H -5.136754   2.007365   1.922971 
39 H  6.597579  -0.44819   1.858727 
40 H -4.154192  -2.603931   0.456658 
41 H -5.479924  -2.303647   1.585733 
42 H -3.808572  -2.056871   2.104358 
43 H  6.894704   0.462778  -1.076521 
44 H  7.546399  -1.061249  -0.310086 
45 H  5.637837  -1.463724  -1.998997 
46 H  3.934685   0.561095  -2.128075 
47 H -6.424689   1.698366  -2.107408 
48 H -4.792655   1.955345  -1.461439 
49 H -6.208605   2.20876  -0.427179 
50 H -7.842047  -0.253427  -1.319359 
51 H -7.612288   0.192238   0.37611 
52 H -7.210136  -1.445046  -0.175211 
53 H -5.889597  -0.629067  -2.858745 
54 H -5.18451  -1.82196  -1.760195 
55 H -4.222784  -0.433562  -2.302652 
56 H  0.513477  -0.026536  -1.581239 
57 H  0.561169  -1.233755  -0.295264 
 
1 imaginary frequency    -535.07 hartree 
Sum of electronic and zero-point Energies   -1313.343003 hartree 
Sum of electronic and thermal Energies   -1313.315268 hartree 
Sum of electronic and thermal Enthalpies   -1313.314324 hartree 
Sum of electronic and thermal Free-Energies  -1313.403231 hartree 
E (thermal)        327.444 kcal/mol    
 
 
 
 
 
 
 
 
 
 
  
 
Tag  Atom        X                           Y                             Z 
1 C  1.101132  -2.268718  -0.605621 
2 O -2.184078  -0.452605  -0.283993 
3 C  0.120193  -1.089991  -0.539381 
4 Si -3.825285  -0.481219   0.086861 
5 C  2.641499  -1.072293   1.691795 
6 C  2.617607  -1.971092  -0.697283 
7 C -4.356556   1.355018  -0.002401 
8 C  3.097094  -1.395439  -2.053532 
9 C -4.085028  -1.219093   1.810146 
10 C  2.74297   0.073242  -2.41709 
11 C -4.749   -1.548846  -1.176226 
12 C  2.882343   1.062885  -1.280743 
13 C  3.568634   2.26751  -1.351029 
14 C -5.872157   1.485429   0.268612 
15 C  3.757383   3.064571  -0.201689 
16 C -4.043861   1.922565  -1.404878 
17 C  3.253251   2.715849   1.043766 
18 C -3.582316   2.175883   1.052988 
19 C  4.114402   0.629261   1.419862 
20 C  4.049035  -0.0646   0.208798 
21 C -1.30922  -1.572961  -0.297893 
22 N  3.137408  -1.124019   0.406614 
23 O  3.24863   0.005712   2.318744 
24 O  1.824825  -1.781455   2.24099 
25 H  0.942876  -2.898536   0.274914 
26 H  0.869663  -2.890351  -1.482501 
27 H  0.383284  -0.413587   0.280867 
28 H  0.12743  -0.503189  -1.464563 
29 H  3.107733  -2.950941  -0.600399 
30 H  2.702189  -2.057309  -2.833687 
31 H  4.187077  -1.511873  -2.098562 
32 H -5.136329  -1.150743   2.11845 
33 H -3.479799  -0.706451   2.567081 
34 H -3.811009  -2.281581   1.832337 
35 H  3.388274   0.372616  -3.253587 
36 H  1.713311   0.113753  -2.796237 
37 H -4.62257  -1.174166  -2.199165 
38 H -4.385392  -2.584557  -1.15594 
39 H -5.82504  -1.581691  -0.962136 
40 H  2.092907   0.993509  -0.53882 
41 H  4.15148   2.498415  -2.243345 
42 H -6.14832   1.11256  1.263305 
43 H -6.473655   0.943849  -0.472774 
44 H -6.175834   2.542066  0.222955 
45 H  4.487922   3.870525  -0.259752 
46 H -2.976245   1.848896  -1.640813 
47 H -4.326962   2.98512  -1.455682 
48 H -4.600583   1.400765  -2.193963 
49 H  3.534385   3.295964   1.919899 
50 H  2.314829   2.180893   1.148707 
51 H -3.800821   1.842606   2.075493 
52 H -3.864481   3.237863   0.989576 
53 H -2.498882   2.109403   0.901532 
54 H  4.991745   1.065053   1.871228 
55 H  4.888182  -0.185249  -0.458599 
56 H -1.608551  -2.274764  -1.09331 
57 H -1.356128  -2.111973   0.66001 
 
1 imaginary frequency    -542.79 hartree 
Sum of electronic and zero-point Energies   -1313.333210 hartree 
Sum of electronic and thermal Energies   -1313.305700 hartree 
Sum of electronic and thermal Enthalpies   -1313.304756 hartree 
Sum of electronic and thermal Free-Energies  -1313.392375 hartree 
E (thermal)        327.690 kcal/mol    
 
 
  
 
Tag  Atom        X                           Y                             Z 
1 C -0.587718  -0.419208   0.596319 
2 O  3.128494   0.076497   0.140784 
3 C  0.724942   0.208223   0.106995 
4 Si  4.6972  -0.496645   0.358577 
5 C -3.306303  -1.74734  -0.554461 
6 C -1.852049   0.206049  -0.02526 
7 C  5.797269   0.764379  -0.568652 
8 C -2.134398   1.634079   0.471562 
9 C  4.850699  -2.240633  -0.361867 
10 C -3.308094   2.369862  -0.223102 
11 C  5.096176  -0.567016   2.208617 
12 C -4.572651   1.55374  -0.367498 
13 C -5.833148   1.942854   0.062378 
14 C  5.387393   0.820647  -2.057298 
15 C -6.931382   1.06069  -0.006826 
16 C  7.282053   0.348069  -0.468855 
17 C -6.826257  -0.21659  -0.546013 
18 C  5.623924   2.169268   0.050329 
19 C -5.17436  -1.208201   0.605094 
20 C -4.197598  -0.250257   0.902635 
21 C  1.946345  -0.560215   0.60723 
22 N -3.021755  -0.660914   0.248422 
23 O -4.60569  -2.132157  -0.280276 
24 O -2.598541  -2.283291  -1.380973 
25 H -0.592408  -1.485486   0.340298 
26 H -0.659856  -0.35334   1.692074 
27 H  0.749364   0.218033  -0.991143 
28 H  0.819616   1.249956   0.438245 
29 H -1.722233   0.218026  -1.117394 
30 H -1.224917   2.225598   0.323543 
31 H -2.300843   1.605254   1.557052 
32 H  4.594766  -2.26678  -1.427789 
33 H  4.186142  -2.944912   0.154975 
34 H  5.872592  -2.626068  -0.253637 
35 H -3.51432   3.292377   0.335176 
36 H -2.974463   2.678252  -1.225675 
37 H  4.441153  -1.28011   2.72595 
38 H  6.129201  -0.893671   2.384021 
39 H  4.967911   0.409899   2.68996 
40 H -4.531733   0.819827  -1.168343 
41 H -5.935496   2.856127   0.649481 
42 H  5.522079  -0.145931  -2.559473 
43 H  4.339235   1.117779  -2.176282 
44 H  6.007531   1.554861  -2.59372 
45 H -7.825333   1.317358   0.560001 
46 H  7.469002  -0.632333  -0.925536 
47 H  7.915884   1.076834  -0.99599 
48 H  7.632506   0.307442   0.570644 
49 H -6.177465  -0.419347  -1.392501 
50 H -7.665934  -0.903188  -0.46109 
51 H  5.943186   2.199387   1.099971 
52 H  6.235515   2.902874  -0.496636 
53 H  4.581407   2.504725   0.005086 
54 H -5.887163  -1.63464   1.29406 
55 H -4.150886   0.30302   1.827643 
56 H  1.943195  -0.59221   1.708613 
57 H  1.901074  -1.598964   0.245128 
 
1 imaginary frequency    -545.54 hartree 
Sum of electronic and zero-point Energies   -1313.343735 hartree 
Sum of electronic and thermal Energies   -1313.315952 hartree 
Sum of electronic and thermal Enthalpies   -1313.315008 hartree 
Sum of electronic and thermal Free-Energies  -1313.403780 hartree 
E (thermal)        327.531 kcal/mol   
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Tag  Atom        X                           Y                             Z 
1 C -0.635192  -1.490361  -0.780279 
2 O  2.951969  -0.346244  -0.269038 
3 C  0.816841  -1.082501  -1.0889 
4 Si  4.173193   0.257153   0.721685 
5 C -3.538335  -1.890654   0.007196 
6 C -1.573643  -0.312927  -0.449573 
7 C  5.741796   0.214147  -0.373803 
8 C -1.945388   0.547526  -1.673339 
9 C  4.345431  -0.828186   2.263875 
10 C -2.776849   1.807334  -1.348924 
11 C  3.735059   2.016309   1.271126 
12 C -4.119596   1.476699  -0.740061 
13 C -4.972291   2.372782  -0.112721 
14 C  6.051611  -1.242556  -0.784085 
15 C -6.149946   1.923348   0.51983 
16 C  6.946854   0.787927   0.40463 
17 C -6.534051   0.58787   0.51409 
18 C  5.514403   1.055851  -1.648776 
19 C -4.74022  -0.513404   1.36056 
20 C -3.572351   0.158332   0.985071 
21 C  1.609815  -0.597766   0.125124 
22 N -2.784997  -0.76288   0.269115 
23 O -4.707608  -1.768358   0.746172 
24 O -3.307785  -2.837056  -0.714303 
25 H -1.04623  -2.049452  -1.625564 
26 H -0.64114  -2.18692   0.067842 
27 H  1.341392  -1.955338  -1.496618 
28 H  0.859307  -0.311527  -1.868785 
29 H -1.066776   0.33843   0.276154 
30 H -1.017862   0.856644  -2.169324 
31 H -2.491703  -0.080659  -2.390888 
32 H  3.432013  -0.798455   2.872004 
33 H  5.16748  -0.482132   2.903518 
34 H  4.539873  -1.876966   2.009055 
35 H -2.207907   2.475578  -0.685169 
36 H -2.924786   2.368131  -2.284809 
37 H  3.577658   2.684452   0.41585 
38 H  4.528053   2.450636   1.893287 
39 H  2.815985   2.024506   1.871637 
40 H -4.570936   0.578715  -1.157959 
41 H -4.631973   3.390028   0.083454 
42 H  6.942303  -1.274296  -1.429628 
43 H  6.258513  -1.878851   0.085588 
44 H  5.220183  -1.690768  -1.340092 
45 H -6.657605   2.60972   1.196292 
46 H  7.851051   0.758257  -0.221479 
47 H  7.164929   0.213025   1.314025 
48 H  6.790223   1.833985   0.697458 
49 H -7.374872   0.271361   1.127725 
50 H -6.344154  -0.056466  -0.338164 
51 H  4.667556   0.680109  -2.234125 
52 H  5.322953   2.111356  -1.416985 
53 H  6.407647   1.021009  -2.290899 
54 H -5.217127  -0.50066   2.328084 
55 H -3.088931   0.940137   1.554121 
56 H  1.583344  -1.367323   0.912878 
57 H  1.165503   0.318398   0.545234 
 
1 imaginary frequency    -547.59 hartree 
Sum of electronic and zero-point Energies   -1313.340375 hartree 
Sum of electronic and thermal Energies   -1313.312632 hartree 
Sum of electronic and thermal Enthalpies   -1313.311688 hartree 
Sum of electronic and thermal Free-Energies  -1313.400154 hartree 
E (thermal)        327.264 kcal/mol    
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